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Abstract 
Abstract 
In part 1 of  this thesis, the antidiabetic activity of a series of novel oxovanadium(IV) complexes 
was investigated. A range of bidentate N,O-donor ligands, which partially mimic naturally 
occurring bioligands, were prepared and reacted with the vanadyl ion to form the corresponding 
bis-coordinated complexes. Initially, 2-(2ˊ-hydroxyphenyl)-1R-imidazoline (where R = H, ethyl and 
ethanol) ligands were prepared. The aqueous pH-metric chemical speciation was investigated 
using glass electrode potentiometry which allowed for the determination of protonation and 
stability constants of the ligands and complexes, respectively. The species distribution diagrams 
generated from this information gave an indication of how the complexes might behave across the 
broad pH range experienced in the digestive and circulatory systems. This information was used 
to create an improved 2nd generation of ligands that were constructed by combining the imidazole 
and carboxylic acid functionalities. These corresponding bis[(imidazolyl)carboxylato]-
oxovanadium(IV) complexes displayed a br oader pH-metric stability. Both sets of complexes 
improved glucose uptake and reduced coagulation in vitro.   
In part 2 of this thesis, a range of homogeneous and heterogeneous oxovanadium(IV) catalysts 
were prepared. Firstly, Merrifield beads were functionalized with ligands from Part 1 and then 
reacted with vanadyl sulfate to afford the corresponding heterogeneous catalysts. These 
displayed promising catalytic activity for the peroxide facilitated oxidation of thioanisole, styrene 
and ethylbenzene as well as the oxidative bromination of phenol red. Smaller imidazole-
containing beads with higher surface areas than the Merrifield beads were prepared by 
suspension polymerization. These beads similarly demonstrated excellent catalytic activity for the 
oxidation of thioanisole and were highly recyclable. In attempt to increase the exposed catalytic 
surface area, while retaining the ease of separation achieved in the before mentioned systems, 
micron to nano s ized electrospun fibers containing coordinating ligands were fabricated. The 
corresponding oxovanadium(IV) functionalized fibers were applied to the oxidation of thioanisole 
using a continuous flow system. The flexible and porous nature of the fiber mats was well suited 
to this approach. After optimization of the reactant flow rate and catalyst amount, near quantitative 
(> 99%) oxidation was achieved for an ex tended period. In addition, leaching of vanadium was 
mitigated by modification of the attached ligand or polymer material. 
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Chapter 1  
Introduction  
 
 
1.1  Diabetes mellitus – an overview 
Diabetes mellitus is a gr oup of metabolic disorders characterized by elevated plasma glucose 
levels. According to the World Health Organization (WHO), more than 180 million people 
worldwide are currently living with this disorder, with these numbers looking set to double by the 
year 2030.1 In 2005, an estimated 1.1 million people died from diabetes with a projected rise in 
deaths of 50% over the next 10 years. It is estimated that at least 1 in 20 deaths, globally and 
across all ages, are attributable to diabetes.2 About 80% of all diabetes deaths occur in the low 
and middle income segments, with the greatest increases expected in Africa and Asia.3,4 The 
increase in incidence of diabetes in developing countries follows the trend of urbanisation and 
lifestyle changes, perhaps most importantly a “Western-style” diet. The widespread prevalence 
and distribution of this disease is well illustrated in figure 1.1.2  
 
Figure 1.1 Population distribution map of people suffering from diabetes created using MapWindow GIS 
v4.8  
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1.2  Forms of diabetes 
 Diabetes occurs in two main forms; type I (insulin deficiency) and type II (insulin resistance). 
Type I requires insulin injections, whereas type II diabetes can often be controlled using oral 
drugs alone.  
(a) Type 1 diabetes  
Type 1 diabetes was previously termed insulin-dependent diabetes mellitus (IDDM) or juvenile-
onset diabetes. It develops when the body’s immune system destroys pancreatic β-cells, the only 
cells in the body that produce the hormone insulin to regulate blood glucose. This form of diabetes 
usually strikes children and young adults, although disease onset can occur at any age. In adults, 
type 1 diabetes accounts for 5% to 10% of all diagnosed cases of diabetes. Risk factors for type 1 
diabetes may be autoimmune, genetic, or environmental.5 
The principal treatment of type 1 diabetes mellitus, even in its earliest stages, is the delivery of 
artificial insulin via injection combined with careful monitoring of blood glucose levels using blood 
testing monitors. Without insulin, diabetic ketoacidosis often develops which may result in coma or 
death. Treatment emphasis is now also placed on lifestyle adjustments such as diet and exercise 
which can impede the progress of the disease, but not reverse it. Apart from the common 
subcutaneous injections, it is also possible to deliver the insulin by a pump, which allows 
continuous infusion of insulin 24 hours a day at preset levels and the ability to program doses of 
insulin as needed at meal times. An inhaled form of insulin was approved by the FDA in January 
2006, although it was discontinued for business reasons in October 2007.6 Non-insulin 
treatments, such as monoclonal antibodies and stem-cell based therapies, are effective in animal 
models but have not yet completed clinical trials in humans.6 
(b) Type 2 diabetes 
This type of diabetes was formerly called non-insulin-dependent diabetes mellitus (NIDDM) or 
adult-onset diabetes mellitus.6 It results from the body’s ineffective use of insulin. Type 2 diabetes 
mellitus is mainly due to insulin resistance or reduced insulin sensitivity, combined with relatively 
reduced insulin secretion which in some cases becomes obsolete.6 The defective responsiveness 
of the body tissues to insulin almost certainly involves the insulin receptor in the cell membranes. 
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However, the specific defects are not known but the low receptor density is due to destruction by 
ketonic bodies.6 In the early stages of type 2 d iabetes, the predominant abnormality is reduced 
insulin sensitivity, characterized by elevated levels of insulin in the blood. At this stage 
hyperglycaemia can be r eversed by a variety of measures and m edication that improve insulin 
sensitivity or reduce glucose production by the liver.6 As the disease progresses, the impairment 
of insulin secretion worsens and t herapeutic replacement of insulin often becomes necessary. 
Type 2 diabetes mellitus comprises 90% of people with diabetes around the world, and is largely 
as a result of excess body weight and physical inactivity.6  
 
1.3  Current therapy 
In 1921 Banting and Best isolated insulin and demonstrated its ability to lower blood glucose 
levels.6 However, with obesity frequently being the resulting cause of diabetes, the first approach 
in treatment should include a healthy diet and exercise plan that will lead to weight reduction.7 A 
diet alone is often not always sufficient for glycaemic control until it is coupled with antidiabetic 
drugs and occasionally painful insulin injections.8 
(a) Insulin 
Proinsulin is produced in the β-cells of the islets of Langerhans and then converted to insulin in 
the same cells. Proinsulin consists of a s ingle chain containing intramolecular disulfide bridges. 
The center portion, or C-chain, is removed enzymatically resulting in two strands joined by 
intermolecular disulfide bonds, giving active insulin.6 Insulin is utterly necessary for controlling 
type I diabetes and it is usually derived from pork or bovine sources. Insulin is often administered 
as a c omplex with protamine and zinc. This slows down its action, providing longer glucose 
control.6 
(b) Sulfonylureas 
The discovery of sulfonylureas was by chance. It was observed that certain sulphonamides 
(antibacterials) often resulted in hypoglycaemia and hence non-antibacterial sulfonylureas which 
also reduced blood glucose levels were developed.6 These drugs function by stimulating the 
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release of endogenous reserves of insulin from the pancreas and therefore are only effective in 
patients who are still able to synthesise and secrete insulin. Unfortunately, sulfonylureas do not 
always succeed in controlling diabetes. Common side effects include; hypoglycaemia, increased 
appetite and weight gain, as well as an increased cardiovascular risk.9 Glybenclamide and 
tolbutamide (figure 1.2) are two examples of commonly used sulfonylureas. 
glybenclamide tolbutamide  
Figure 1.2 Chemical structures of commonly prescribed sulfonylureas, glybenclamide and tolbutamide 
 
(c) Biguanides 
Similarly to sulfonylureas, the discovery of the biguanides was also serendipitous. It was found 
that a guanidine derivative lowered blood glucose levels in rabbits. This led to the development of 
phenformin (figure 1.3). Unlike sulfonylureas, biguanides lower blood glucose levels without 
stimulating the release of insulin from the pancreas. There are three proposed modes of action: 
1. Inhibition of intestinal transport and absorption of sugars 
2. Inhibition of gluconeogenisis at the liver  
3. Affect metabolism in peripheral tissues by enhancing the uptake of glucose  
Metformin and ph enformin (figure 1.3) were introduced for the treatment of diabetes in the 
1950s.6 Phenformin, however, was withdrawn from clinical use shortly after introduction, leaving 
metformin as the only ‘surviving’ example in this class. 
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Figure 1.3 Chemical structures of the biguanides, phenformin and metformin 
 
Metformin showed the added benefit of reducing weight gain, and even caused weight loss in 
certain patients. While the side-effect profile of metformin is mostly favourable, there are certain 
negatives. Gastrointestinal side effects such as a m etallic taste, nausea, abdominal pain and 
diarrhoea occur in varying severity in up to 30% of patients.9  
(d) Thiazolidinediones 
Thiazolidinediones (TZDs), also known as glitazones, bind to a nuclear receptor known as 
peroxisome-proliferator-activated receptor gamma. This has several downstream effects including 
promoting insulin-stimulated glucose uptake by skeletal muscle cells. Thus, these compounds 
decrease insulin resistance. Furthermore, TZDs also slightly reduce blood pressure, enhance 
fibrinolysis and improve endothelial function.10-12 Some adverse effects of TZDs include; weight 
gain, edema, and an emia.13 This class of drugs is currently represented by rosiglitazone and 
pioglitazone (figure 1.4). 
N
N
O
S
NH
O
O
N O
NH
S
O
O
rosiglitazone pioglitazone  
Figure 1.4 Chemical structures of two thiazolidinediones, rosiglitazone and pioglitazone 
 
(e) Meglitinides 
The meglitinides, repaglinide and nateglinide (figure 1.5), are secretagogues that stimulate rapid 
insulin production by the pancreas. They achieve this by closing adenosine triphosphate (ATP)-
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dependent potassium channels in the membrane of the β-cells. This depolarizes the β-cells, 
opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion. The 
glinides have a faster onset and shorter duration of action than the sulphonylureas and as such 
mimic a more physiological pattern of insulin release. They are associated with a reduced risk of 
hypoglycaemia, cause less weight gain, and are metabolized and excreted by the liver, and so 
can be used in patients with impaired renal function.9 The most common adverse effects include 
hypoglycaemia, weight gain and peripheral edema.14 
repaglinide nateglinide
N
N
H
O
O
O
OH
N
H
O
OHO
 
Figure 1.5 Chemical structures of two meglitinides, repaglinide and nateglinide 
 
1.4  Diabetes associated conditions 
Together with inadequate blood sugar control, there are several other complications associated 
with diabetes, some of which have been listed in table 1.1.15 Approximately 80% of diabetic 
patients pass away due to a thrombotic complication, with 75% of these deaths due to 
cardiovascular complications and t he remainder due to cerebrovascular events and per ipheral 
vascular complications.16 In diabetic patients, the vascular endothelium, the body’s primary 
defence against thrombosis, is abnormal which together with elevated levels of coagulation 
activation markers eg. prothrombin activation fragment 1 and 2, thrombin-antithrombin complexes, 
as well as increased levels of several clotting factors (eg. fibrinogen) puts diabetic patients in a 
hypercoagulable state. In addition to these factors, anticoagulant protein C levels are decreased 
and the fibronolytic system (responsible for removing clots) is less effective due to the abnormal 
clot structures in diabetic patients.16,17 
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Table 1.1 Chronic and acute complications of diabetes15 
Macrovascular 
Retinopathy 
- Impaired vision, blindness 
Nephropathy 
- Proteinuria, chronic kidney disease, dialysis 
Neuropathy 
- Peripheral: sensory (pain, numbness, paresthesias) and motor neuropathy 
- Autonomic: gastroparesis, postural hypotension, impotence 
Macrovascular 
Coronary artery disease 
- Myocardial infraction 
Peripheral vascular disease 
- Claudication, ulcers, amputation 
Cerebrovascular disease 
- Stroke 
Perioral 
Gingivitis 
Periodontitis 
Xerostomia 
Candidiasis 
Oral lichen planus 
Leucoplakia (premalignancy) 
Oral cancer 
Acute complications of diabetes 
Hyperosmolar hyperglycemia 
Diabetic ketoacidosis 
Acute infections 
 
1.4.1  A brief introduction to the coagulation pathways 
The formation of clots is an extremely important hemostatic process. Once an injury to the blood 
vessels has been incurred, platelets aggregate to form a ‘ plug’ (primary hemostasis) which is 
subsequently strengthened by fibrin strands (secondary hemostasis). The coagulation cascade for 
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the latter can be divided into two principal pathways namely the intrinsic and the extrinsic 
pathways which join to form a final common pathway (scheme 1.1).18,19 
 
 
Scheme 1.1 The blood coagulation cascade 
 
(a) The intrinsic pathway 
This pathway begins with Factor XII cleaving and activating its substrates, prekallikrein and Factor 
XI (scheme 1.1). These proteins are anchored to the sub-endothelium by high molecular weight 
kininogen. Prekallikrein is converted to kallikrein which serves to activate Factor XII to Factor XIIa. 
10 
 
 
Part 1. Chapter 1 
After a series of activation steps, Factor IX is activated and forms a complex with activated Factor 
VIII and calcium which binds to the phospholipid rich surface of platelets where activation of 
Factor X occurs. This event marks the end of the intrinsic pathway and the start of the common 
pathway of the coagulation cascade.18,20 
(b) The extrinsic pathway 
The description of the extrinsic pathway was first reported by Marowitz in 1905.15 Damage to the 
endothelium exposes the sub-endothelium, which expresses tissue factor on its cells surface.15 
Once tissue factor is exposed to the blood, circulating Factor VII binds to it to form a TF-Factor VII 
complex which promotes the auto-activation of Factor VII to Factor VIIa (scheme 1.1). In the 
presence of calcium and membrane phospholipids, the TF-Factor VIIa complex proceeds to 
activate Factor X which marks the initiation of the first step of the common pathway.18  
(c) Common pathway 
The activation of Factor X marks the point where the intrinsic and extrinsic pathways converge. 
Factor X is activated on the phospholipid rich surface of activated platelets. Activated Factor Xa 
forms a complex with its activated cofactor, Factor Va, in the presence of calcium which converts 
prothrombin to thrombin. Thrombin is the master regulator of the coagulation cascade. Thrombin 
cleaves activation peptides from fibrinogen to form soluble fibrin monomers which subsequently 
polymerize to form an i nsoluble loose fibrin clot at the site of injury. Thrombin also activates 
circulating Factor XIII which catalyzes the formation of covalent intermolecular crosslink’s 
between fibrin molecules combining the necessary structure for a stable fibrin clot. Thrombin also 
serves to activate surrounding platelets that in conjunction with the clot seal the breach in the 
vessel wall. Finally, thrombin activates Factor V and Factor VIII in a positive feedback loop to 
further amplify the activation of the coagulation cascade.18,20 
Other than treating the elevated blood sugar levels associated with diabetic patients, it is 
important to consider adding an anticoagulatory therapy. Aspirin, for example, has been shown to 
be a highly beneficial treatment and is prescribed for those who are at high risk for cardiovascular 
complications.21 It would be beneficial to create antidiabetic drugs which simultaneously improve 
glucose metabolism as well as reducing the hypercoagulable state of diabetic patients. 
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1.5  Medicinal inorganic chemistry 
Inorganic compounds have been used in medicine for centuries, but with little understanding of 
their mechanism of action.22 Regarding design, it is now known that certain events including; 
hydrolysis, protein binding, membrane transport and molecular targeting should be considered.22 
The discovery of cisplatin and its role as a chemotherapeutic agent in the late 1960’s stimulated 
interests in medicinal inorganic chemistry and the development of new metal complexes to treat 
diseases such as cancer23,24 and diabetes,4,25 to name a few. The unique chemical and physical 
properties of metals also make them ideal for applications in the fields of in vivo imaging26,27 and 
radiopharmaceuticals.28,29  
The investigation of the biochemistry of vanadium has only recently begun to catch up to that of 
its transition metal neighbours in the first row. The interest in vanadium chemistry was initiated by 
the discovery of vanadate as a potent inhibitor of Na+, K+ and ATPase.30 
 
1.5.1 Metals in the treatment of diabetes 
In 1979 Tolman et al.,31 and a bit later in 1981 Degani et al.,32 showed that vanadium was capable 
of affecting glucose metabolism on a cellular level. However, it was not until John McNeill’s work 
in 1985, which focused on the effects of vanadate on elevated blood glucose levels of 
streptozotocin (STZ)-induced diabetic rats,33 that the academic world began to take serious 
notice.34 STZ-induced diabetes is considered to be a model for type 1 diabetes. It is however, 
essential to note that not all the insulin producing pancreatic β-cells are destroyed, and thus some 
insulin is still produced.  This is especially important considering that vanadium compounds do not 
substitute for a c omplete lack of insulin, as is the case in type 1 di abetes, but may alleviate 
dependence on exogenous insulin or possibly substitute for other oral drugs currently used in the 
treatment of type 2 diabetes.35  
Although the simple inorganic salts of vanadium used in these early studies showed great 
potential, the undesirable toxicity and poor intestinal absorption of vanadate and vanadyl shifted 
focus towards designing new organovanadium compounds.36,37 Smart ligand design may help to 
mitigate the latter problem in particular.35 On this note, it is interesting to find that despite the huge 
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toxicity and carcinogenic concerns, chromium(III) supplements have found their way into the 
pharmacy.38 Initially, the activity of these compounds was thought to be v ia binding of Cr3+ (the 
‘safer’ species) to chromodulin, which enhances interactions of insulin with its cellular receptors. It 
has been shown to be quite likely however, that Cr3+ undergoes intra or extracellular oxidations to 
form the genotoxic and carcinogenic Cr6+ and Cr5+, which are possibly the real insulin-enhancing 
species.39 Besides chromium and vanadium, the antidiabetic activities of molybdenum and 
tungsten have also been investigated.40 All of these metals (V, Cr, Mo, W) operate on the same 
basic principle which involves the formation of an ox o anion (for example VO4
3-) which 
subsequently acts as a protein tyrosine phosphatase (PTP) inhibitor.40 Other than these metals, 
zinc, magnesium, arsenic and c obalt have also been proposed as possible adjuncts in the 
treatment of diabetes.41 
Vanadium has been implicated in performing many of the functions related to insulin such as 
inhibition of lipolysis and gluconeogenesis, as well stimulating lipogenesis and cellular glucose 
uptake,42 hence its compounds are loosely termed insulin-mimetics.43,44 Since these compounds 
do still require insulin to control glucose levels, a slightly preferred term is ‘insulin-enhancers’. 
 
1.5.2 Mechanism of action of vanadium complexes 
The true form of the necessary vanadium species under physiological conditions is a subject of 
much debate but a f ocal mechanism of action which seems to enjoy a broad consensus is its 
involvement in the inhibition of phosphate-metabolizing enzymes. The action of vanadium at an 
intracellular level is due to the structural similarity between phosphate and vanadate.45-47 Once the 
vanadium compounds are in the blood they may decompose partially or completely, losing the 
coordinated ligands in the process. In this form the metal ion may undergo a series of complex 
redox processes. Vanadium(V) for example, can be reduced by biological molecules such as 
ascorbic acid, cysteine and glutathione, while non-bound vanadium(IV) is easily oxidised at 
intracellular pH. However, blood-circulating method electron paramagnetic resonance (BCM-EPR) 
studies revealed that almost independently of the initial oxidation state of the vanadium compound 
administered, the metal ion is transported in the +4 oxidation state in the blood. There are 
therefore two possible routes for vanadium to enter the cell. Vanadyl may bind to transferrin (Tf) 
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and subsequently enter the cell via the Tf-receptors following the iron pathway, or it may be 
oxidised to vanadate (H2VO4
-) and enter the cell via the phosphate or sulfate pathways.48 
Nevertheless, once in the cell it is thought that vanadate may bind to and inhibit PTP.49 The 
proposed mechanism is shown in figure 1.6. The processes occurring in this figure are discussed 
below: 
Scenario 1: This is the situation before insulin has bound to its receptor. For simplicity, 
the cell contains only a phosphate (PO4
3- Ch) channel, an insulin receptor with α and β 
subunits, a pr otein tyrosine phosphate (PTP), insulin receptor substrates (IRS) and t he 
glucose transporter – Glut 4. 
Scenario 2: Insulin binds to the insulin receptor (α subunit) on the cell membrane. This 
leads to phosphorylation of a tyrosine residue on the β subunit of the receptor, which in 
turn initiates the phosphorylation of the insulin receptor substrates (IRS) leading to a 
signal transduction cascade that inevitably results in the translocation of the glucose 
transporter Glut 4 to the membrane. At this point glucose may be internalized and 
metabolized. 
Scenario 3: In the absence of insulin as in type 1 diabetes, or lack of an efficient insulin 
response as is the case with type 2 diabetes, PTP counteracts the autophosphorylation of 
the β subunit which subsequently halts phosphorylation of IRS and the associated signal 
transduction. 
Scenario 4: Vanadium enters the cell by either diffusion, endocytosis or via ion channels 
such as phosphate channels, the latter being the likely path for vanadate. Vanadate, a 
known phosphatase inhibitor, then binds to PTP, thereby re-initiating and prolonging 
signal transduction. This mechanism of action involving formation of vanadate and 
binding of this to PTP is supported by crystal structure evidence. Crystals suitable for 
single crystal X-ray diffraction were obtained after soaking a bis-coordinated 
oxovanadium(IV) complex with a PTP.46 This work suggested that the coordination 
complex was oxidized to vanadate along with an associated loss of ligands. Vanadate 
subsequently binds to a serine residue as shown in figure 1.7, thereby giving evidence 
for the likely mode for the inhibition of the enzyme.  
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Figure 1.6 Mechanism of stimulation of glucose uptake by insulin or vanadate43 
 
 
Figure 1.7 Crystal structure of PTP1B (C215S mutant) soaked with an oxovanadium(IV) complex46 
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1.5.3 Antidiabetic vanadium complexes 
As mentioned earlier, McNeill et al., (1985) demonstrated that vanadate was capable of affecting 
glucose metabolism in STZ-induced diabetic rats.25 However, it was nearly a century earlier, that 
the antidiabetic effects of vanadate were first noticed. Fourty-four test subjects with various 
ailments including diabetes, were treated orally over 24 hours, three times per week, with 4-5 mg 
of sodium metavanadate which had been dissolved in water. All of the patients showed an 
increase in appetite, slight weight gain and a general improvement in their physical status. More 
relevant however, was that of the diabetic patients, two out of three experienced a slight decrease 
in blood sugar levels.25,43 Other than the +5 oxidation state of vanadium, vanadyl sulfate, the +4 
oxidation state salt, had also been shown to produce ‘insulin-like’ effects in diabetic rats.50-52 This 
was promising considering the lower toxicity of vanadyl compared to vanadate. The facile 
formation of insoluble vanadyl hydroxides at intestinal pH’s, unfortunately results in poor 
absorption (< 1%). Research in this field declinded until the 1990’s when both Orvig’s group53 and 
slightly later Sakurai’s group54 developed chelated oxovanadium(IV) compounds. The idea behind 
this was that the organic ligands would stabilize vanadyl under physiological conditions as well as 
improve membrane permeability. Indeed these compounds proved successful and since then, the 
drive has been to develop suitable ligands which are capable of stabilizing vanadyl under 
physiological pH.  
The literature is saturated with references to bis(maltolato)oxovanadium(IV) (BMOV) and 
bis(ethylmaltolato)oxovanadium(IV) (BEOV) (figure 1.8) for good reason.4,45,55,56 First tested in 
1992, these highly popular compounds have proven exemplary as insulin-enhancing agents. 
Metal complexes of maltol and its derivatives not only show low toxicity and reasonable intrinsic 
bioactivity,55 but also display the desired properties including water solubility, balanced 
lipophilicity/hydrophilicity, a neutral charge and thermodynamic stability.57 Furthermore, both 
maltol and ethylmaltol are approved food additives in many countries. Considering the 
pharmacokinetic challenges associated with compounds containing both organic and metal 
segments (as is the case in coordination complexes), each of which can form a range of by-
products in the body, it was a h uge advantage that the ligand had at least already undergone 
extensive pharmacological and pharmacokinetic studies.  
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Figure 1.8 Chemical structures of BMOV and BEOV 
 
BMOV not only lowers glucose and l ipid levels, but also delays or possibly prevents long term 
diabetes induced pathology and limits hyperlipidemia and hyperinsulinemia in diabetic rats.55 The 
vanadium uptake in bone, liver and t he kidney tissue was approximately 2-3 times greater for 
BMOV than VOSO4, while the residence time of BMOV was also significantly longer than that of 
VOSO4. BEOV was chosen for clinical studies due to its slightly better hydrolytic stability and 
lipophilicity. Phase I clinical trials of this compound were successfully completed in early 2000. 
The outcomes of this were positive; no volunteers experienced any adverse side effects, 
gastrointestinal, kidney and liver functions as well as blood parameters remained within normal 
levels.58 Phase IIa clinical trials were first disclosed in Lisbon (Vanadium 6 Symposium, Lisbon, 
Portugal, 18 July, 2008), the objectives being to assess the safety and efficacy of the compound 
in type 2 diabetic individuals over a 28-day period. Not only was BEOV well-tolerated in this study, 
but most subjects experienced significant reductions in blood glucose levels compared to those 
subjects taking a placebo.35  
The structurally similar pyridinone derivatives have also been studied. Sakurai et al. found that the 
oxovanadium(IV) complex containing the pyridinone ligand, bis(1,2-dimethyl-3-hydroxy-4-
pyridinonate)oxovanadium(IV) ([VO(dmpp)2]) (figure 1.9), was effective in suppressing the 
release of free fatty acids (FFAs) from rat adipocytes and also had significantly better insulin-
enhancing behaviour than VOSO4.
59,60 These results were confirmed later in a study by 
Passadouro and co-workers.61 After incubation of adipocytes with non-toxic concentrations of 
[VO(dmpp)2], glucose uptake increased by 5-fold compared to the basal level. Furthermore, the 
compound showed a significant inhibitory effect on lipolysis (78%).The pyridinone ligand itself also 
goes by the names of deferiprone and ferriprox and is often used to treat iron-overload and as 
such has been extensively studied.62,63  
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Figure 1.9 Chemical structure of [VO(dhp)2] 
 
Several oxovanadium(IV) complexes with a VO(N2O2) coordination mode have been proposed as 
insulin-enhancers, one of the most successful of these being bis(picolinato)oxovanadium(IV). 
Although synthesized several years ago,55 this compound was only fully characterized and tested 
biologically a while later.54,64 The insulin-enhancing effects of picolinato chelates of 
oxovanadium(IV) have been clearly shown to be dependent on dose as well as delivery method. 
When [VO(pic)2] (figure 1.10) was administered orally to STZ-induced diabetic rats  (0.2 mmol.kg
-
1 for 2 days followed by 0.1 mmol.kg-1 for 11 da ys), plasma glucose levels normalised while 
plasma insulin levels increased.65 However, when administered as a s olution (2.4 mM), as a 
substitute for drinking water, only glucose-lowering tendencies and not insulin-elevation was 
observed. The latter method was also accompanied with signs of gastrointestinal irritation.65 On 
the other hand, comparing [VO(pic)2] with BMOV, the picolinate complex had lower solubility and 
more gastrointestinal irritation for an equivalent dose, suggesting that there is room for further 
structural improvement in order to increase bioavailability and lessen side effects. 
N
O O N
OO
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Figure 1.10 Chemical structure of bis(picolinato)oxovanadium(IV) [VO(pic)2] 
 
Only the most successful oxovanadium(IV) compounds or those most related to this study have 
been discussed, there are several other oxovanadium(IV) complexes that have demonstrated 
antidiabetic activity and there are numerous reviews dealing with these,55,65,66 nevertheless it is 
evident from the above examples that these complexes show excellent promise. There does 
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however remain room for improving the stability and biocompatibility of these complexes by 
appropriate modification of the ligands. 
 
1.6  Vanadium chemistry 
Vanadium was named after Vanadis, the Scandinavian goddess of beauty. It is element number 
23, has an atomic weight of 50.94, and an electronic configuration of 3d34s2 in the ground state.67 
The element was initially thought to have been discovered in 1801 by A.M del Rio in a sample of 
Mexican lead ore. He later withdrew his claim when it was suggested, albeit incorrectly, that the 
sample he found was in fact lead chromate. In 1830, N.G Sefström rediscovered it in Swedish iron 
ore.67 This transition metal is found in about 65 minerals and makes up about  0.014% of the 
Earth’s crust.68 In the marine environment, vanadium is the second most abundant transition 
element (30 nM) only outmatched by molybdenum (100 nM). Vanadium can be found in a variety 
of oxidation states including +5 (yellow), +4 (blue), +3 (green), +2 (lavender) all the way to down 
to -3 (skipping only ox. state of -2) (figure 1.11). V2+ is not stable in aqueous media, rapidly 
oxidizing to V3+, thus only the +5, +4 and +3 oxidation states are biologically relevant. The 
beautiful colours of vanadium were no doubt one of the driving factors for it being named after 
Vanadis.  
 
 
Figure 1.11 The colour of vanadium in biologically relevant oxidation states. From left to right, V5+, V4+, V3+ 
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It has been accepted that VO2+ can be assigned the name oxovanadium(IV), VO3+ 
oxovanadium(V) and VO2
+
 dioxovanadium(V), this removes ambiguity associated with the term 
vanadyl. However, this term is still used to describe ‘simple’ compounds for example vanadyl 
sulfate (VOSO4), whilst anionic complexes are commonly referred to as vanadates. Lately there 
has been a t rend to follow the IUPAC principles and call the VO2+ core oxidovanadium(IV). 
Vanadium chemistry has been recorded as far back as 1801, with reviews dating back to the early 
1900’s.69,70  
The highly stable VO2+ ([Ar]3d1) ion forms anionic, cationic and neutral complexes which may exist 
as solids, liquids or as vapour and the single electron system provides an ideal model for 
theorists.70 High oxidation state metal ions that occur at the beginning of the transition series have 
been known to frequently form stable oxycations.71 The VO2+ ion occurs coordinated to other 
groups in both solid and solution state, elevating the coordination number of vanadium to five or 
six. Oxovanadium complexes have been studied using a wide variety of techniques including, but 
not limited to; potentiometry, polarography, magnetic susceptibility, X-ray diffraction, UV/VIS 
spectroscopy, infrared and Raman spectroscopy, and electron paramagnetic resonance. 
 
1.6.1 Atomic structure and bonding of oxovanadium 
Ballhausen and Gray,71 considered VO2+ in an aqueous solution as the VO(H2O)5
2+
 molecule ion 
to elucidate the molecular orbital description of the vanadyl ion. They proposed that the vanadium 
3d, 4s, and 4p orbitals, along with the 2s, 2pσ (2pz) and 2pπ (2px, 2py) oxide oxygen orbitals, and 
the spσ hybrid oxygen (from water) orbitals were involved in bonding. The possibility of π-bonding 
of water oxygens was regarded as unlikely. The bonding strengths were arranged in the order (V 
– O) > (four square planar waters) > (axial water). With this in consideration, one can predict the 
following (symmetry in parenthesis): 
1. A strong σ bond between the spσ oxygen hybrid orbital and the (4s + 3dz2) vanadium 
hybrid orbitals (a1)  
2. Two π-bonds between the oxygen 2px and 2py orbitals and the vanadium 3dxz and 
3dyz (e)  
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3. Four σ bonds between spσ orbitals of the water oxygens and the vanadium (4s-3dz2) 
(a1), 4px and 4py (e), and 3dx2-y2 (b1) orbitals.  
4. The axial water oxygen is bonded to the remaining 4pz (a1) orbital  
5. The vanadium 3dxy (b2) is non-bonding  
From this information, the energy level scheme was predicted and is shown in figure 1.12. This 
model allowed for the prediction and interpretation of magnetic, electron spin resonance (ESR) 
and optical properties. McGlynn proposed, using a ligand field approach, that the π-bonding of the 
equatorial ligands should not be neglected.72  
This consideration only affects the order of the b1* and eπ*, however these energy levels are so 
close together that the inversion might occur between different complexes.70 This model predicts 
three transitions for the C4v symmetrical VO
2+
 molecular ion: 
 
𝑏2 → 𝑒𝜋
∗  � 𝐵22 → 𝐸2 � 
𝑏2 → 𝑏1
∗ ( 𝐵22 → 𝐵12 ) 
𝑏2 → 𝑎1
∗  ( 𝐵22 → 𝐴12 ) 
 
Bands appearing at a lower wavelength than 200 nm are assumed to be due to charge transfer. 
The lowering of symmetry to C2v has little or no effect on the observed spectra, since the splitting 
of the eπ* level is too small to be observed experimentally most of the time.
71
  
The Ortolano, Selbin and McGlynn (OSM) scheme predicts three visible transitions from the 
ground state, b2 (dxy). These include; dxy → (dxz,dyz); dxz → (dx2-y2) and d xz → (dz2). The first two 
transitions may invert depending on the σ-donor strength of the ligands. The third transition may 
overlap or be c ompletely occluded by charge transfer bands. Insertion of a f ifth or sixth (polar) 
ligand would not be expected to lead to any noticeable effects (figure 1.13).73 
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Figure 1.12 Molecular orbital scheme for the VO2+ species as outlined by Ballhausen71 
 
 
Figure 1.13 Clustered energy level scheme of OSM for vanadyl(IV) complexes73  
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Vanadium exhibits a m ultitude of stereochemical arrangements (figure 1.14), with V(V) 
complexes being founds in tetrahedral, octahedral, trigonal and pentagonal bipyramidal and 
square pyramidal geometries while V(IV) exhibits fewer geometries. Mainly square pyramidal, or 
distorted octahedral (if a sixth position is occupied) are found.74 
 
octahedral square pyramidaltrigonal bipyramidaltetrahedral pentagonal bipyramidal
 
Figure 1.14 Some typical geometries of vanadium compounds 
 
1.6.2  Infrared spectroscopy of oxovanadium complexes 
Evidence of the oxovanadium species can be r eadily detected using infrared. In fact, so 
characteristic is the ν(V=O) mode that attempts have been made to use this stretch to establish a 
certain ligand series, similar to the spectrochemical series. For example, a c omplex of type 
[VO(a)5]
n±
 can be arranged as follows; H2O > NCS
-
 > CN- > DMSO ~ F-, where H2O gives the 
highest VO stretching frequency and F- the lowest. Similarly for [VO(AA)2a] and [VO(AA)2] the 
series order is; ophen > malan2- ~ ox2- > dipy and D BM > acac- > ophen > dipy, respectively.75 
Although similar, this ligand series is not identical, as seen with CN- being displaced from its usual 
extreme spectrochemical position.70 This deviation can be attributed to the fact that metal-ligand 
π-bonding plays a significant role within the spectrochemical series meanwhile infrared vibrations 
are dependant primarily on σ-bonding and only secondarily on metal-ligand π-bonding.70 The 
frequency of the VO stretch can be broken into three components:  
1. σ-Bonding: The V–O bond is a multiple-covalent bond. This consists of electron 
donation from pπ (oxygen)  dπ (vanadium), superimposed on the σ-bond. The 
stretching frequency of this bond will therefore be affected by the donating ability of the 
oxygen to the metal and the capacity of the metal to accept electron density. The latter is 
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largely dependent on the coordinated ligands. Ligands that are strong Lewis bases 
increase the electron density within the d-orbitals of the metal, thereby lowering the V – O 
stretching frequency.  
2. π┴-Bonding: This is the same as for σ-bonding, except that overlaps constitute a 
smaller factor.  
3. π║- Bonding: Contribution of charge from the ligand to the original b2 atomic orbital.  
 
This change in frequency can be written as the sum of these factors, shown below. 
Δν = -σ(LM) - π┴(LM) - π║(LM) 
A wide number of oxovanadium compounds have been characterised in this way, and in general 
the ν(V=O) frequency stretch was summarised by 985±50 cm-1.70 Oxo-bridged oxovanadium 
species, which have been noted to form readily in the presence of air, can be identified using 
infrared. The ν(V=O) stretch appears at comparatively lower wavenumbers of ~920 cm-1, than the 
non-bridged five coordinate species. An additional lower energy band appearing at approximately 
780 cm-1, corresponds to the ν(V-O-V) mode.75 Vanadium can retain its oxidation state of +4 and 
form polymeric rather than bridged structures, the ν(V=O) in such complexes appears shifted to 
lower wavenumbers compared to the monomeric five coordinate species. For example in a bis-
coordinated polymeric 2-(2’-hydroxphenyl)benzoxazole oxovanadium(IV) complex prepared by 
Back et al., this band appeared at 894 cm-1.76    
 
1.6.3  Redox chemistry 
As already mentioned, the three biologically relevant oxidation states of vanadium are +5, +4 and 
+3. The one electron redox couples for the above mentioned oxidation states are presented in the 
equations below, with standard potentials (Eo) and potentials at pH 7 (relative to normal hydrogen 
electrode) shown in parenthesis.43 
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𝑉𝑉𝑂2
+ + 2𝐻+ + 𝑒− ⇌ 𝑉𝐼𝑉𝑂2+ + 𝐻2𝑂   (Eo = +1.016; EpH7= -0.19)  
[𝐻2𝑉𝑉𝑂4]− + 4𝐻+ + 𝑒− ⇌ 𝑉𝐼𝑉𝑂2+ + 3𝐻2𝑂 (Eo = +1.31; EpH7= -0.34)   
𝑉𝐼𝑉𝑂2+ + 2𝐻+ + 𝑒− ⇌ 𝑉𝐼𝐼𝐼 + 𝐻2𝑂  (Eo = +0.359; EpH7= -0.462)  
 
From the above potentials, one can conclude that under aerobic conditions, V5+ is the most stable 
form. However, in oxygen free environments such as the cytoplasm, biological reducing agents 
such as ascorbate, glutathione and NADH may reduce VVO2
+ to VIVO2+ provided that the species 
is not complexed to ligands of any kind (including biological ligands). As can be seen in the above 
redox potentials, vanadate is reduced with greater difficulty, while reduction of VIVO2+ to VIII is 
unlikely under typical physiological conditions.43  
 
1.6.4  Solution chemistry of vanadium 
Orally administered metallo-pharmaceuticals need to survive the acidic pH of the stomach and the 
slightly more alkaline pH of the intestine.77 Vanadyl sulfate, while stable under acidic conditions, 
readily hydrolyzes forming insoluble hydroxides in the slightly more basic pH’s experienced in the 
intestine. The consequence of this is that much less vanadium can be absorbed and thus higher 
doses are required.77 
The aqueous chemistry of vanadate and vanadyl is quite complex due to the formation of 
polyoxometallates and mono/divanadylhydroxy products respectively. This complexity is well 
displayed in the speciation diagrams for V(V) and V(IV) which are shown in figure 1.15 and 
figure 1.16, respectively. The stability constants used for each of these species distribution plots 
were obtained from publications by Pettersson,78 Henry68 and Komura.79,80 Vanadate dissolved in 
acidic solution turns a yellow colour due to the formation of decavanadate (HnV10O28)
6-n (where n 
= 0-3). At pH less than 2, a colourless tetrahydrated VO2
+ monocation forms.  
Considering vanadyl, one can see that at pH values of 6 and greater, there is significant formation 
of insoluble hydroxides. Furthermore, above pH 3, vanadyl is susceptible to oxidation to 
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vanadium(V). This early hydrolysis and facile oxidation can be c ombated to some degree by 
appropriate ligand complexation. Some oxovanadium(IV) complexes for example, possess 
oxidation half-lives several times greater than vanadyl sulfate.81,82 The pH-metric chemical 
speciation of the vanadium compounds can be appropriately designed through the correct 
combination of donor atoms involved in the bidentate coordination of the ligands in order to 
achieve the requisite stabilization under the physiological pH range. 
 
 
Figure 1.15 Speciation diagram for aqueous vanadate (VO2+). Concentration of [VO2+] = 1.0 mM 
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Figure 1.16 Speciation diagram for aqueous vanadyl (VO2+). Concentration of [VO2+] = 10 mM 
 
1.7  Vanadium in biology 
Vanadium can be f ound in reasonably high quantities in many sea-dwelling animals. Ascidians 
typically accumulate large quantities of vanadium, for example Ascidia nigra stores up to 14 500 
ppm of vanadium. In humans vanadium is found in multiple organs and tissues, particularly the 
kidneys, bone, blood, liver, spleen and heart37,45,83 but has also been found in brain and muscle 
tissue in lower concentrations.83 Vanadium is preferentially retained in the bone for longer periods, 
for example the residence time of 48V-BMOV in the bone was 31 days compared to 7 mins in the 
blood for the same compound. Ultimately vanadium is excreted via the urine and faeces.37 In 
healthy humans, vanadium blood concentrations were found to be between 0.18 and 0.22 ppm.84 
The the main sources of vanadium in the diet include; mushroom, fish, black pepper, fresh fruits 
and parsley.85 
 
1.7.1  Biospeciation of vanadium 
For any pharmaceutical drug, the absorption, distribution, metabolism and ex cretion (ADME) 
profiles are of considerable importance. The chelated oxovanadium(IV) complexes typically 
2 6 10 14 
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27 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
undergo a s imilar, albeit relatively complex fate in vivo.86-89 After oral administration the 
complexes enter the acidic conditions of the stomach (pH ~2). Under these conditions a 
coordinated ligand is lost and ionic vanadium species predominate.87,90,91 This is not ideal 
considering that it is believed that these complexes should have a n eutral charge to improve 
lipophilicity and hence cell membrane permeability.65 Nevertheless, it seems enough of the 
complexes survive as they still display improved absorption and tissue accumulation profiles over 
the inorganic salts.37 Of course these complexes can be protected from the harsh stomach 
conditions by tailoring the drug formulation, for example via the encapsulation technique, thereby 
protecting the complex from stomach acidity.92,93 
Once in the blood stream (after absorption), high molecular weight proteins including human 
serum albumin (HSA) and transferrin (Tf) as well as low molecular weight bioligands such as 
lactate, oxalate, citrate and phosphates, bind to vanadium.48,90,94,95 This is thought to be of critical 
importance since these bioligands protect vanadium from forming water-insoluble hydrolysis 
products which have very slow aqueous substitution kinetics and help transport vanadium to the 
relevant site of action.96 An in vitro investigation by Chasteen and co-workers as well as Kiss and 
co-workers, revealed that apo-Tf binds vanadyl much more strongly than HSA, approximately 4 
times more strongly in fact.48,97 Thus, even though HSA is found in significantly higher 
concentrations (~20 times more than Tf), most vanadyl remains bound to Tf making it the primary 
transport protein. Studies using blood circulated method electron paramagnetic resonance (BCM-
EPR) confirmed these results, also indicating that the majority (~77%) of vanadium in the blood 
was bound by Tf, with the remainder presumably being bound by low molecular weight serum 
binders (citrate, lactate, etc). A latter study further showed that vanadium was bound to Tf in the 
+4 oxidation state regardless of the form of vanadium initially administered (either V4+ or V5+).98  
Several years back, Chasteen et al. showed that binding of vanadium to Tf occurred less rapidly 
in the absence of bicarbonate ions (HCO3
-). They subsequently demonstrated that in the absence 
of bicarbonate certain ligands could act synergistically, especially those containing carboxylic acid 
functional groups like citrate and lactate.97,99 It was therefore suspected that ligands such as 1,2-
dimethyl-3-hydroxy-4(1H)-pyridinone (dhp) or maltol (mal) can substitute the synergistic anion and 
improve VO2+ binding. Kiss et al. showed by circular dichroism (CD) and EPR, that incubation of 
Tf with various bis-coordinated oxovanadium(IV) complexes resulted in the formation of ternary 
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complexes. The ternary complexes were in the form (V4+O)Tf(L), (V4+O)2Tf(L)2 and (V
4+O)2hTf(L), 
where L was a bidentate carrier ligand, either maltol (mal) or 1,2-dimethyl-3-hydroxy-4-pyridinone 
(dhp). However a s imilar EPR study using VO(pic)2 revealed that the EPR spectrum of VO
4+-
apoTf was practically the same as that obtained after incubating VO(pic)2 with apoTf, suggesting 
complete ligand displacement.48 While it is certainly interesting to study and understand the 
possible species existing in the blood, how this affects the antidiabetic activity of these complexes 
remains unanswered, especially considering that HCO3
- or other biological anions may substitute 
these ligands.97 
Despite the dominance of Tf as a binder of vanadium, the interactions of the low molecular weight 
bioligands such as citrate, lactate and phosphate with vanadium should not be neglected since 
these may displace the original ligand forming a binary complex, or coordinate to form ternary or 
quinary complexes. This may subsequently affect transport and delivery processes and possibly 
even the physiological activity.91 
In summary, the transport mechanism of oxovanadium(IV) complexes seems similar regardless of 
the ligands used. Once in the blood, the strong binder Tf is capable of abstracting the vanadyl ion 
from the complex. Thus complexes such as VO(mal)2, VO(pic)2 and VO(acac)2 (where mal = 
maltol; pic = picolinate; acac = acetylacetonate) as well as their derivatives are quite likely 
delivered to the target sites as a s imilar vanadium(IV)-serum protein complex.54,100 The ligands, 
therefore serve primarily as transporter molecules, assisting only by shuttling vanadyl from the 
gastro-intestinal tract into the blood stream. This was substantiated by a 48V biodistribution study 
in which 48VOSO4 and 
48V-BMOV were both administered orally to Wistar rats.37 Both exhibited 
similar tissue distribution, however, BMOV accumulated in significantly higher concentrations 
despite the same administration dose.  
 
1.8  Aims and objectives of this study 
The main aim of this study was to prepare and characterize new oxovanadium(IV) complexes and 
evaluate their potential as possible antidiabetic drugs. As previously discussed, the primary 
function of the ligands is to shuttle vanadyl into the blood stream via the stomach and 
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gastrointestinal tract. New ligands are to be designed which are capable of stabilizing vanadyl 
under these conditions as well as imparting a ba lanced lipo/hydrophilicity to the complex, thus 
allowing for adequate absorption. The research objectives can be briefly summarized as follows: 
1. Prepare nature-inspired bidentate ligands containing the N,O-donor atoms and the 
corresponding neutral bis-coordinated oxovanadium(IV) complexes.  
2. Use glass electrode potentiometry to determine the ligand pK’s as well as the stability 
constants of the oxovanadium complexes. This may give an indication of the fate of the 
complexes not only in the stomach and intestine, but also in the blood. 
3. Prepare species distribution diagrams to evaluate the different species existing over the 
biological pH range and use these results to improve the ligand design. 
4. Determine the in vitro cytotoxicity and glucose-lowering effects of the synthesized 
vanadium complexes using three cell culture lines; muscle (C2C12), fat (3T3-L1) and liver 
(Chang) cells. 
5. Investigate the effect of the prepared complexes on the coagulation process using the PT, 
and APTT clotting time assays as well as monitoring the fibrin and D-Dimer formation. 
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Chapter 2  
Experimental materials and methods 
 
2.1  General reagents 
Vanadyl sulfate hydrate was obtained from BDH Limited (England). Methylsalicylate, 
ethylenediamine, N-ethanolethylenediamine, N-ethylethylenediamine, imidazole-4-carboxylic and 
methylimidazole were purchased from Sigma-Aldrich (SA). Unless otherwise stated, all 
complexation reactions were performed under an inert atmosphere of argon. 
Tetramethylammonium chloride (97%) and tetramethylammonium hydroxide (10% solution in 
H2O) were purchased from Sigma-Aldrich (SA). Analytical grade hydrochloric acid (1 N) was 
purchased from Merck (SA). All solvents were obtained from Merck Chemicals (SA) and were of 
reagent grade and used without further purification. Other reagent grade chemicals were also 
obtained from commercial sources and used as received. N-butyllithium (BuLi) (2.5 M, in hexane) 
was purchased from Sigma-Aldrich and stored at 4 °C. Anhydrous diethyl ether was prepared by 
addition of sodium wire. Aqueous hydrogen peroxide (30%) was obtained from Merck and stored 
at 4 °C. 
 
2.2  Techniques and instrumentation 
2.2.1 General instrumentation 
The infrared spectra were recorded on either a Perkin Elmer 2000 FTIR spectrometer in the mid-
IR range (4000 – 400 cm-1) as KBr pellets or a Perkin Elmer 100 ATR-TIR (4000 – 650 cm-1) as 
neat compounds. Melting points were determined using Galenkamp Melting point apparatus 
equipped with a thermometer (0 – 400 °C).  1H and 13C NMR spectra of all ligands were recorded 
on a Bruker AMX 400 NMR MHz spectrometer and reported relative to tetramethylsilane (δ 0.00). 
Electronic spectra were recorded on either a Perkin Elmer Lambda 25 UV-V or Varian Cary 500 
Scan UV-Vis spectrophotometer using 1 cm quartz cells. Microanalysis was carried out using a 
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Vario Elementar Microcube ELIII.  Cyclic voltammetry was performed using a BAS CV 100 Cyclic 
Voltammogram. Potentiometric studies were performed using either a Metrohm 794 T itrino or a 
Metrohm 888 T itrando equipped with a Met rohm LL Ecotrode. The temperature of the jacketed 
vessel was maintained at 25 °C using a Thermo Scientific Haake water circulator. A Bio-Tek KC4 
powerwave XS microtiter plate reader was used to measure absorbance for 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and Glucose assays. 
 
2.2.2 Cyclic voltammetry 
Cyclic voltammograms were recorded using a glassy carbon electrode as the working electrode, 
platinum wire as the counter electrode and s ilver chloride-coated silver wire as the reference 
electrode (when using DMF as the solvent) or a s ilver-silver chloride combination electrode 
(aqueous). Tetrabutylammonium perchlorate or potassium chloride was used as a supporting 
electrolyte. Argon was bubbled through the solutions for 5 minutes before each run. A scan rate of 
100 mV.s-1 was used. 
 
2.2.3 Potentiometric studies 
The protonation and stability constants for the ligands and oxovanadium(IV) complexes were 
determined by potentiometric titration of approximately 25 mL samples. All solutions were 
prepared using freshly boiled and degassed deionized milli-Q water to ensure the removal of 
dissolved oxygen and c arbon dioxide. The ligand concentration was 1 mM and metal-to-ligand 
ratios of 1:1, 1:5 and 1:10 were used. Titrations were performed over the pH range of 2-11 under 
a continuous flow of purified nitrogen using HCl and tetramethylammonium hydroxide (TMAOH). 
The vanadium stock solution containing 0.10 M HCl was standardized by titration with 
permanganate. The ionic strength of the titration solutions was kept constant at 0.10 M 
tetramethylammonium chloride (TMACl). Titrations were controlled using Tiamo 2.0 software. The 
glass electrode was calibrated for a strong acid-base reaction by the Gran-method1 using GLEE,2 
which allows one to determine the standard potential E°. The ionic product of water (pKw) of 
13.83(1) at 25.0±0.1  °C in 0.10 M TMACl was used in all calculations.3 The hydrolysis model of a 
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vanadyl system was included in the model; [VO(OH)]+ (logβ1-1 = -5.94), [(VO)2(OH)2]
2+ (logβ2-2 = -
6.95), [VO(OH)3]
- (logβ1-3 = -18.0)
4 AND [(VO)2(OH)5]
- (logβ2-5 = -22.0).
5 Where relevant, the 
Davies equation was used when taking into consideration different ionic strengths.6 The 
concentration stability constants βpqr = [MpLqHr]/[M]
p[L]q[H]r were calculated by using the computer 
program HYPERQUAD.7 The final values of the constants were obtained from an average of six 
independent titrations using an average of 400 data points in total for each refinement.    
 
2.2.4 X-ray crystal structure resolution and refinement 
Intensity data for [VO(pimin)2] and [VO2(pimin)(piminHˊ)] (Part 1, Chapter 3) were collected on a 
Bruker APEX II CCD area detector diffractometer with graphite monochromated Mo Kα radiation 
(50 kV, 30 mA) using the APEX 2 data collection software.8 The collection method involved ω-
scans of width 0.5° and 512x512 bit data frames. Data reduction was carried out using the 
program SAINT+9 and absorption corrections were made using the program SADABS.9 
The crystal structures were solved by direct methods using SHELXTL.10 Non-hydrogen atoms 
were first refined isotropically followed by anisotropic refinement by full matrix least-squares 
calculations based on F2 using SHELXTL. Hydrogen atoms were first located in the difference 
map then positioned geometrically and allowed to ride on their respective parent atoms. Diagrams 
and publication material were generated using SHELXTL, PLATON11 and ORTEP-3.12 
 
2.2.5 Biological studies 
(a) Maintenance of cells lines  
3T3-L1 preadipocytes, were maintained in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), while C2C12 mouse skeletal myoblasts and 
Chang liver cells were maintained in RPMI-1640 medium (Sigma) supplemented with 10% FBS. 
These were incubated at 37 °C in a humidified incubator with 5% CO2. Cells were subcultured at 
70% confluence and seeded at a density of 35 000 cells.mL-1 (for 3T3-L1) and 25 000 cells.mL-1 
(for Chang and C2C12) in 24-well culture plates.  
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(b) MTT Cytotoxicity studies 
Cells were seeded in 24 well plates (Nunc) at densities of 25 000 cells.mL-1 for C2C12 and Chang 
liver cells, and 35 000 cells.mL-1 for 3T3-L1. After overnight attachment, the culture medium was 
replaced with medium containing the test compounds at a range of concentrations (0.5-100 μM). 
Cells were incubated for 24 hours at 37 °C after which the MTT (Sigma) assay was performed.13  
(c) Glucose uptake studies 
The glucose uptake assay was performed using the GLUCOSE (Glu-cinet) kit (BAUER).14 Control 
cells were represented by untreated differentiated fat (3T3-L1), liver (Chang) and muscle (C2C12) 
cells (Con) incubated in culture media. Positive control cells (Met) were represented by untreated 
differentiated fat, liver and muscle cells exposed to metformin. Cells were then exposed for 48 
hours to the test compounds. Thereafter glucose uptake was determined and the cell number was 
normalized using the MTT assay.13 
(d) Anticoagulation studies 
The effect of the various vanadium compounds on blood coagulation was investigated using a CL 
Coagulation Analyzer (Beckman). The assays used were the HemosIL® activated partial 
thromboplastin time (APTT), prothromin time (PT), Fibrinogen (Fib)-C, and D -Dimer as per the 
instructions which can be found on the manufacturers website.15 The APTT assays were 
performed by adding the test compounds, positive control or diluent, and APTT reagent to 
plasma. This was incubated for 3 minutes at 37 °C  followed by addition of CaCl2 to initiate 
coagulation. PT was performed by incubating PT reagent and treatments followed by the addition 
of plasma. Fib-C was performed by treating diluted plasma [1:4 (v/v)], incubating, and a dding 
bovine thrombin. D-Dimer was performed by adding treatments and r eaction buffer to plasma, 
hereafter D-Dimer latex reagent was added, the vial was mixed 1-2 times and the agglutination 
measured. Vanadium compounds were used at 10 μM for screening assays and 0.01 μM, 0.1 μM, 
and 10 μM for concentration dependence studies, positive control was heparin at 0.1 U.mL-1. 
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(e) Statistical Analysis 
Error bars indicate the standard error of the mean (SEM) unless specified otherwise (n = 3). The 
two-tail paired test was used to determine significance of results (p<0.05) and (p<0.01).  
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Chapter 3  
Oxovanadium(IV) complexes with 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands 
 
 
3.1  Introduction 
There have been several studies concerning the preparation and characterization of 
oxovanadium(IV) complexes with ligands containing N,O-donor atoms.1-6 Many of these 
complexes have proven to be ef fective insulin-enhancers. The oxovanadium(IV)-picolinate 
complex, VO(pic)2, probably the most successful of the lot, was capable of inhibiting free fatty acid 
release as well as lowering glucose levels.1  
The 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands prepared in this study are structurally related to 
the naturally occurring 2-(2ˊ-hydroxyphenyl)-2-oxazoline and thiazoline ligating moieties found in 
siderophores – a class of microbial iron chelators.7,8 In terms of hard and soft acid base theory 
(HSAB), oxovanadium(IV) being a hard acid, should form a stable complex with the relatively hard 
phenol oxygen and imidazoline nitrogen bases. Furthermore, with the phenol group deprotonated 
each ligand holds a -1 charge. Thus, upon reaction of two of these ligands with vanadyl (VO2+), a 
neutral complex forms – a prerequisite for effective metallopharmaceuticals.9 The imidazoline 
moiety is also structurally similar to imidazole, a c hemical functionality abundant in biological 
systems. Imidazole forms part of the side chain of the amino acid histidine and commonly plays a 
role in metal coordination in metalloenzymes.10,11 As shown in figure 3.1, the proposed binding 
modes for the binary vanadyl-apoTf species involve coordination of a proximal phenol group from 
a tyrosine residue (TYR92) and an imidazole group from a hi stidine residue (HIS253). The 
resultant ligation is thus quite similar to that of the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligand. 
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Figure 3.1 The proposed coordination environment of the vanadyl-transferrin binary complex 
 
Other than stable complex formation, another important property to consider when designing 
metallopharmaceuticals includes imparting an optimal lipophilicity/hydrophilicity balance, such that 
the complexes while being water soluble, may still be sufficiently lipophilic to cross cell 
membranes.9 The ethyl substituted complex bis(ethylmaltolato)oxovanadium(IV), for example, 
demonstrated improved lipophilicity as well as hydrolytic stability, and as such this compound 
rather than the methyl derivative, bis(maltolato)oxovanadium(IV), was taken to clinical trials.12  
Beyond optimizing the physico-chemical properties of the complexes, it may be beneficial to 
consider using ligands which exhibit certain therapeutic effects. This is by no means a nov el 
idea.13,14 Vanadyl-biguanide complexes have been prepared and tested for antidiabetic activity 
and while there were no positive associative effects observed in this study, the possibility for using 
therapeutic ligands remains an ex citing option.13 In this regard, several imidazoline-containing 
compounds have in fact been shown to exhibit antihyperglycemic activity.15-18 The exact 
mechanism of action remains debatable; however they are thought to act either by α2-
adrenoreceptor activation or via activation of I1 imidazoline receptors.
15 While this is undoubtedly 
interesting, it should be noted that the antidiabetic activity of the ligands themselves is beyond the 
focus of this study but could be examined in the future.  
In this chapter, the synthesis and c haracterization of a s mall series of oxovanadium(IV) 
complexes with 2-(2ˊ-hydroxyphenyl)imidazoline, 2-(2ˊ-hydroxyphenyl)-ethylimidazoline and 2-(2ˊ-
hydroxyphenyl)-1-ethanolimidazoline as coordinating ligands is presented. The protonation 
constants of 2-(2ˊ-hydroxyphenyl)-ethylimidazoline and 2-(2ˊ-hydroxyphenyl)-1-ethanolimidazoline 
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as well as the stability constants of these with oxovanadium(IV) were determined using glass 
electrode potentiometry. This gives an indication as to whether the complexes would stabilize 
vanadyl across a biological pH range. The anticoaulatory effect was evaluated by a range of 
assays while the antidiabetic potential of these complexes was assessed via an in vitro assay 
using 3T3-L1 adipocytes, C2C12 muscle cells and Chang liver cells. 
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3.2  Preparative work 
3.2.1 2-(2ˊ-hydroxyphenyl)-1H-imidazoline (piminH). 
Methyl salicylate (1.84 g, 0.012 mol) was added to an excess of ethylenediamine 
(3.2 g, 0.053 mol) in a conical flask and heated in a microwave for 7 minutes at 180 
W. Excess ethylenediamine was distilled off under reduced pressure until a solid material was left 
behind. This solid was then digested overnight in chloroform, filtered and then washed with cold 
chloroform to afford a cream solid. Yield: 78.1%. 1H NMR (δ, 400 MHz, DMSO-d6): 3.71 (s, 4H, 
Im-CH2), 6.69 (t, 1H, Ar-H) 6.77 (d, 1H, Ar-H), 7.27 (t, 1H, Ar-H), 7.56 (d, 1H, Ar-H). 
13C NMR (δ, 
100 MHz, DMSO-d6): 46.5, 110.2, 115.5, 118.4, 127.2, 132.7, 163.5, 166.1; IR (cm
-1, KBr disk): 
3217, ν(N-H); 1618, ν(C=N). Anal. Calcd (Found) for C9H10N2O (%): C, 66.65 (66.68); H, 6.21 
(6.20); N, 17.27 (16.98). 
3.2.2 2-(2ˊ-hydroxyphenyl)-1-ethylimidazoline (EtpiminH).  
This was prepared in a similar manner as above (3.2.1) except that N-
ethylethylenediamine was used. Yield: 50.3%. 1H NMR (δ, 400 MHz, CDCl3): 1.26 
(t, 3H, N-CH2CH3), 3.39-3.44 (q, 2H, N-CH2), 3.48-3.53 (t, 2H, Im-CH2), 3.89-3.94 
(t, 2H, Im-CH2),  6.76 (t, 1H, Ar-H), 6.98 (d, 1H, Ar-H), 7.27 (t, 1H, Ar-H), 7.36 (t, 1H, Ar-H). 
13C 
NMR (δ, 100 MHz, CDCl3): 14.48, 45.52, 50.47, 50.92, 112.31, 117.11, 118.66, 127.31, 132.16, 
162.19, 167.09. IR (cm-1, KBr disk): 1608, ν(C=N); Anal. Calcd (Found) for C11H14N2O (%): C, 
69.45 (69.54); H, 7.42 (7.67); N, 14.73 (14.44). 
3.2.3 2-(2ˊ-hydroxyphenyl)-1-ethanolimidazoline (EtOHpiminH).  
This was prepared in a similar manner as for piminH above (3.2.1), except that N-
ethanolethylenediamine was used. Yield: 54.1%. 1H NMR (δ, 400 MHz, D2O): 
3.56-3.59 (t, 2H, N-CH2), 3.78-3.81 (t, 2H, N-CH2CH2), 4.03-4.19 (m, 4H, Im-CH2), 
6.67-6.71 (t, 1H, Ar-H), 6.75-6.77 (d, 1H, Ar-H), 7.26-7.28(d, 1H, Ar-H), 7.40-7.45 (t, 1H, Ar-H).  
13C NMR (δ, 100 MHz, D2O): 43.13, 49.15, 49.19, 58.18, 112.21, 114.18, 121.81, 130.19, 134.93, 
166.02, 169.49. IR (cm-1, KBr disk): 3138 ν(O-H);  1612, ν(C=N). Anal. Calcd (Found) for 
C11H14N2O2 (%): C, 64.06 (64.31); H, 6.84 (6.55); N, 13.58 (13.44). 
N
N
HO
N
N
HO
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N
H
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3.2.4 [VO(pimin)2] 
To a s olution of piminH (0.25 g, 1.5 mmol) in methanol (5 mL) was 
added vanadyl sulfate (0.152 g, 0.70 mmol) in water (5 mL). A blue-
green precipitate formed immediately. The reaction was allowed to 
proceed for a further 2 hours. The precipitate was collected, washed with water, then methanol 
and dried at 100 °C. Yield: 56.9%. IR (cm-1, KBr disk): 944, ν(V=O); 3260, ν(N-H); 1609, ν(C=N). 
Anal. Calcd (Found) for C18H18N4O3V (%): C, 55.53 (55.43); H, 4.66 (4.74); N, 14.39 (14.16). 
UV/Vis (DMSO) λmax (ε, M
-1cm-1): 617 (55), 542 (44), 403sh (196).   
3.2.5 [VO2(pimin)(piminHˊ)] 
Upon standing the synthetic mother liquor of [VO(pimin)2] at room 
temperature and und er aerobic conditions, yellow crystals of 
[VO2(pimin)(piminHˊ)] were obtained. Yield wrt V: 12.3%. IR (cm
-1, KBr 
disk): 913, 882, ν(V=O); 3346, ν(N-H); 1617, ν(C=N). Anal. Calcd (Found) for C18H19N4O4V (%): 
C, 53.21 (53.14); H, 4.71 (4.71); N, 13.79 (13.82). 
3.2.6 [VO(Etpimin)2]  
This was prepared in a similar manner as for [VO(pimin)2] above except 
that EtpiminH was used. Yield: 47.6%. IR (cm-1, KBr disk): 987, ν(V=O); 
1602, ν(C=N). Anal. Calcd (Found) for C22H26N4O3V (%): C, 59.32 
(59.04); H, 5.88 (5.88); N, 12.58 (12.27). UV/Vis (DMSO) λmax (ε, M
-1cm-1): 621 (120), 547 (99), 
401sh (300). 
3.2.7 [VO(EtOHpimin)2]  
This was prepared in a similar manner as for [VO(pimin)2] except 
that EtOHpiminH was used. Yield: 52%. IR (cm-1, KBr disk): 966, 
ν(V=O); 1603, ν(C=N). Anal. Calcd (Found) for C22H26N4O5V (%): 
C, 55.35 (55.30); H, 5.49 (5.63); N, 11.74 (11.66). UV/Vis (DMSO) 
λmax (ε, M
-1cm-1):  625 (84), 548 (66), 404sh (269). 
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3.3 Results and discussion 
3.3.1 Synthesis and general considerations 
The ligands were synthesized according to a modified method by Parik et al.19 with the main 
exception being the use of a conventional household microwave. The use of a microwave allowed 
us to reduce the reaction time from 11 hours to 7 mins, whilst increasing the yield from 50.3 to 
78.1% for piminH. The 2-(2ˊ-hydroxyphenyl)-1-ethylimidazoline (EtpiminH) and 2-(2ˊ-
hydroxyphenyl)-1-ethanolimidazoline (EtOHpiminH) ligands were prepared by substituting 
ethylenediamine with N-ethylethylenediamine and N-ethanolethylenediamine, respectively. The 
goal of including the ethyl and ethanol substituents, was to obtain a small range of compounds 
with different lipo/hydrophilicity, since a delicate balance is required for optimal absorption of 
these metallopharmaceuticals.20  
NMR spectroscopy was used as the primary tool to confirm the successful preparation of the 
ligands. In all 1H NMR spectra, four peaks corresponding to the aromatic di-substituted benzene 
ring were found between 6.5 and 7.6 ppm. Of these four peaks, two were split into doublets and 
the remaining two into triplets (figure 3.2). This corresponds to the substitution pattern of the 
benzene ring (i.e. the two triplets corresponding to the protons at the 4 a nd 5 position of the 
benzene ring and the doublets corresponding to the protons at the 3 and 6 position). The 
methylene protons of the alkyl substituent’s (EtpiminH and EtOHpiminH) as well as the methylene 
protons from the imidazoline ring, appear upfield from the aromatic region as expected. For 
piminH, the imidazoline CH2s appear as a broad singlet, however substitution at the N-H position 
with either an ethyl or ethanol group, alters the chemical environment of the imidazoline CH2s and 
thus separates these signals as shown for EtpiminH in figure 3.2. The 13C NMR spectrum shown 
in figure 3.3 further confirmed the structure with all the expected carbon signals being accounted 
for. NMR analysis of the complexes was not performed due t o the paramagnetic nature of d1 
VO(IV) metal ion.   
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Figure 3.2  1H NMR spectrum of 2-(2ˊ-hydroxyphenyl)-1-ethylimidazoline (δ ppm). The insert shows an 
expanded view of the aromatic region  
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Figure 3.3 13C NMR spectrum of 2-(2ˊ-hydroxyphenyl)-1-ethylimidazoline (δ ppm). Solvent peak (CDCl3) 
has been omitted  
 
The oxovanadium(IV) complexes were synthesized by addition of an aqueous vanadyl sulfate 
solution to a methanolic solution of the corresponding ligand in a 1:2 (metal:ligand) molar ratio 
(scheme 3.1), under an argon atmosphere. The complexes which precipitated out of solution 
were easily collected by filtration. All of these complexes were soluble in various alcohols, DMF 
and DMSO. Both [VO(Etpimin)2] and [ VO(EtOHpimin)2] were soluble in dichloromethane, 
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acetonitrile and slightly soluble in water. Upon standing the mother liquor of [VO(pimin)2] in open 
air at room temperature, the colour of the solution changed from green (symbolic of V4+ in this 
case) to a yellow-green (possibly a m ixture of V4+ and V5+), due to hydrolysis and c oncurrent 
autooxidation. After a few days, yellow crystals deposited and were collected, filtered and dried. 
The yellow crystals were later identified as the dioxovanadium(V) species by single crystal X-ray 
crystallography.  
This facile autooxidation incited us to study the oxidation potentials of these complexes which was 
carried out using cyclic voltammetry. The cyclic voltammograms are shown in figure 3.4. All of the 
complexes display irreversible V4+ – V5+ oxidation peaks between 400 – 490 mV. The Epa for 
[VO(pimin)2], [VO(Etpimin)2] and [ VO(EtOHpimin)2] appeared at 490, 440 and 400 m V, 
respectively. These low oxidation potentials correspond well to the observed facile autooxidation 
upon exposure to air. 
 
.
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Scheme 3.1 Preparation of [VO(pimin)2] and [VO2(pimin)(piminHˊ)]. The other oxovanadium(IV) complexes 
were prepared in a similar fashion 
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Figure 3.4 Cyclic voltammograms of complexes [VO(pimin)2], [VO(Etpimin)2] and [VO(EtOHpimin)2] in 
DMSO 
 
All of the ligands display infrared stretching frequencies between 1618 to 1608 cm-1 which can be 
assigned to the azomethine (C=N) stretch.19,21 The ν(N-H) of piminH appears at 3346 cm-1, and 
the alcohol stretch for EtOHpimin appears at 3125 cm-1, the position of the latter band indicating 
strong intramolecular hydrogen bonding.22 Coordination to oxovanadium(IV) was evident from a 
~9 cm-1 shift of the (C=N) stretch to lower frequencies.23 The uncoordinated ligands show 
phenolic ν(C-O) stretches between 1287-1269 cm-1 which upon coordination shift to a hi gher 
wavelength of 1313-1319 cm-1.24 This suggested that coordination was likely taking place via the 
azomethine nitrogen and t he phenolate group in a b identate fashion. Furthermore, the ν(V=O) 
bands appear at 941, 987 and 965 cm-1 for [VO(pimin)2], [VO(Etpimin)2] and [VO(EtOHpimin)2] 
respectively, and are within the reported range for V=O stretches of 930-1030 cm-1.25 For the 
dioxovanadium(V) complex [VO2(pimin)(piminHˊ)], two ν(V=O) bands appear at 913 and 881 cm
-1. 
The higher energy band is assigned to the νas stretch and the lower energy band is assigned to 
the νs stretch of the cis-VO2
+ moiety.26 The IR spectra of the oxovanadium(IV) complexes are 
shown in figure 3.5. 
In general, square-pyramidal oxovanadium(IV) complexes display three low intensity d-d 
transitions in the range of 330-1000 nm.27 The high energy transition, (a1←b2), occurs between 
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401 - 404 cm-1 (ε = 196 - 300), while the (b1←b2) and (eπ←b2) transitions fall in the range 538-545 
cm-1 and 617 - 625 cm-1. As shown in figure 3.6 for [VO(pimin)2], the higher energy transition is 
much more intense as it appears as a shoulder to the charge transfer band.  
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Figure 3.5 Stacked IR spectra of [VO(pimin)2], [VO(Etpimin)2] and [VO(EtOHpimin)2], in the range 4000 – 
650 cm-1 
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Figure 3.6 Electronic spectrum of [VO(pimin)2], in DMSO. Insert shows an expanded view of the region 
between 450-700 nm 
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After several attempts blue-green crystals of [VO(pimin)2] suitable for X-ray crystallography were 
obtained upon recrystallization of the compound in acetonitrile at -20 °C. If heating or sonication 
was used to assist dissolution of the compound, the solution rapidly turned yellow indicating 
oxidation had taken place. The yellow crystals of [VO2(pimin)(piminHˊ)] were obtained after 
standing a m ethanolic mother liquor of [VO(pimin)2] at room temperature for 2-4 days. The 
ORTEP diagrams for the structures of [VO(pimin)2]and [VO2(pimin)(piminHˊ)] are represented by 
figures 3.7 and figure 3.8 respectively. The bond lengths and angles are presented in table 3.1 
and other selected crystallographic data in table 3.2.  
For [VO(pimin)2], the V=O bond length of 1.619(2) Å is slightly longer than those observed for 
similar compounds, which fall in the range of 1.591-1.605 Å.3,6 The geometry of [VO(pimin)2] (τ = 
0.49)28 falls between trigonal bipyramidal (τ = 1) and square pyramidal (τ = 0) and sits on a 
crystallographic two-fold axis. Vanadium is situated 0.550 Å above the plane defined by the N2O2 
ligand donor atoms and the N(1)-V(1)-O(2) and O(1)-V(1)-O(2) angles are 99.12(6) and 
113.92(6)° respectively. The N(1)-V(1)-N(1) and O(1)-V(1)-O(1) angles in the equatorial plane are 
161.8(1) and 132.2(1)° respectively, showing marked deviations from an ideal of 180° expected 
for a square pyramidal geometry. 
The bidentate ligand coordinates through the neutral imidazoline nitrogen and phenolate oxygen 
resulting in the formation of the neutral bis[(imidazolinyl)phenolato]oxovanadium(IV) complex. The 
average bite angle of the ligands is 86.32(8)°. The V(1)-O(1) and V(1)-N(1) bond lengths have 
averages of 1.911(1) and 2.048(2) Å respectively. The imidazoline and phenyl rings are not co-
planar, and h ave an a verage dihedral angle of 20.11° between them. As expected, the 
imidazoline ring is not planar with the torsion angles C(9)-C(8)-N(1)-C(7)=13.4(3)° and C(8)-C(9)-
N(2)-C(7)=16.9(3)°. 
The five-coordinate dioxovanadium(V) complex, [VO2(pimin)(piminHˊ)] adopts a highly distorted 
trigonal bipyramidal geometry (τ = 0.59) with O(1), O(3) and O(4) forming the trigonal plane. The 
deviations in this plane are given by O(1)-V(1)-O(3)=128.05(9)°, O(1)-V(1)-O(4)=123.40(9)° and 
O(3)-V(1)-O(4)=108.3(1)°. The N(1)-V(1)-O(2) at 159.02(8)° is also far from the ideal of 180°.  
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Figure 3.7 ORTEP diagram of [VO(pimin)2], showing 50% thermal probability ellipsoids 
 
 
Figure 3.8 ORTEP diagram of [VO(pimin)(piminHˊ)], showing 50% thermal probability ellipsoids 
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The V(1)-O(3) and V(1)-O(4) at 1.617(1) and 1.648(1) Å are within the lengths expected for a five-
coordinate dioxovanadium(V) system.26 One of the ligands attaches to the dioxovanadium(V) 
center in a monodentate fashion through the phenolate oxygen while the other ligand attaches in 
a bidentate manner through the imidazoline nitrogen (N1) and phenolate oxygen (O1) with a bite 
angle of 81.56(8)°. The imidazoline nitrogen (N3) of the mono-coordinated ligand is protonated to 
afford a positively charged species which neutralizes the extra negative charge resulting from the 
two phenolate oxygens and the two dioxo ligands, and the vanadium(V) center. 
 
Table 3.1 Selected bond lengths (Å) and angles (°) for [VO(pimin)2] and [VO2(pimin)(piminHˊ)] 
[VO(pimin)2] [VO2(pimin)(piminHˊ)] 
V(1)-O(2) 1.619(2) V(1)-O(3) 1.617(1) 
V(1)-O(1) 1.911(1) V(1)-O(4) 1.648(1) 
V(1)-N(1) 2.048(2) V(1)-O(1) 1.949(1) 
O(1)-V(1)-O(1) 132.2(1) V(1)-O(2) 1.932(1) 
N(1)-V(1)-N(1) 161.8(1) V(1)-N(1) 2.062(2) 
O(1)-V(1)-O(2) 113.91(6) O(3)-V(1)-O(4) 108.3(1) 
N(1)-V(1)-O(2) 99.12(6) O(1)-V(1)-O(3) 128.08(9) 
N(1)-V(1)-O(1) 86.26(8) O(1)-V(1)-O(4) 123.40(9) 
N(1)-V(1)-O(1)i 86.37(8) N(1)-V(1)-O(2) 159.07(8) 
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Table 3.2 Selected crystallographic data for [VO(pimin)2] and [VO2(pimin)(piminHˊ)]  
Compound [VO(pimin)2]     [VO2(pimin)(piminHˊ)]     
empirical formula  C18H18N4O3V C18H19N4O4V 
formula weight 389.30 406.32 
crystal color Blue-green Yellow 
crystal system  Orthorhombic Monoclinic 
space group  Fdd2 P21/c 
temperature 173(2) K 173(2) K 
a, Å 12.4698(7)  8.9544(8) 
b, Å 36.810(2) 22.6383(19) 
c, Å 7.3123(4) 8.6648(7) 
α, deg 90 90 
β, deg 90 90.736(2) 
γ, deg 90 90 
V, Å3 3356.5(3)  1756.3(3) 
Z 8 4 
ρcalc, g/cm
3 1.541 1.537 
wavelength, Å  0.71073  0.71073 
total reflections 4875 12519 
unique reflections 1827 4234 
R 0.0384 0.0501 
Rw 0.0735 0.0962 
 
3.3.2 pH-Metric chemical speciation 
As has been discussed, it is important to gain an understanding of the aqueous speciation of 
metallopharmaceuticals to predict what species may exist over a biological pH range. The stability 
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constants of the metal-ligand complexes may give further indication of the type of binding that 
might take place between the complexes and other bioligands, for example the formation of 
ternary complexes. Thus, in the context of V(IV) complexes, pH stability may provide a g ood 
indication of biological efficacy. 
The protonation constants of EtpiminH and EtOHpiminH were determined using aqueous 
potentiometric titrations, from an average of six independent titrations. Solution studies with the 
ligand piminH were precluded due to the low water solubility of this ligand. The stability constants 
for the VO(IV) – EtpiminH and EtOHpiminH (VO:L ratio’s of 1:1, 1:2, 1:5 and 1:10) systems were 
determined from an average of six titrations and are summarized in table 3.3. For the metal:ligand 
speciation, the best fitting experimental curves were obtained using higher metal-to-ligand ratios. 
At 1:5 and 1:10 metal-to-ligand ratios no precipitation occurred in the pH range examined. For the 
1:1 ratio, only the first binding constants could be calculated. The species distribution diagrams 
were generated using the program HySS2009,29 by inclusion of protonation, stability and 
hydrolysis constants. 
Both EtpiminH and EtOHpiminH are basic ligands with pK values of 7.52 and 7.33, and 11.26 and 
11.09 for the imidazoline nitrogen and phenolate oxygen, respectively. The relevant protonation 
reactions are shown in scheme 3.2 and species distribution diagrams for EtpiminH and 
EtOHpiminH are shown in figure 3.9 and figure 3.10, respectively, both being relatively similar. 
Under acidic conditions (pH < 4), the ligands remain fully protonated (both the imidazoline 
nitrogen as well as the phenolate oxygen). As the pH increases (pH > 4), the imidazoline nitrogen 
is deprotonated followed by deprotonation of the phenolate oxygen. Thus it is only at relatively 
high pH values that the ligand appears fully deprotonated. These pKa values were slightly higher 
(more basic) than the structurally similar, fully aromatized derivative, 2-(2ˊ-
hydroxyphenyl)imidazole, which had reported pKa values of 6.5 (imidazole protonation) and 9.25 
(phenolate protonation).30 Benzimidazole has a known pKa of around 5.41
31 and imidazole around 
6.95.32 Thus one can see that the pKa values are largely related to the extent of delocalization of 
the π-electron density on these rings. It is therefore no surprise that the non-conjugated 
imidazoline ligands have slightly higher first protonation values than the imidazoles.  
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As a c onsequence of the ligand basicity, coordination to vanadyl begins at relatively higher pH 
values making way for hydrolysis at a low pH (3<pH<5). However, as the pH increases a single 
fully deprotonated ligand binds (3.5<pH<7), followed by a second fully deprotonated ligand (pH>5) 
to form a neut ral complex which is stable at a r elatively high pH (scheme 3.3). The binary 
hydroxyl species [(VO)2(OH)5]
- and [VO(OH)3]
- did not fit within the model and no hydrolysis was 
detected up to a pH of 9. The overall stability constants for these VO-ligand systems are high at 
17.13(3) and 16.66(3) for VO-EtpiminH (figure 3.11) and VO-EtOHpiminH (figure 3.12) systems, 
respectively. Both systems (VO-EtpiminH and VO-EtOHpiminH) show good overall stability, but 
are however, subject to hydrolysis at acidic pH values due to the basic nature of the ligands.  
 
Figure 3.9 Species distribution as a function of pH for 2-(2ˊ-hydroxyphenyl)-1-ethylimidazoline 
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Figure 3.10 Species distribution as a function of pH for 2-(2ˊ-hydroxyphenyl)-1-ethanolimidazoline 
Table 3.3 Protonation (log K) and complex formation constants (log β) for VO(IV)-ligand systems at 25±0.1 
°C and I = 0.10 M (TMACl) 
 
 
Reaction 
Ligand 
EtpiminH EtOHpiminH Maltol33 
pK1 LH2
+ ⇌ H+ + LH 7.52(1) 7.33(1)  - 
pK2 LH ⇌ H+ + L- 11.26(1) 11.09(1) 8.44(2) 
logβ110 VO2+ + L
-  ⇌ [VO(L)]+ 10.73(1) 10.53(2) 8.80(2) 
logβ120 VO2+ + 2L
- ⇌ [VO(L)2] 17.13(3) 16.66(3) 16.29(2) 
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Scheme 3.2 Deprotonation steps for the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands. H+ have been 
omitted from the equilibria 
 
4 8 12 
pH 
0 
20 
40 
60 
80 
100 
EtOHpiminH2 EtOHpiminH EtOHpimin 
%
 F
or
m
at
io
n 
60 
 
 
Part 1. Chapter 3 
 
Figure 3.11 Species distribution diagram for the complexation of VO(IV) with EtpiminH (LH), cVO = 0.002 
mol.L-1 and cligand = 0.004 mol.L-1 
 
Figure 3.12 Species distribution diagram for the complexation of VO(IV) with EtOHpiminH (LH), cVO = 
0.002 mol.L-1 and cligand = 0.004 mol.L-1 
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Scheme 3.3 The stepwise formation of oxovanadium(IV) complexes. LH and L - are omitted in the 
complexation equilibria as are the hydrolysis equilibria 
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In summary, the basicity of these 2-(2ˊ-hydroxyphenyl)-1R-imidazolines make them less than 
ideal ligands for stabilizing vanadyl at acidic pH, such as that experienced in the stomach. 
However, this could be circumvented by improving the drug formulation, for example by using a 
drug encapsulation technique.34,35 The speciation studies suggest that in more alkaline conditions 
(such as the intestine), the ligands may help to prevent the formation of hydrolysis species which 
may consequently improve absorption of vanadyl into the bloodstream. 
3.3.3 In vitro glucose uptake studies 
The vanadium compounds [VO(pimin)2], [VO(Etpimin)2], [VO(EtOHpimin)2] and VOSO4 showed 
no cytotoxicity between 0.5-10 µM in the 3T3-L1, Chang and C2C12 cell lines tested as 
determined by an MTT-assay. At concentrations above 10 μM, however, the vanadium 
compounds proved to be cytotoxic (less than 80% cell viability). Similar toxicity profiles were 
reported by Rehder et al., in SV-3T3 mice fibroblasts for a r ange of oxovanadium(IV) 
complexes.36 Thus, the glucose uptake ability of the vanadium compounds, at non-cytotoxic 
pharmacologically relevant concentrations of 0.5, 1 and 10 μM, was screened.  
Generally at 1 μM concentrations of the oxovanadium(IV) compounds, the highest and most 
consistent glucose uptake activity was observed across all three cell lines tested, once again a 
similar trend to that observed by Rehder and co-workers.36 The results at this concentration are 
presented in figure 3.13, while the results for all concentrations tested can be found in table 3.4. 
In the 3T3-L1 adipocytes (figure 3.13), the oxovanadium(IV) compounds (VOSO4, [VO(pimin)2], 
[VO(Etpimin)2], [VO(EtOHpimin)2]) enhanced glucose uptake significantly, either equalling or 
surpassing the effects observed for metformin, a drug commonly used in the treatment of type II 
diabetes.37 The uptake of glucose in C2C12 muscle cells was not as significant as that observed 
in the other cell lines (figure 3.13). Nevertheless, vanadyl sulfate as well as compounds 
[VO(pimin)2] and [VO(Etpimin)2] improved glucose uptake relative to the control. The Chang liver 
cells exhibited the greatest response to the tested compounds compared to the other cell lines 
tested, however activity was slightly lower than the positive control, metformin.  
62 
 
 
Part 1. Chapter 3 
Treatment (1x10-6 M) 
%
 G
lu
co
se
 U
pt
ak
e
0
20
40
60
80
100
120
140
160
180
200
Chang
C2C12
3T3-L1
**
**
* *
Co
ntro
l
VO
SO 4
[VO
(pim
in) 2
]
[VO
(Et
pim
in) 2
]
Me
tfor
min
[VO
(Et
OH
pim
in) 2
]
 
Figure 3.13 The effects of metformin (Met), vanadyl sulfate (VOSO4), [VO(pimin)2],  [VO(Etpimin)2] and 
[VO(EtOHpimin)2] (at 1 μM concentration) on Chang, C2C12 and 3T3-L1 glucose uptake. The 
basal glucose uptake, is represented as 100% (Control). Error bars indicate SEM (n=3), *(p 
<0.05) and **(p < 0.01) relative to the (Con) 
 
Vanadyl sulfate proved to be the most effective of the oxovanadium(IV) compounds in stimulating 
the uptake of glucose. This can be attributed to the fact that an in vitro model does not take into 
account that uncomplexed vanadyl (VOSO4) may be simply oxidized to vanadate, the active 
species for PTP-inhibition, whilst compounds [VO(pimin)2],  [VO(Etpimin)2] and [VO(EtOHpimin)2], 
must first undergo oxidation and ligand dissociation. This extra ligand dissociation step may be 
the reason for the decreased in vitro activity of the synthesized compounds.38 However, the 
increased stability of the organovanadium compounds, imparted by the organic ligands, may allow 
vanadium to survive the harsh conditions of the digestive system unlike VOSO4 which undergoes 
facile hydrolysis and subsequent excretion. It has also been shown that the intestinal cell 
permeability of complexed vanadium compounds far exceeds that of the inorganic salt (VOSO4).
20 
The effect of the R-substituents (R = H, Et, EtOH) in compounds [VO(pimin)2],  [VO(Etpimin)2] and 
[VO(EtOHpimin)2], makes little difference to the in vitro activity, but would perhaps become 
important in an in vivo model when considering the lipophilicity/hydrophilicity of the complexes. 
Although the in vitro model used may have certain shortcomings, in that it does not exactly 
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replicate in vivo conditions,5 it does provide a simple and ethical platform for the rapid assessment 
of new complexes.  
Table 3.4 The effects of metformin (Met), VOSO4, [VO(pimin)2], [VO(Etpimin)2] and [VO(EtOHpimin)2] on 
3T3-L1, Chang and C2C12 cells at 0.5, 1.0 and 10 μM concentrations. Basal glucose uptake is represented 
as 100% 
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3.3.4 Anticoagulation studies 
Diabetes mellitus sufferers are at a hi gher risk of thrombotic associated fatalities and as  such 
quite often benefit from anticoagulatory medication. Despite this, there has been very little 
investigation into the anticoagulatory effects of oxovanadium(IV) complexes. We therefore 
decided to investigate whether or not [VO(pimin)2] a representative example of the compounds in 
this class, displayed any activity in this regard.  
The prothrombin time (PT) is the screening test for the extrinsic coagulation pathway, which is 
initiated by tissue factor. In the PT test, the time required for plasma to clot following conversion of 
prothrombin to thrombin upon addition of CaCl2 is measured. The activated partial thromboplastin 
time (APTT) assay investigates the intrinsic pathway. In an A PTT reagent, negatively charged 
particles such as silica are mixed with phospholipids and buffers providing an ideal environment 
for activation of intrinsic plasma proteins. After incubation of the APTT reagent with plasma, CaCl2 
is added which initiates multiple steps of the intrinsic pathway penultimately leading to a fibrin clot. 
The time from addition of the calcium salt until the clot formation is measured in seconds. D-dimer 
fragments are contained in the soluble derivatives formed upon pl asmin degradation of Factor 
XIIIa crosslinked fibrin. Plasmin, a s erine protease, is capable of digesting the insoluble fibrin 
producing a v ariety of soluble derivatives. These soluble products contain neoantigen (D-dimer 
domain) which is not present on the original fibrinogen molecule. In the D-Dimer assay, elevated 
levels of fibrin reflect a state of activated coagulation and fibrinolysis (hypercoagulation state). The 
Fibrinogen-C (Fib-C) screening test uses an excess of thrombin to convert fibrinogen to fibrin in 
diluted plasma. High levels of fibrinogen are associated with an increased risk of cardiovascular 
disease. 
For the APTT and PT screening tests, only heparin (positive control) significantly increased 
clotting times relative to the control (figure 3.14). Thus, [VO(pimin)2] did not affect the intrinsic or 
extrinsic pathways. For the Fib-C test, there was a very slight reduction in fibrin formation when 
the oxovanadium(IV) complex was administered, however compared to heparin the effect was not 
too significant. The D-Dimer test showed the most promising results, with [VO(pimin)2] reducing 
D-Dimer formation comparably to that of heparin thereby reducing the state of hypercoagulation. 
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Figure 3.14 The effect of [VO(pimin)2] (10 μM) on APTT (A) and PT (B) clotting times, on fibrin formation 
(C) and D-Dimer formation. The control represents untreated sample while the positive control 
represents the anticoagulant heparin (0.1 U.mL-1) (n = 3) 
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3.4  Conclusions 
A range of neutral oxovanadium(IV) complexes with bidentate imidazolinyl-phenolato ligands were 
successfully prepared and characterized. Aqueous potentiometry was used to determine the pK 
values for the ligands as well as the stability constants for the formation of the corresponding 
oxovanadium(IV) complexes. The highly basic character of the ligands prevented vanadyl 
hydrolysis in basic conditions, such as that experienced in the intestine. In more acidic conditions 
however, ligand dissociation was prevalent as was the formation of hydrolysis species, an 
obstacle which could be remedied by drug encapsulation. The oxovanadium(IV) complexes 
showed promising glucose lowering properties in vitro in liver, muscle and fat cells. Improvements 
could however be made by increasing complex stability over a broader pH range. In addition to 
the antidiabetic properties, [VO(pimin)2] displayed anticoagulative activity as evidenced by 
inhibition of D-Dimer formation. This effect of oxovanadium(IV) complexes has barely, if at all, 
been studied and represents an additional therapeutic avenue for the treatment of diabetes.  
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Chapter 4 
Oxovanadium(IV) complexes with imidazole-carboxylic acid ligands 
 
 
4.1  Introduction 
 
Imidazole (figure 4.1) is a planar, 5-membered, aromatic molecule, consisting of a t rigonal 
nitrogen atom with two electrons in the p-orbital of the N-1 “pyrrole” nitrogen and at position 3 (N-
3), a het erocyclic, “imino” nitrogen containing a l one pair of electrons in a h ybrid orbital and a 
single electron in the p-orbital.1 The electrons in the unhybridised p-orbital of N-1 atom form part 
of the aromatic sextet. The N-1 electrons are not available for bonding since the aromaticity of the 
imidazole would be compromised. However, if deprotonation were to occur, a lone pair of 
electrons would be available for bonding. 
N
H
N1
2
34
5
N
N
 
Figure 4.1 Structure of neutral imidazole (a), and the anionic form (b) 
 
The net charges for imidazole and pyridine molecules have been calculated using ab initio 
methods2,3 and are reported in table 4.1. The N-3 σ and π electron charges are slightly negative 
indicating moderate σ-donating and weak π-accepting properties. The unshared electron pair on 
N-3 and the possibility of overlap between the d-orbitals of a m etal ion and the imidazole π-
orbitals, allow for the formation of stable metal complexes.  
Nature certainly caught on to the idea of using imidazoles to bind metals, specifically the transition 
metals. The imidazole group which forms part of the side chain of histidine is found bound to 
nickel, iron and zinc whereas cobalt is coordinated to a similar benzimidazole group in vitamin 
B12.4 Functioning as biocatalysts, these imidazole-metal systems not only catalyze oxidation and 
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hydroxylation reactions, but can also function as electron storage sites and dioxygen 
transporters.4 More pertinently, vanadium has also been found bound to imidazoles in the 
naturally occurring vanadium-dependent haloperoxidases.5 Other than metal binding capabilities, 
imidazole compounds are well established in the field of medicinal chemistry with applications 
such as anticancer,6 antibacterial,7 antifungal8 and antidiabetic9 drugs, to name a few.  
 
Table 4.1 Calculated net charges on the nitrogen atoms of imidazole and pyridine2,3 
Nitrogen Atom σ π 
N1 -0.84 0.4 
N3 -0.1 -0.1 
Pyridine -0.22 -0.01 
 
This study explores the use of imidazole derivatives as a binding moiety to oxovanadium(IV) since 
imidazoles are known to play a significant role in a large variety of biological processes. It is 
therefore envisaged that these ligands should not pose a threat to the body once cleaved from the 
vanadium ion in vivo. The studies performed in Part 1, Chapter 3 made us aware of the 
undesirable effects of using ligands with high basicity (ligand dissociation at low pH) and for this 
reason we have incorporated the acidic carboxylate group (instead of a phenol group) to provide 
stability in the low pH range. The combination of both the imidazole and carboxylate functionalities 
should therefore provide suitable stabilization of vanadyl over a biological pH range. In addition, 
alkylation at the “pyrrole” nitrogen allows for modification of the balance between lipophilicity and 
hydrophilicity of the resultant complexes. 
In this chapter, the synthesis and c haracterization of a s mall series of oxovanadium(IV) 
complexes with imidazole-4-carboxylic acid, imidazole-2-carboxylic acid and 1-methylimidazole-2-
carboxylic acid, as coordinating ligands is presented. The protonation constants of the ligands as 
well as the stability constants of these with oxovanadium(IV) were determined using glass 
electrode potentiometry. This provided an indication as to whether the complexes would stabilize 
vanadyl across a biological pH range. The formation of ternary complexes with citric acid was also 
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investigated using potentiometry in the hope of gaining an understanding of the possible species 
that may exist in the bloodstream where bioligands are prevalent.  
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4.2 Preparative work 
4.2.1 Imidazole-4-carboxylic acid (Im4COOH) 
As discussed in section 2.2.1 this ligand was purchased from Sigma-Aldrich 
Chemical Company and used in subsequent steps without further purification.  
4.2.2 1-Methylimidazole-2-carboxaldehyde (MeIm2CHO) 
1-Methylimidazole-2-carboxaldehyde was prepared according to a literature method.10-
12 To a suspension of 1-methylimidazole (2.20 g, 0.020 mol) in dry diethyl ether (50 
mL) was added 2.5 M butyllithium (8.40 mL, 0.021 mol) at -78 °C. After stirring for an hour, DMF 
(2.33 mL, 0.030 mol) was added and this solution was stirred overnight. After completion of the 
reaction, 2 mL of water was added followed by 15 mL of 4 N HCl. The aqueous layer was made 
basic by addition of potassium carbonate following which the product was extracted into 
chloroform. This organic layer was concentrated and the product was distilled at 3.0x10-1 mBar 
and 80 °C to yield a brownish crystalline solid after cooling. Yield: 76.1%. 1H (δ, 400 MHz, CDCl3):  
4.03 (s, 3H, NCH3), 7.16-7.27 (m, 2H, Im-H), 9.81 (s, 1H, CHO); 
13C NMR (δ, 100 MHz, CDCl3): 
35.20, 127.69, 131.74, 144.00, 182.37. IR (cm-1, KBr disk): 3108(m), 2956(m), 2835(m), 1671(s), 
1532(w), 1509(m), 1479(m), 1380(s), 1330(s), 1289(s), 1218(m), 1150(m), 1077(m), 920(s), 
766(s), 682(s). Anal. Calcd (Found) for C5H6N2O (%): C, 54.54 (54.25); H, 5.49 (5.65); N, 25.44 
(25.19). 
4.2.3 Imidazole-2-carboxylic acid.H2O (Im2COOH) 
 An aqueous 30% H2O2 (10 g) was added dropwise to a stirred solution of imidazole-
2-carboxaldehyde (2.88 g, 0.030 mol) in water (10 mL). The reaction was allowed to 
proceed at room temperature for 72 hours, following which the water was removed in vacuo at 
room temperature to afford a white crystalline solid. This solid was washed with a m ixture of 
diethyl ether/methanol/water (4:1:1) to remove the excess peroxide. Note: The product should be 
stored in an anhydrous environment since it is hygroscopic. Slow decarboxylation may occur at 
room temperature, thus refrigeration is suggested. Yield: 97.5%. Mp = 156-158 °C. 1H NMR (δ, 
400 MHz, D2O): 7.56 (2H, s, Im-H); 
13C NMR (δ, 100 MHz, D2O): 158.86, 141.02, 120.49. IR (cm
-
1, KBr disk): 3392(m), 3124(m), 2861(m), 1618(s), 1502(m), 1462(m), 1421(s), 1388(s), 1322(m), 
N
N O
H
HN
N
O
OH
N
H
N O
OH
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1108(s), 925(s), 910(s), 819(m), 797(s), 774(m). Anal. Calcd (Found) for C4H6N2O3 (%): C, 36.92 
(37.18); H, 4.65 (4.94); N, 21.53 (21.47).  
4.2.4 1-Methylimidazole-2-carboxylic acid.H2O (MeIm2COOH) 
The procedure followed that of Im2COOH above except that 1-methylimidazole-2-
carboxyaldehyde was used and the yield was quantitative after the removal of water 
under high vacuum (no washing with diethyl ether/water was necessary). Note: The product 
should be stored in an anhydrous environment since it is hygroscopic. Slow decarboxylation may 
occur at room temperature, thus refrigeration is suggested.  Yield: 100%. Mp = 99-101 °C. 1H 
NMR (δ, 400 MHz, D2O): 7.42, 7.39 (2H, s, Im-H) and 4.08 ppm (3H, s, NCH3); 
13C NMR (δ, 100 
MHz, D2O): 158.67, 139.68, 125.83, 118.46, 36.73. IR (cm
-1, KBr disk): 3347(m) 3119(m), 
2663(w), 1641(s), 1683(m), 1507(s), 1449(m), 1388(s), 1338(s), 1285(s), 1173(m), 1123(s), 
961(m) 910(m), 776(s), 685(s). Anal. Calcd (Found) for C5H8N2O3 (%): C, 41.67 (41.28); H, 5.59 
(5.23); N, 19.44 (19.12).  
4.2.5 [VO(Im4COO)2] 
This complex was prepared according to a literature method but with slight 
modifications.10 To a s tirred aqueous solution of Im4COOH (0.254 g, 2.26 
mmol) in water (10 mL), was added 10% TMAOH (1.04 mL, 1.13 mmol). To 
this solution was added aqueous VOCl2 (1.13 mmol), prepared by the reaction of VOSO4 with 
BaCl2. The reaction was allowed to stir overnight, following which the light blue precipitate was 
collected, washed with methanol and ether and dried in an oven at 100 °C. Yield: 64.6%. Mp > 
300ºC. ATR-IR (cm-1, neat): 3129(m), 2992(m), 2856(m), 1606(s), 1573(s), 1499(m), 1439(m), 
1356(s), 1209(m), 1080(m), 1012(m), 981(s), 878(m), 819(s), 780(s). Anal. Calcd (Found) for 
C8H6N4O5V.H2O (%): C, 31.29 (31.20); H, 2.63 (2.67); N, 18.24 (18.14). UV/Vis (H2O) λmax (ε, M
-
1cm-1): 746 (25), 561 (10), 310sh (194). UV/Vis (solid reflectance), λmax  (nm): 712, 570, 339.  
4.2.6 [VO(Im2COO)2] 
This complex was prepared in the same manner as [VO(Im4COO)2], except 
that an aqueous solution of VOSO4 was added to the ligand solution 
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instead of aqueous VOCl2.  Yield: 69.9%. Mp > 300ºC. ATR-IR (cm
-1, neat): 3448(m), 3129(w), 
3008(m), 2906(m), 1625(s), 1558(m), 1487(m), 1398(s), 1338(m), 1277(m), 1171(m), 1112(s), 
984(s), 908(m), 829(m), 769(s), 658(s) cm-1. Anal. Calcd (Found) for C8H6N4O5V.H2O (%): C, 
31.29 (31.21); H, 2.63 (2.53); N, 18.24 (18.07). UV/Vis (H2O) λmax (ε, M
-1cm-1): 749 (23), 550 (10), 
317sh (191). UV/Vis (solid reflectance), λmax   (nm): 715, 559, 333.  
4.2.7 [VO(MeIm2COO)2] 
This complex was prepared similarly to [VO(Im4COO)2]. However, upon 
stirring overnight a blue precipitate did not form. The blue solution was 
then allowed to stand for 24 ho urs and a l ight blue precipitate formed, 
which was filtered and washed with methanol and then ether and dr ied in an oven at 100 °C. 
Yield: 62.3%. Mp = 218-220ºC. ATR-IR (cm-1, neat): 3134 (m), 1628(s), 1487(s), 1426(s), 1327(s), 
1286(m), 1180(s), 1166(s), 963(s), 837(m), 797(s), 769(s), 698(s) cm-1. Anal. Calcd (Found) for 
C10H10N4O5V.H2O (%): C, 35.83 (36.01); H, 3.61 (3.47); N, 16.72 (16.67)%. UV/Vis (H2O) λmax (ε, 
M-1cm-1): 761 (23), 576 (10). UV/Vis (solid reflectance), λmax  (nm): 718, 578, 352. 
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4.3 Results and discussion 
4.3.1 Synthesis and general considerations 
The most common method for preparing 2-substituted N-alkylimidazoles involves lithiation 
typically using n-butyllithium (n-BuLi), followed by reaction with a s uitable electrophile.11,12 The 
hydrogen at the 2-position of N-alkylimidazoles is the most acidic and therefore the carbanion is 
readily generated at this position. In our case, 1-methylimidazole was reacted with n-BuLi followed 
by formylation using DMF, giving 1-methylimidazole-2-aldehyde in good yield (scheme 4.1). The 
reaction was carried out under inert and anhydrous conditions to prevent the lithiated intermediate 
from decomposing upon reaction with air or water. Furthermore, we have noticed that an increase 
in temperature or rapid addition of n-BuLi can result in di-substitution, most likely at the 2 and 5-
positions.13 1-Methylimidazole-2-aldehyde was then converted to the carboxylic acid by oxidation 
with hydrogen peroxide (scheme 4.1). This novel reaction was ‘green’ in that water was 
generated as the only by-product. Additionally, it was also much simpler and higher yielding than 
other reported methods.14,15 At the end of this reaction, the product (1-methylimidazole-2-
carboxylic acid) was recovered by removal of water under a high vacuum giving a h igh purity 
crystalline material. Importantly, removal of water was performed at room temperature. Increasing 
the temperature to facilitate solvent removal gave the decarboxylated product. This facile 
decarboxylation has also been acknowledged by others.14,16  
 
N
N
i) BuLi
ii) DMF
diethyl ether N
N
H
O H2O2
H2O N
N
OH
O
 
Scheme 4.1 Synthesis of 1-methylimidazole-2-carboxylic acid from the starting material 1-methylimidazole 
 
Imidazole-2-carboxylic acid was prepared by the same method, however unlike 1-
methylimidazole-2-carboxylic acid, this ligand seemed to contain peroxide impurities even after 
extensive drying under vacuum. This was first noticed after addition of a s olution of vanadyl 
sulfate to an a queous solution of imidazole-2-carboxylic acid resulted in a c olour change from 
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blue (V4+) to yellow/orange (V5+). The peroxide was removed by thoroughly washing of the ligand 
with a solvent mixture consisting of cold diethyl ether/methanol/water. A methanolic vanadyl 
sulfate solution was added to the washings to ascertain when the peroxide had been completely 
removed (washings remained blue).  
NMR spectroscopy (along with other techniques) was used to confirm the successful synthesis of 
the ligands. Shown in figure 4.2 and 4.3 are the 1H NMR spectra of 1-methylimidazole-2-
aldehyde and 1-methylimidazole-2-carboxylic acid. The most descriptive indicator of successful 
oxidation was the disappearance of the aldehyde proton which appeared at ~9.8 ppm in 
MeIm2CHO. In the 13C NMR spectrum (figure 4.4), the aldehyde carbon signal of MeImCHO 
appeared 182 ppm while the more shielded carboxylic acid carbon for MeImCOOH appeared 
further upfield at 159 ppm. In both spectra, all five carbon signals were accounted for. 
 
3 .54 .04 .55 .05 .56 .06 .57 .07 .58 .08 .59 .09 .510 .0
3
.0
9
1
. 0
2
1
. 2
8
1
. 0
0
 
Figure 4.2 1H NMR spectrum of MeIm2CHO (δ ppm). The solvent (CDCl3) is responsible for the inflated 
integration at 7.3 ppm  
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Figure 4.3 1H NMR spectrum of MeIm2COOH (δ ppm). The solvent (D2O) is left un-integrated  
020406080110140170200  
Figure 4.4 Comparison of the 13C NMR spectra of MeIm2CHO (top) (in CDCl3 residual solvent peak at 
~77 ppm) and MeIm2COOH (bottom) (in D2O) 
 
The oxovanadium(IV) complexes were prepared using two slightly different procedures. Both 
[VO(Im4COO)2] and [VO(MeIm2COO)2] were prepared by addition of an aqueous solution of 
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VOCl2 to a t wo-fold excess of Im4COOH and MeI m2COOH, respectively (scheme 4.2). The 
vanadyl chloride (VOCl2) was prepared separately by addition of one mole equivalent of BaCl2 to 
VOSO4. Finally, the resultant VOCl2 solution was filtered through a Millipore filter to remove 
precipitated BaSO4.
10 [VO(Im2COOH)2] was prepared by the direct reaction with VOSO4 rather 
than using VOCl2 (scheme 4.2). It should be noted that either VOSO4 or VOCl2 can be used. The 
only reason for using VOCl2 to prepare [VO(Im4COO)2] and [ VO(MeIm2COO)2] was that the 
complexes precipitated out of solution quicker compared to when using VOSO4. The complexes 
were slightly soluble in water, but sparingly soluble in many common organic solvents such as 
DMSO, DMF, dichloromethane and methanol. Furthermore, after standing solutions of the 
oxovanadium(IV) complexes, the solutions gradually turned yellow indicating that oxidation had 
taken place. This was especially rapid when organic/aqueous mixtures were used or when the 
solution was heated or sonicated. This made crystal growth especially difficult, even when 
measures were taken to prevent aerial oxygen from entering the vessel. 
N
N O
OH
R
HN
N
O
OH
2
2
VOCl2 / VOSO4
H2O / MeOH
N N
OO
R
NN
O O
R
V
O
NH
N
OO
HN
N
O O
V
O
R = H, Me
 
Scheme 4.2 Preparation of oxovanadium(IV) imidazole-carboxylic acid complexes 
 
Cyclic voltammetry was conducted to determine the oxidation potentials of these complexes. 
Quite interestingly, the methyl-substituted complex [VO(MeIm2COO)2] displayed notably different 
electrochemical properties to the non-substituted complexes, [VO(Im4COO)2] and [VO(Im2COO)2] 
(figure 4.5). For [VO(MeIm2COO)2], a reversible oxidation (ipa/ipc = 1.1) took place at a potential 
of 300 mV corresponding to the V4+ – V5+ oxidation. The remaining two complexes 
[VO(Im4COO)2] and [VO(Im2COO)2] displayed irreversible oxidation peaks at higher potentials of 
480 and 410 mV, respectively. This corresponded well to what was observed visually considering 
that an aqueous solution containing [VO(MeIm2COO)2] turned yellow well before that of the other 
two complexes. 
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[VO(MeIm2COO)2]
Potential (V)
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Figure 4.5 Cyclic voltammograms of complexes [VO(MeIm2COO)2] and [VO(Im4COO)2] in H2O 
 
4.3.2 Spectroscopic characterization 
In the IR spectra of the ligands, the ν(C=N) appeared in the range 1618-1641 cm-1, shifting to 
lower values (1608 - 1628 cm-1) after coordination to vanadium. The prominent vanadyl stretching 
vibration, ν(V=O), appeared between 981 – 963 cm-1, well within the range reported for 
oxovanadium(IV) complexes.17 Representative infrared spectra of Im2COOH and t he 
corresponding oxovanadium(IV) complex have been illustrated in figure 4.6. 
Wavenumber (cm-1)
800100012001400160018002000
(B)
(A)
 
Figure 4.6 Infrared spectra of (A) [VO(Im2COO)2] and (B) Im2COOH 
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The solution UV/Vis studies were performed using water as a solvent (c = 1x10-3 M) as well as in 
the solid state. In solution state, both [VO(Im4COO)2] and [VO(Im2COO)2] displayed three low 
intensity d-d transitions, while for [VO(MeIm2COO)2] only the two lower energy transitions were 
observed. In the former two complexes, the (a1←b2) transition was comparatively intense (ε = 194 
- 191 M-1cm-1) due to the effects of the neighbouring charge transfer band. These transitions 
appear at 310-317 nm. The (b1←b2) and (eπ←b2) transitions were found for all three complexes at 
wavelengths of 550-576 nm (ε = 10 M-1cm-1) and 746-761 nm (ε = 23 - 25 M-1cm-1) respectively. 
The representative solution state UV/Vis spectrum of [VO(Im4COO)2] has been included in figure 
4.7. Solid state UV/Vis studies gave similar results with all three d-d transitions once again being 
observed in all complexes. The high energy (a1←b2) transition was however more clearly resolved 
as shown in figure 4.8 for a representative example, [VO(MeIm2COO)2]. This confirmed that all of 
the complexes were structurally similar, adopting a square-pyramidal geometry and d1 electronic 
configuration.17 
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Figure 4.7 Solution electronic spectrum of [VO(Im4COO)2] in water. Insert shows an expanded view of 
the region between 400-900 nm 
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Figure 4.8 Solid state electronic spectrum of [VO(MeIm2COO)2]  
 
4.3.3 pH-Metric chemical speciation 
It is important, when dealing with metallopharmaceuticals, to gain a clear understanding of the 
various species that may exist over a bi ological pH range. In the previous chapter (Part 1, 
Chapter 3) it was shown that the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands did not effectively 
stabilize vanadyl in the low pH range due to the high protonation constants of the donor groups.  
The consequence of this was that the ligands easily dissociated in acidic conditions releasing free 
vanadyl. The negative implications of this include an increased susceptibility to the formation of 
insoluble hydrolysis species (in more basic conditions) and p oorer absorption into the 
bloodstream.18 Because of this, we decided to prepare ligands containing the imidazole as well as 
the carboxylic acid functional groups. The latter functional group we expected would provide 
additional stability in the acidic pH range.  
The protonation constants of Im4COOH, Im2COOH and MeI m2COO were determined using 
aqueous potentiometric titrations from an average of six independent titrations each. The stability 
constants for the VO(IV) – Im4COOH, Im2COOH and MeIm2COOH (VO:L ratio’s of 1:1, 1:2, 1:5 
and 1:10) systems were determined from an average of six titrations and are summarized in table 
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4.2. At a metal:ligand (M:L) ratio of 1:1, only the first binding constants could be calculated due to 
the formation of hydrolysis species. The species distribution diagrams were generated using the 
program HySS2009,19 by inclusion of protonation, stability and hydrolysis constants. 
 
Table 4.2 Protonation (log K) and complex formation constants (log β) for VO(IV)-ligand systems at 25±0.1 
°C and I = 0.10 M (TMACl) 
 
 
Reaction 
Ligand 
Im4COOH Im2COOH MeIm2COOH pic20 
pK1 LH2
+  H+ + LH 2.70(3) 2.72(3) 1.3(1) ~1 
pK2 LH  H+ + L
- 6.13(1) 6.44(2) 6.75(3) 5.19(2) 
logβ110 VO2+ + L
-   [VO(L)]+ 7.11(2) 7.53(3) 9.84(6) 6.66(2) 
logβ111 VO2+ + H+ + L
-   [VO(LH)]2+ - - 14.85(7) - 
logβ120 VO2+ + 2L
-  [VO(L)2] 11.38(8) 11.62(6) 15.49(9) 12.11(2) 
 
The relevant protonation/deprotonation reactions are shown in scheme 4.3 and species 
distribution diagrams for Im2COOH and MeIm2COOH are shown in figures 4.9 and 4.10, 
respectively. The species distribution diagram for Im4COOH was extremely similar to that of 
Im2COOH and as  such has not been included. Unlike the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline 
ligands, these ligands exhibit deprotonation at much lower pH values – a property that we had 
expected to achieve by introducing the carboxyl functionality.  
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Scheme 4.3 Deprotonation steps of the Im2COOH and MeIm2COOH (A) as well as Im4COOH (B) 
systems. H+ have been omitted from the equilibria 
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The ligands Im4COOH and Im2COOH had similar pK1 values of 2.70 and 2.71 respectively, while 
that of MeIm2COOH was 1.3. Halina (2008),18 who was investigating the formation constants of 
V3+ with various imidazole carboxylic acids, found the pK1 of Im4COOH to be slightly lower at 2.3, 
compared to 2.70 determined in this study. The pK1 of MeIm2COOH (pK1 = 1.3) was comparable 
to that of picolinic acid (Hpic) (pK1 ~1) (table 4.2).
20 The lower acidity of the carboxylic acid 
groups in Im4COOH and Im2COOH compared to Hpic and MeIm2COOH may be due to 
additional stabilization by hydrogen bonding, since these ligands contain unsubstituted N-H 
groups.21 The pK2 (N-deprotonation) for Im4COOH, Im2COOH and MeIm2COOH were 6.13, 6.44 
and 6.75 respectively, while that of free imidazole is around 6.95. The carboxylic acid functionality 
has been known to exert a base weakening effect on the parent heterocycle which explains why 
in all cases, the pK2 for the imidazole group in the ligands was lower than that of free imidazole.
22 
The pK2 of the N-methyl substituted derivative (MeIm2COOH) (6.75) was more basic than the N-
H analogues (Im4COOH and Im2COOH) and quite similar to that reported by Franz (6.88).14 This 
increased basicity observed upon N-methylation follows the same trend seen for imidazole (pK = 
6.95) and 1-methylimidazole (pK = 7.20).  
 
 
Figure 4.9 Species distribution as a function of pH for imidazole-2-carboxylic acid 
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Figure 4.10 Species distribution as a function of pH for N-methylimidazole-2-carboxylic acid 
 
The proposed interactions of these ligands in aqueous solutions with oxovanadium(IV) are  
represented by scheme 4.4. The ligand imidazole-2-carboxylic acid (Im2COOH) shows similar 
interactions and s tability with vanadyl as imidazole-4-carboxylic acid (Im4COOH). The species 
distribution diagrams are represented by figures 4.11 and 4.12 for the (VIVO)-imidazole-2-
carboxylic acid and (VIVO)-1-methylimidazole-2-carboxylic acid systems, respectively. 
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Scheme 4.4 The stepwise formation of oxovanadium(IV) complexes with Im4COOH and MeIm2COOH (R = 
Me) or Im2COOH (R = H). LH and L - are omitted in the complexation equilibria as are the 
hydrolysis equilibria 
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Figure 4.11 Species distribution diagram for the complexation of VO(IV) with Im2COOH (LH), cVO = 0.002 
mol.L-1 and cligand = 0.004 mol.L-1 
 
 
Figure 4.12 Species distribution diagram for the complexation of VO(IV) with MeIm2COOH (LH), cVO = 
0.002 mol.L-1 and cligand = 0.004 mol.L-1 
 
The first binding constants could be calculated with a 1:1 metal-to-ligand ratio (M:L), however at 
low M:L ratio’s (1:1 and 1:2) hydrolysis occurred, preventing accurate determination of the second 
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determination of the second binding constant. The fitting of the titration data supports the 
formation of monomeric [VO(L)]+ and [VO(L)2] species as well as the monomeric protonated 
species, [VO(LH)]2+, for MeIm2COOH. As shown in figures 4.11 and 4.12 the presence of the 
carboxylic acid group on the ligands allowed for coordination at much lower pH values. 
Considering the VO-Im2COOH system as an ex ample; at pH 3 t he main species existing in 
solution was [VO(Im2COOH)]+ while for the VO-EtpiminH system the [VO(EtpiminH)]+ species 
predominated at pH 6 (Part 1, Chapter 3). Certainly, looking at the VO-MeIm2COOH system 
(figure 4.12) one c an see the predominance of ligand-bound vanadyl species existing over a 
biological pH range, with hydrolysis products being observed only at relatively high pH values (pH 
>7.2). The imidazole-carboxylic acid ligands used in this study compared favourably with the 
structurally similar pyridine-2-carboxylic acid (or picolinic acid) ligand. This was promising 
considering that the oxovanadium complex of picolinic acid (pic), VO(pic)2, has been shown to 
exhibit reasonable antidiabetic activity.23 The protonation and stability constants can be found in 
table 4.2. 
Once the oxovanadium(IV) complexes have passed through the digestive tract and have been 
absorbed into the bloodstream, they may encounter numerous metal-binding bioligands. These 
bioligands may completely displace the original ligands or partially displace them to form ternary 
complexes. This may subsequently affect the transport, absorption and biological activity of the 
drug. Thus, studying ternary complex formation can be of significant importance. Of the low 
molecular weight bioligands, citric acid has proven to be one of the strongest binders of the hard 
vanadyl ion. For this reason, the ternary complex formation between vanadyl, the imidazole-
carboxylic acid ligands (Im4COOH, Im2COOH and MeI m2COOH) and c itrate has been 
performed. In this context, the imidazole-carboxylic acid ligands may be interchangeably and 
collectively referred to as ligand A, while citric acid may be referred to as ligand B. The titrations 
were performed using different ratios of VO:A:B including; 1:1:1, 1:2:1, 1:2:2 and 1:4:4. Pertinent 
data regarding citric acid protonation and vanadyl complex formation has been included in table 
4.3 and were considered (along with the metal hydrolysis constants) when fitting the experimental 
data. 
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Table 4.3 Proton (logK) and VO2+ stability constants (logβ) for the complexes of citric acid (B) at 25.0±0.1 °C 
and I = 0.2 M (KCl)24 
Complex logK/logβ 
HB 5.57(2) 
H2B 4.27(2) 
H3B 2.87(3) 
  
VOBH 10.65(6) 
VOB 7.85(7) 
(VO)2B2H-1 15.71(7) 
(VO)2B2H-2 10.73(4) 
(VO)2B2H-3 1.6(2) 
VOB2H-2 -2.89(7) 
VOBH-2 -5.7(2) 
 
As illustrated in figure 4.13 - 4.15, the formation of ternary complexes with citric acid is highly 
favoured with VOABH, VOAB and VOABH-1 dominating over a wide pH range. Starting from an 
acidic pH, the unsubstituted imidazole-carboxylic acid systems Im2COOH and Im4COOH share 
similar stability constants for the monoprotonated ternary complex (designated 1,1,1 in table 4.4) 
of 19.82 and 19.67, respectively. These values were comparable to that of maltol and slightly less 
than kojic acid (dhp) (table 4.4). The N-methylated analogue, MeIm2COOH, displayed a 
significantly higher stability constant (22.71) for the formation of this species and was comparable 
to kojic acid (dhp). For all systems, as the pH increased (4 < pH < 6), the fully ligand-deprotonated 
ternary species predominated. Finally, under more basic conditions, the mixed hydroxo species 
[VOAB(OH)]-  begins to form (pH > 6). The stability constant for the formation of this species was 
significantly higher than that of maltol (mal) and picolinic acid (pic) and slightly more comparable 
to kojic acid (dhp) (table 4.4). One may initially suspect that this may be due to the more acidic 
nature ligands used in this study, especially considering that the stability constant for the 
formation of this species using dhp (which is structurally similar to mal) was higher than that for 
mal, and dhp is slightly more acidic than mal (pKmal = 8.44; pKdhp = 7.67). However, picolinic acid 
90 
 
 
Part 1. Chapter 4 
which is more acidic than the imidazole-carboxylic acid ligands (table 4.4) has a l ower stability 
constant for this process.  
 
 
Figure 4.13 Species distribution diagram for the complexation of VO(IV) with Im4COOH (LH) and citric 
acid (Cit), cVO = 0.002 mol.L-1, VO:A:B (1:2:2) 
 
 
Figure 4.14 Species distribution diagram for the complexation of VO(IV) with Im2COOH (LH) and citric 
acid (Cit), cVO = 0.002 mol.L-1, VO:A:B (1:2:2) 
1 3 5 7 
pH 
0 
20 
40 
60 
80 
100 
VO2+ 
VOLCitH VOLCit VOLCitOH 
VOL 
VOCit 
%
 F
or
m
at
io
n 
re
la
tiv
e 
to
 V
O
2+
 
1 3 5 7 
pH 
0 
20 
40 
60 
80 
100 
VO2+ 
VOLCitH 
VOLCit VOLCitOH 
VOL 
VOCit 
%
 F
or
m
at
io
n 
re
la
tiv
e 
to
 V
O
2+
 
91 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
 
 
Figure 4.15 Species distribution diagram for the complexation of VO(IV) with MeIm2COOH (LH) and citric 
acid (Cit), cVO = 0.002 mol.L-1, VO:A:B (1:2:2) 
 
 
Table 4.4 Stability constants of mixed ligand VO2+ complexes of Im2COOH, Im4COOH and MeIm2COOH 
with citric acid at 25±0.1 °C. P,q,r represents ligand A, ligand B and protons/hydroxides, respectively 
p,q,r Im2COOH* Im4COOH* MeIm2COOH* mal25† dhp26† pic27† 
1,1,1 19.82(2) 19.67(3) 22.71(1) 18.85(6) 22.28(3) 16.96(4) 
1,1,0 16.78(2) 16.48(3) 19.21(2) 15.41(3) 18.66(2) 13.33(4) 
1,1,-1 10.72(4) 11.01(5) 12.43(5) 7.54(3) 10.25(3) 7.57(3) 
*This work, I = 0.10 M (TMACl); †I = 0.20 M (KCl) 
 
4.3.4 In vitro glucose uptake studies 
The vanadium compounds [VO(Im4COO)2], [VO(Im2COO)2], [VO(MeIm2COO)2] and t he simple 
vanadium salt, VOSO4, showed no cytotoxicity (>80% cell viability) between 0.5-10 µM in the 3T3-
L1, Chang and C2C12 cell lines tested as determined by an MTT-cell viability assay. Similar to 
the vanadium compound prepared in the previous chapter (Part 1, Chapter 3), at concentrations 
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over 10 μM, the vanadium compounds proved to be too cytotoxic (<80% cell viability). Thus, the 
glucose uptake ability of the vanadium compounds, at non-cytotoxic concentrations of 0.5, 1 and 
10 μM, was screened. The results for the 1 μM concentrations are presented in figure 4.16, while 
the results for all concentrations tested can be found in table 4.5. 
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Figure 4.16 The effects of metformin (Met), vanadyl sulfate (VOSO4), [VO(Im4COO)2],  [VO(Im2COO)2] 
and [VO(MeIm2COO)2] (at 1 μM concentration) on Chang, C2C12 and 3T3-L1 glucose uptake. 
The basal glucose uptake, is represented as 100% (Control). Error bars indicate SEM (n=3), 
*(p <0.05) relative to the (Con). 
 
There were varying effects observed in the 3T3-L1 adipocytes (figure 4.16). Metformin, along 
with vanadyl sulfate and [VO(Im2COO)2] improved glucose uptake. However for [VO(Im4COO)2] 
and [VO(MeIm2COO)2], less than basal glucose uptake was observed. For the Chang cells, 
enhanced glucose uptake was observed for all (besides [VO(Im2COO)2]) of the oxovanadium(IV) 
compounds. In the C2C12 cells, VOSO4 and [VO(Im4COO)2] enhanced glucose uptake to a level 
comparable to Metformin. When higher than 1 μM concentrations of the oxovanadium(IV) 
compounds were administered to the cells, the general trend was a slight drop in glucose uptake, 
possibly due to some cytotoxicity at these conditions (table 4.5).  
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Table 4.5 The effects of metformin (Met), VOSO4, [VO(Im4COO)2], [VO(Im2COO)2] and [VO(MeIm2COO)2] 
on 3T3-L1, Chang and C2C12 cells at 0.5, 1.0 and 10 μM concentrations. Basal glucose uptake is 
represented as 100% 
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4.3.5 Anticoagulation studies 
A similar trend was observed for these compounds as was observed for [VO(pimin)2] as 
discussed in Part 1, Chapter 3. For the APTT and P T screening tests, only heparin (positive 
control) significantly increased clotting times relative to the control (figure 4.17). Thus, the 
oxovanadium(IV) complexes did not affect either the intrinsic or extrinsic pathways. No significant 
or conclusive results could be drawn from the Fib-C screening test either. [VO(Im4COO)2] 
decreased Fibrin formation slightly however this was within error of the control (solvent vehicle) 
and certainly not as significant as the positive control, heparin. The D-Dimer test once again 
showed promising results, with all the oxovanadium(IV) complexes reducing D-Dimer formation 
comparably to that of heparin thereby suggesting a reduction in the state of hypercoagulation. 
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Figure 4.17 The effect of [VO(Im4COO)2], [VO(Im2COO)2] and [VO(MeIm2COO)2] (10 μM) on APTT (A) 
and PT (B) clotting times, on fibrin formation (C) and D-Dimer formation (D). The control 
represents untreated sample while the positive control represents the anticoagulant heparin 
(0.1 U.mL-1) (n = 3) 
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4.4 Conclusions 
A range of oxovanadium(IV) complexes with bidentate imidazolyl-carboxylato ligands were 
successfully prepared and characterized. Aqueous potentiometric titrations revealed that 
incorporation of the acidic carboxylic acid group did indeed improve stability at low pH values 
compared to the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands in Part 1, Chapter 3. Additionally, 
when including citric acid in the titrations, ternary complex formation of vanadyl with the imidazole-
carboxylic acid and citric acid was highly favoured. The prepared complexes exhibited minimal 
toxicity in the concentration range tested as well as glucose lowering activity in an in vitro assay 
using muscle, liver and fat cells. In addition, all of the complexes displayed anticoagulative activity 
as evidenced by inhibition of D-Dimer formation. The prepared oxovanadium(IV) complexes may 
represent an a lternative and competitive option to the well studied BMOV and V O(pic)2 
complexes, however in vivo studies would be required to unequivocally confirm this. 
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Chapter 5 
Conclusions and future work 
 
 
5.1  Conclusions 
The first set of oxovanadium(IV) complexes with 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands 
were successfully prepared and characterized. The solution model predicted that in the acidic pH-
range, these complexes would dissociate and thus, when administered orally would require the 
use of a drug encapsulation technique. Conversely, the excellent stability of the complexes under 
basic conditions would mitigate the formation of insoluble vanadyl hydrolysis species in the 
intestine and therefore improve uptake into the blood stream and subsequently cause less 
gastrointestinal stress. A series of imidazole-carboxylic acid ligands and the corresponding 
oxovanadium(IV) complexes were then prepared. The carboxylic acid group was significantly 
more acidic than the phenol group of the 2-(2ˊ-hydroxyphenyl)-1R-imidazoline ligands, which had 
the desired effect of improving low pH stability. All of the complexes demonstrated mild 
antihyperglycemic activity along with anticoagulation activity via D-Dimer inhibition.  
 
5.2  Future work 
It became very clear while undertaking this work that although the in vitro assay may be a useful 
indicator for antidiabetic activity, it does not accurately mimic the biological system, especially 
considering that the proposed mechanism of action of these vanadium drugs is not a typical drug-
receptor interaction (where the drug remains in-tact). Rather, it has been proposed that the main 
function of the ligands is to transport vanadium into the blood stream and prevent hydrolysis, after 
which they may be replaced partially or completely by bioligands.  
Thus rat-model studies (eg. STZ, Zucker or Cafeteria diabetic rats), which account for the 
digestive system and t he interaction of the vanadium complexes with transport proteins in the 
blood, would be important to make any reasonable comparisons with current lead compounds. On 
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that note, the interaction of these complexes with transferrin in particular may provide further 
information, especially considering that there has been few, if any, studies relating the formation 
of ternary complexes to toxicity or antidiabetic activity. Thus an in-depth study comparing a range 
of different oxovanadium(IV) complexes, each coordinated to ligands which fall under the 
categories of weak, intermediate or strong carrier, may provide insight into a different or parallel 
mechanism of cellular uptake or antidiabetic action. 
  
101 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
 
 
 
 
 
 
 
 
 
 
This page has been left blank intentionally 
102 
 
 
Part 2. Chapter 1 
 
 
 
 
 
 
Part 2 
Catalytic properties of heterogeneous oxovanadium(IV) complexes 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
Chapter 1  
Introduction 
 
1.1 Catalysis 
The term catalysis, first coined in 1836 by Berzelius, refers to a process in which a substance (the 
catalyst) influences the rate of a r eaction without being consumed.1 Since then, the field of 
catalysis has expanded rapidly especially with the advent of ‘green chemistry’. The chemical 
industry is arguably the most successful sector of the manufacturing industry. Within this industry 
approximately 75% of chemicals are produced with the aid of catalysts.2 Catalysts can be 
subdivided into two main types namely; homogeneous and heterogeneous catalysts. These 
names refer to the phase in which they exist with the reaction medium.  
The value of homogeneous catalysts cannot be understated, especially under laboratory scale 
conditions. However, the industrial applicability of these catalysts is quite limited compared to the 
heterogeneous counterparts. The main reason for this can be l inked primarily to the difficulties 
associated with separation of homogeneous catalysts from the reaction solution. Not only does 
this lead to increased costs, but also environmental concerns. The very nature of these catalysts 
also limits their use to batch rather than continuous flow reactions, another negative for industrial 
application.3 A table comparing these two types of catalysts has been included (table 1.1). 
 
Table 1.1 Comparison of homogeneous and heterogeneous catalysts2 
Heterogeneous Catalysts Homogeneous Catalysts 
Simple separation and recyclability Often difficult to separate 
Diverse process applicability Limited process applicability (batch only) 
Diffusion controlled Diffusion limitations practically absent 
Lower selectivity Generally high selectivity 
Thermally stable Lower thermal stability 
Well defined structure Structure can be difficult to identify 
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1.2  Vanadium in catalysis 
Vanadium is one of  the most abundant metals in the earth’s crust, found in over a h undred 
different minerals as well as in crude oils bound by porphyrins.4 The majority of vanadium is 
extracted from titaniferrous magnetite ores, with about 38 000 tonnes being produced annually. 
Most of this is used as a steel additive (80%) or in combination with other metals to form strong 
light weight alloys, commonly used in the aerospace industry.  
Other than the metallurgical applications, the most common use of vanadium is in the field of 
catalysis, accounting for about 5% of the annual production of this metal.5 Vanadium catalysts are 
used in the manufacture of a number of important chemicals, the most commonly known of these 
probably being the production of sulfuric acid by the Contact process. Other industrial applications 
include the production of phthalic and maleic anhydride,6 oxidation of sulfur dioxide7 as well as the 
removal of nitrogen oxides which are of environmental concern.8 The catalytic capabilities of 
vanadium go far beyond these few reactions. To name a few, supported vanadium catalysts have 
been used for the selective oxidation of alkanes and alkenes, oxidation of methanol to 
formaldehyde, photo-oxidation of CO, oxidation of H2S, polymerization of olefins and the oxidative 
coupling of methane.5 A brief description of some of the reactions in which vanadium based 
heterogeneous catalyst are utilized has been included (table 1.2). 
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Table 1.2 Overview of a few reactions catalyzed by supported vanadium catalysts 
Catalytic Reaction References 
Oxidation of alkanes, alkenes and alcohols 9,10 
Olefin polymerization 11 
Oxidative halogenation 12 
Oxidation of methanol to formaldehyde 13 
Epoxidation of alkenes 14 
Hydroxylation of benzene and phenol 15,16 
Oxidation of H2S to S 17 
Hydroamination and oxidative amination 18,19 
Asymmetric epoxidations and oxidations 20 
Addition of propargyl alcohols and imines 21 
Biginelli condensation of an aldehyde β-keto ester and urea 22 
Enantioselective oxidative coupling of 2-naphthols 23 
 
Many of these processes utilize the heterogeneous forms of vanadium catalysts. Commonly, a 
vanadium oxide phase is deposited on the surface of an oxide support such as, SiO2, Al2O3, TiO2 
and ZrO2. Other than the silica, alumina and other metal oxides; organic polymers, zeolites and 
carbon have been used as supports for immobilization of homogeneous catalysts. The four main 
methods for preparing heterogeneous catalysts or immobilizing (heterogenization) homogeneous 
catalysts are listed below and include;  
1. Adsorption 
2. Encapsulation 
3. Covalent linking  
4. Electrostatic interactions. 
 
In the first method (adsorption), predominantly van der Waals interactions keep the catalyst bound 
to the support. This is typically a weak interaction which may be improved by hydrogen bonding or 
other interactions such as π-stacking. Encapsulation does not rely on bonding interactions but 
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rather on pore sizes of the support. Of course the catalyst must be l arger than these pores to 
prevent leaching. The advantage of this technique is that it probably best represents the original 
homogeneous catalyst since there are no bonding interactions that could affect the electronic 
properties of the metal. Conversely, techniques such as covalent linking and immobilization via 
electrostatic interactions have obvious ramifications in terms of the catalysts’ electronic properties. 
The latter technique relies on the same concept as ion exchange with silicates and zeolites 
commonly used as supports in this regard. Covalent linking, as the name suggests, utilizes strong 
covalent bonds to immobilize the catalysts resulting in a fairly stable material.  
 
1.2.1  Naturally occurring vanadium-dependent haloperoxidases 
As is so often the case, ‘mother nature’ was the first to discover the oxidative catalytic potential of 
vanadium. The class of enzymes known as vanadium-dependent haloperoxidases (VHPO’s) are 
capable of oxidising halides (iodide, bromide, chloride) in the presence of hydrogen peroxide to 
form halogenated organic compounds which are thought to provide chemical defence for the 
associated organisms.24 These enzymes are further classified based on the most electronegative 
halogen oxidized. Thus, vanadium chloroperoxidases (V-ClPOs) can oxidize chloride, bromide 
and iodide, while vanadium bromoperoxidase can oxidize bromide and iodide.25 The general 
reaction that these enzymes catalyze is shown below: 
𝐻2𝑂2 + 𝑋− +  𝑹 − 𝑯 + 𝐻+ → 𝑹 − 𝑿 + 2𝐻2𝑂 
VHPO’s catalyze the two electron oxidation of a halide (X-) using H2O2 as an oxidant to afford a 
halogen intermediate (such as Br+ or biological equivalent).26 Following this, the halogen 
intermediate can react with either an organic substrate to afford the halogenated organic 
molecules, or with another equivalent of hydrogen peroxide, producing singlet state diatomic 
oxygen (1O2*).
27,28 
These enzymes are quite robust, capable of withstanding temperatures of up to 70 °C as well as 
surviving in organic solvents and excess H2O2. VHPO’s are commonly found in marine algae such 
as A. nodusum, C. pilulifera, Cor. officinalis to name a few (figure 1.1).26 Several single crystal X-
ray structures of these enzymes have been solved and while some differences between them 
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exist, the vanadium binding sites are relatively conserved. 24,29 As the name suggests, the 
enzymes contain a vanadium atom located in the active site which adopts a five-coordinated 
trigonal-bipyramidal geometry. This centre is coordinated to four oxygen atoms, three hydroxyl 
oxygens in equitorial positions and an oxo group in an axial position. Interestingly, in the binding 
site of all VHPOs, vanadium is bound by an imidazole group of a histidine residue coordinated to 
the remaining axial position trans to the oxo group in the trigonal-bipyramid (figure 1.2).24,29  
 
 
Figure 1.1  Bromoperoxidases are found in A. nodusum (A), Cor. officinalis (B) and X. parietina (C)30,31 
 
 
Figure 1.2 The active site of the bromoperoxidase from Ascophyllum nodusum showing vanadium 
coordinated to the imidazole group of a histidine residue (HIS 486) and the close proximity of 
two other histidine residues (HIS 418 and HIS 411). PDB ID: 1QI9, illustrated using UCSF 
Chimera29 
 
The discovery of these enzymes has incited the development of structural and functional VHPO 
model complexes.32 Many of these complexes contain imidazole33,34 and benzimidazole-based 
ligands,35,36 and all have shown promising catalytic activity. Despite this, there is still a need for 
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further perfection of these complexes in terms of geometrical similarity and activity.37 In addition, 
the activity of these VHPO models is not limited to halogenation reactions and encompasses 
numerous oxidation reactions including sulfides, alkanes, alkenes and alcohols.36,38 
 
1.2.2  Catalytic mechanism of oxovanadium(IV) oxidations 
Several studies have been performed focusing on the determination of the catalytic mechanism of 
these so called ‘VHPO-inspired’ catalysts.36 Comprehensive 51V NMR,39 UV/Vis33 and EPR39 
studies suggest initial oxidation of oxovanadium(IV) to dioxovanadium(V) followed by addition of 
the peroxide to form the oxoperoxo-species (scheme 1.1). Furthermore, in an acidic medium, the 
peroxo may protonate to form the hydroxyl-peroxovanadium(V) species.40 These peroxovanadium 
species are more reactive than the original hydrogen peroxide and react with the substrate to 
afford the oxidation product.24  
 
 
Scheme 1.1 Simplified catalytic mechanism for the vanadium-peroxide oxidation of alkenes, alkanes and 
sulfides. Here L may refer to an adjacent donor atom or a solvent molecule. 
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1.3  Support materials for immobilization of homogeneous catalysts 
The support material influences the performance of the catalysts significantly and as such should 
be developed with a sound understanding of the chemical processes being investigated. Thermal, 
chemical and mechanical stability along with large surface areas are just a few of the desirable 
components that make for a us eful support.3 Silica-based resins have become an ex tremely 
popular choice as catalytic support materials due t o the low cost, wide availability, mechanical 
stability and high porosity.41 The group of crystalline alumisilicates known as zeolites form another 
popular choice. The well-defined pore shape and size of these materials offers the advantage of 
shape/size selective catalysis, in which only molecules smaller than the pore diameter will take 
part in the reaction.42 This thesis focuses on the use of polymers as support materials.  
 
1.3.1  The basics of polymerization 
Polymer supports have only recently (the last few decades) begun to gain popularity. The initial 
lack of interest was possibly due to the underlying suspicion that being organic themselves, these 
supports could take part in the reaction, for example by being oxidized, thus eventually leading to 
deterioration of the support. Although this is a valid concern, it has proven to be less of a problem 
than initially suspected.43 As will be shown in this section, there are a vast number of chemical 
modifications that can be performed on po lymers, producing unique materials with interesting 
functionalities.  
Perhaps the most popular method of producing polymeric material is that of radical initiated 
polymerization. This is probably due to the wide variety of monomers that lend themselves to this 
type of reaction. Certain vinyl monomers may undergo polymerization on heating even in the 
absence of an initiator; however most require an initiator of some kind. Radical initiators may be 
divided into four major groups; peroxides and hydroperoxides, azo compounds, redox initiators 
and photoinitiators. The most popular of these are benzoyl peroxide, tert-butyl hydroperoxide, 2,2-
azobisisobutyronitrile, potassium persulfate and benzophenone respectively (table 1.3).  
These initiators provide the initial radical which then reacts with the vinylic monomer. This radical 
containing monomer reacts with another monomer to form a dimer radical species. This process 
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is known as chain propagation and continues until terminated by radical coupling, combination or 
disproportionation (scheme 1.2). Chain transfer in radical polymerization refers to the process 
whereby the propagating radical combines with a transfer agent yielding a dead polymer and a 
small radical. Should this radical be unstable, it may combine with the monomer to initiate chain 
growth of a new polymer. The general effect of a chain transfer agent is a reduction in the degree 
of polymerization and hence shorter polymer chains are produced.44 
 
Table 1.3 Some common thermal free radical initiators for polymerization of vinyl monomers 
Name Structure Name Structure 
Benzoyl peroxide 
 (BPO) O
O
O
O
 
2,2-Azobisisobutyronitrile  
(AIBN) 
 
 
N
C N
N C
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Scheme 1.2 Radical initiation (a), propagation (b-c) and termination (d) 
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1.3.2  Soluble polymer supports 
The use of polymers as support materials is widespread.45,46 Soluble (linear) polymers have been 
used as support materials for catalysts, the aim of these being to bridge the gap b etween 
heterogeneous and homogeneous catalysts. Diffusion limitations associated with heterogeneous 
catalysts are reduced due to the polymer solubility, but the polymers may be collected by 
precipitation using a non-solvent however, this method can result in sticky polymers that are 
difficult to work with. Other methods of recovery include tedious micro and ul trafiltration. Then 
there are the solution problems, the polymer must dissolve in the reaction solvent, but should not 
be used at high concentrations that make the solution too viscous. For this reason, the concern 
from here on will be on purely heterogeneous polymer supports. 
  
1.3.3  Techniques for producing polymer beads 
Polymers can be made insoluble by the addition of a crosslinking agent. The crosslinker typically 
contains two or more sites for polymerization thereby linking different polymer chains to make a 
highly branched but interconnected network. The most frequently used crosslinkers are 
divinylbenzene (DVB) and ethylene glycol dimethacrylate (EGDMA), however there are many 
others (table 1.4). Different forms of these insoluble polymers can be obtained depending on the 
type of polymerization used. Probably the simplest method is that of bulk polymerization, in which 
the functionalized monomer, crosslinker and initiator are polymerized in the absence of a solvent. 
The resultant monolith can be crushed and sieved to obtain particles with relevant diameters.  
In this study we are primarily concerned with the forms of polymerization that produce particles 
with specific morphologies since irregularly shaped particles may, for instance, break down to 
form fine particles. A number of different polymerization techniques exist which are capable of 
meeting these requirements, the most popular being emulsion, dispersion and s uspension 
polymerization. Emulsion polymerization typically gives uniform sized particles with diameters of 
less than 1 μm. Dispersion and suspension polymerization produce larger beads but with a broad 
particle size distribution.47  
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Table 1.4 Structures and names of some common crosslinking agents 
Name Structure Name Structure 
Divinylbenzene (DVB) 
 
N,N’-m-
phenylenebis-
(methacrylamide) 
 
m-Diisopropenyl-
benzene (DIP) 
 
N,N’-m-
phenylenebis-
acrylamide  
Ethylene glycol 
dimethacrylate 
(EGDMA) 
 
N,N’-
Bisacrylylcystamine 
 
Tetramethylene glycol 
dimethacrylate 
(TDGMA) 
 
Trimethyloylpropane 
trimethacrylate 
(TRIM) 
 
N,N’-
ethylenebisacrylamide 
(EBAAM) 
 
Pentaerythritol 
triacrylate (PETRA) 
 
N,N’-hexamethylene-
bisacrylamide 
(HMEBAAM) 
 
Pentaerythritol 
tetraacrylate 
(PETRA) 
 
 
(a)  Emulsion polymerization 
First developed in the 1920’s by the Goodyear Tire and R ubber Company, emulsion 
polymerization accounts for a huge amount of the total polymer production, more than 20 million 
tons per year.48 In this technique, a hydrophobic monomer is dispersed in an aqueous phase by 
use of a surfactant (often termed emulsifying agent). Unlike suspension polymerization, a water-
soluble radical initiator is used. The radicals diffuse from the aqueous phase into the swollen 
monomer containing micelles and as the monomer is depleted, more migrates into the micelles 
(figure 1.3)49 allowing for the formation of very large molecular weight polymers. Much smaller 
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diameter spheres (compared to suspension polymerization) can be obtained using this method.42 
The main disadvantage of this type of polymerization is contamination of the product with 
surfactants and additives. Although these resins are much smaller and consequently may have 
high surface area-to-volume ratios, they can become difficult to separate from solution and often 
centrifugation is required.  
 
Surfactant Molecule
Initiator Molecule
Monomer
Droplet
Micelle FormationPolymerization  
Figure 1.3 Illustration of the process of emulsion polymerization 
 
(b)  Dispersion and precipitation polymerization 
In dispersion and precipitation polymerization a monomer, initiator and often a s tabilizer are 
dissolved in a solvent. As the polymer grows it becomes insoluble in the solvent and precipitates 
out as discrete particles. The stabilizer, often a polymer modifier, helps to prevent agglomeration 
by providing a steric barrier. This technique produces spheres with sizes between those produced 
by emulsion and suspension polymerization (0.1 – 10 μm). In dispersion polymerization the 
polymer particles formed early on are the mean locus of polymerization. On the other hand in 
precipitation polymerization the locus of polymerization is the continuous phase because of the 
lack of swelling of the precipitated polymer. This means that polymer particles continue to grow 
during polymerization and diameters from nanometer to low micrometer can be obtained.42,50  
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(c)  Suspension polymerization 
The relative simplicity and reproducibility of suspension polymerization make it a practical, 
frequently exploited option under both lab and industrial scales. In normal suspension 
polymerization, the monomers and the polymerization initiator are dissolved in an organic solvent 
which is immiscible with water. This organic phase is added to an aqueous phase containing 
stabilizing agents. Small droplets containing the monomers and initiator form upon m ixing. The 
mixture is then heated to initiate polymerization (for thermal based initiators). Since the kinetics 
during this type of polymerization are essentially identical to bulk, one could regard the droplets as 
minibulk polymerization reactors. However, unlike bulk polymerization the heat is more effectively 
controlled by the surrounding aqueous phase. For normal phase suspension polymerization, the 
monomers should be insoluble in the aqueous phase, while reverse phase suspension 
polymerization as the name suggest, is essentially the inverse (monomer soluble in water). The 
stabilizing agents maintain stable droplets, prevent droplet coalescence and adhesion of partially 
polymerized particles so that beads with similar spherical morphology can be obtained.  
The process has been illustrated in figure 1.4. Flask (A) contains an organic phase consisting of 
a monomer, initiator (I*) and organic solvent as well as an aqueous phase containing a stabilizer. 
After mixing and heating (B), polymer beads form. These beads are coated by the stabilizing 
agent (C) which can be removed by washing.  Some examples of stabilizing agents include; 
poly(vinylalcohol) (PVA), poly(vinyl pyrrolidone) (PVP), cellulose derivatives and gelatine.  
 
R +  I*  + Solvent
H2O  +  Stabilizer
(A) (B)
(C)
 
Figure 1.4 A schematic of a typical suspension polymerization procedure 
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The bead s ize depends on several factors including; stirring speed, ratio of water to monomer, 
concentration and type of stabilizer and solution viscosities. Typically, beads with sizes in the 
micrometer range are prepared by this method. These beads can be easily collected and 
separated by filtration and sieving, respectively. Porosity is another important property which 
depends primarily on the amount of crosslinker as well as the type of solvent, in this context 
referred to as the porogen. Beads obtained when using a low amount of crosslinker (typically less 
than 8%) are referred to as gel type resins which may swell significantly in certain solvents. This 
swelling ensures efficient diffusion of reactants and products. The swelling is highly dependent on 
the solvent used as well as any chemical modifications made to the polymer. Using a gel-type 
chloromethylated polystyrene resin as an example, the resin swells significantly in toluene but 
completely collapses in water (due to the hydrophobic nature of the material) but after reacting 
this resin with trimethylamine to form the benzyltrimethylammonium groups, the resin swells in 
water and collapses in toluene.51 These gel type resins are soft and compressible and as such 
unsuitable for many robust applications. Higher amounts of crosslinker can produce macroporous 
resins. These resins typically have higher surface areas in the dry state, are more resistant to 
osmotic shock and do not need to be swelled in a solvent since the pores are rigid.    
The particle/bead diameters that can be o btained using the above mentioned and other 
techniques have been illustrated in the figure below (figure 1.5).  
 
100 101 102 103 104 105 106
Emulsion Polymerization Suspension Polymerization
Nonaqueous dispersion
Microgels
Surfactant free emulsion polymerization
Microemulsion
Unilamellar vesiclesMicelles
(nm)
 
Figure 1.5 Typical particle sizes obtained using different polymerization techniques42 
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1.3.4  Techniques for producing polymer fibers 
Fibers may be produced by a variety of methods including; drawing,52 template synthesis,53 
deposition on a substrate, thermally induced phase separation and spinning. Of the spinning 
methods, electrospinning allows for fabrication of extremely fine (low nanometer) fibers54 and will 
be discussed in greater detail below. Each of these methods have their associated advantages 
and disadvantages as summarized below (table 1.5). 
1. Drawing: This method is very similar to dry spinning. Fibers are drawn from a 
microdroplet of polymer solution by dipping an object, for example a micropipette, into the 
droplet and withdrawing at a certain speed. This discontinuous process requires 
viscoelastic materials and has a lower limit for fiber diameters of 100 nm.52 
2. Template Synthesis: Template synthesis, as the name suggests, utilizes a nanoporous 
template through which the polymer solution is pushed. The resultant polymer fibers 
solidify in a suitable solvent. The diameter of the fibers is directly related to the diameter 
of the pores of the template and as such, excellent reproducibility can be obtained.55 
3. Phase Separation: There are several steps to this process including; polymer 
dissolution, gelation, solvent extraction, freezing and freeze drying to finally give a porous 
nanofibrous structure. The formation of fibers occurs due to physical incompatibility.56  
4. Self Assembly: This method provides ultrafine fibers with diameters typically less than 
100 nm. Unlike the other methods, this is a ‘ bottom-up’ approach in which atoms and 
molecules arrange via weak non-covalent interactions into well defined structures.57 
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Table 1.5 Advantages and disadvantages of various fiber processing techniques66,67 
Process Advantages Disadvantages 
Electrospinning - Up-scalable 
- Repeatable 
- Convenient (and cheap) 
- Can control fiber size and 
orientation to an extent 
- Well established technique 
- Cost effective 
- Long continuous fibers 
produced 
- Difficult to control porosity and 
pore shape 
- Has lower limit to fiber diameter 
- Jet instability 
- Difficult to fabricate 3D shapes 
- Can be time consuming 
- Harmful solvent vapours 
Self Assembly - Simple fabrication 
- Repeatable 
- Excellent control of 3D 
shape 
- Good for obtaining smaller 
nanofibers 
- Inconvenient/complex process 
- Poor control of fiber diameters 
- Difficult to control pore size and 
shape 
 
Phase Separation - Excellent control over pore 
shape and size 
- Excellent control over 3D 
shape 
- Good consistency 
- Little control over fiber diameter 
and orientation 
- Longer fabrication times (many 
steps involved) 
- Limited to specific polymers 
Template Synthesis - Repeatable 
- Convenient 
- Good control of diameters – 
different diameters obtained 
using different templates 
- Limited fiber length 
- Difficult to upscale process 
Drawing - Repeatable 
- Convenient 
- Minimum equipment 
required 
- Poor control of fiber diameters 
- Discontinuous process 
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(a)  Electrospinning 
One of the great draw cards of electrospinning is the low cost and relative simplicity of the 
equipment needed. Perhaps the most sophisticated piece would be the high voltage DC power 
supply. This is connected to an electrode in contact with a suitably viscous polymer solution or 
melt. Fibers can be c ollected on a gr ounded or oppositely charged surface.58 Commonly the 
collector used is a rotating drum or a piece of grounded foil, however several interesting variations 
exist.59 Charge is commonly introduced to the polymer solution by connecting a needle (through 
which the polymer flows) to the power supply.60 Another simple method involves immersing a 
copper wire connected to the power supply into a polymer solution contained within a simple glass 
pipette.61,62 The typical electrospinning set-up used in this study has been illustrated in figure 1.6. 
 
 
Figure 1.6 The electrospinning equipment used for the fabrication of polymer fibers for this thesis 
 
The first electrospinning apparatus was developed over a century ago by Cooley (figure 1.7)63 but 
Anton Formhals was the first to describe the electrospinning of plastics in 1934.64 While there 
were some developments after this, the technique only became widely popularized with the 
advent of nanotechnology. One can see a huge increase in the number of publications relating to 
electrospinning - in 1994 there were just 3 and in 2010 there were over 2,500 publications (figure 
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1.8). The research into this field seemed to grow almost exponentially after the publication of a 
review on t he topic by Huang and co-workers entitled; “A review on polymer nanofibers by 
electrospinning and their applications in nanocomposites”, in 2003.65  
 
 
Figure 1.7 Drawing of the first recorded electrospinning apparatus as described by Cooley in 190263 
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Figure 1.8 Scifinder Scholar© publication frequency analysis for the search term “electrospinning” or 
“electrospun” between 1994 and 2010 
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(b)  The process of electrospinning 
The viscous polymer (composite or sol-gel) solution, or melt forms a dr op at the spinneret, 
typically a blunt end needle or pipette. The electric field draws this droplet into a structure known 
as the Taylor cone.68 The surface tension is overcome when there is sufficient electrostatic 
repulsion resulting in the formation of a pol ymer jet. As the jet accelerates towards a c ounter 
electrode (typically ground) it undergoes bending and elongation and at the same time solvent 
evaporates until a fine solid fiber forms.69 Although electrospinning seems simple from an 
instrumentation point of view, there are several parameters that influence this process. These 
parameters can be r oughly divided into three groups; polymer solution, process and am bient 
condtions.70 
 
i) Polymer solution properties include parameters surrounding the type and molecular weight 
of the polymer. 68,70 Viscosity is an extremely important property to consider when conducting 
electrospinning. An increase in the molecular weight or concentration of polymer results in an 
increase in chain entanglements in the polymer solution, a critical property for effective 
electrospinning.58 Too low a viscosity and fibers will not form due to insufficent chain 
entanglement. Typically bead-on-string or electrospraying occurs under these conditions. 
Increasing the viscosity, on the other hand, generally results in an increase in fiber diameters 
up to a critical point, after which interactions between polymer chains become too significant 
to be overcome by the applied electric field. Other polymer solution parameters include; type 
of solvent used, conductivity of the polymer solution and the dielectric constant of the 
solvent.68,70  Of course it is important that the polymer be s oluble in the solvent, however, 
rate of evaporation and surface tension of the solvent should also be considered. The rate of 
evaporation dictates the solidification of the fibers, however, premature solidification which 
results in clogging, may take place should evaporation occur too rapidly. Surface tension 
along with solution viscosity influences the critical voltage required to begin the 
electrospinning process. This follows considering that the polymer jet erupts from the 
hanging polymer solution drop. The stretching of a pol ymer jet is caused primarily by the 
build up and repulsion of charges at its surface. A higher solution conductivity assists with 
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the accumulation of charge and t hus assists the formation of fibers and f urther promotes 
stretching of fibers. The effect of of this is to decrease the resultant fiber diameters. The 
limited conductivity of organic solvents is commonly remedied by introducing a salt such as 
lithium chloride into the solution. Finally, a high dielectric constant of a solvent concentrates 
the electrostatic flux lines leading to better stretching of the polymer jet.68,70 
 
ii) Process parameters include the applied voltage, the polymer solution feed rate, the tip-to-
collector distance.68,70 The applied voltage which provides the charges necessary to 
overcome surface tension and s ubsequently produce the polymer jet, drives the 
electrospinning process. The polymer solution feed rate or flow rate, is the speed at which 
the polymer solution is delivered to the needle tip. For example, too high a f low rate may 
result in deposition of wet fibers and the flow rate also has a definite effect on the resultant 
fiber diameters. Increasing the tip-to-collector distance increases the flight time of the 
polymer jet and provides time for solvent evaporation as well as time for stretching of the jet. 
The net result is typically a decrease in diameter of the fibers with an increase in tip-to-
collector distance.68,70 
 
(iii)  Ambient parameters include temperature, humidity, and atmospheric conditions. The effect 
of temperature has an effect on several other parameters.68,70 An increase in temperature 
decreases the polymer solution viscosity and surface tension, while increasing polymer 
solubility, conductivity and rate of solvent evaporation. The humidity also affects solvent 
evaporation which consequently affects the solidification process of the polymer jet. Finally, 
the atmospheric conditions also affect electrospinning. The rate of evaporation for a pur e 
liquid from a free surface is proportional to the difference between the saturated and t he 
surrounding vapour pressure. Thus, the solvent will evaporate slower if the same solvent is 
present in the atmosphere. Since solvent evaporation takes place continually throughout 
electrospinning, this may result in a change in atmosphere which consequently results in 
non-homogeneous fiber characteristics.68,70 
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1.4 Functionalization of polymer supports 
Three of the main methods for functionalizing a polymer with a desired ligand are listed below: 
1. Attachment of a ligand, which contains an appropriate functional group, to a pre-prepared 
polymer which also contains a suitable functionality. This strategy will be referred to as 
the ligand-immobilization strategy. 
2. Graft polymerization of a suitable ligand monomer to a prepared polymer. 
3. Addition of a p olymerizable group to a ligand (monomerization) followed by 
(co)polymerization.  
The first method is probably the simplest and m ost commonly used. Merrifield resin, a 
chloromethylated polystyrene resin crosslinked with divinylbenzene, contains the “reactive” 
chloromethyl groups which readily undergo substitution reactions in the presence of a nucleophile. 
Therefore, any ligand which contains a s uitable nucleophilic group (eg. N-H, O-H, S-H, COOH 
etc.) will form a covalent bond ‘locking’ itself to the polymer backbone.71  
Graft polymerization involves connecting a p olymerizable ligand, for example a vinyl containing 
molecule, to the surface of a preformed polymer. Reactive radicals on the polymer surface can be 
introduced using a chemical or radiation (UV, ɣ-irradiation, etc) based approach. Following this, 
radical polymerization may proceed thereby ‘coating’ the surface of the polymer. 
The third method is not as simple since it combines both synthetic organic chemistry with polymer 
chemistry. Some of the synthetic strategies for producing monomerized ligands have been 
discussed below. Unlike radiation-induced graft polymerization (2), however, both 
copolymerization (1) and ligand-immobilization methods (3) do not require additional equipment. 
 
1.4.1  Monomerization  
As mentioned above, there are a few approaches to prepare ligand-functionalized polymers. The 
copolymerization strategy relies on the availability of a po lymerizable ligand and the process of 
preparing such ligands is commonly referred to as monomerization. One of the simplest methods 
for achieving this involves alkylating the ligand with a s uitable polymerizable precursor. This 
123 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
procedure has been illustrated in scheme 1.3. In this scheme, an alcohol containing compound 
(this could also be any other nucleophile such as amine or thiol) is reacted with a polymerizable 
group which contains a good leaving group (L). This alkylation is promoted by addition of a base 
such as a metal hydroxide (MOH). This final result of this procedure is the production of a new 
polymerizable ligand. 
A few of these polymerizable starting materials have been included below (table 1.6). To use 
vinylbenzyl chloride (VBC) as an example; this commercially available reagent, reacts with 
nucleophiles by a substitution reaction, thereby connecting the ligand to the styryl group. Typically 
these reactions are carried out in polar aprotic solvents such as acetonitrile or DMF in the 
presence of a base like triethylamine, potassium carbonate, or potassium hydroxide.47 Catalytic 
amounts of potassium iodide (KI) are often added because iodide, which is a better leaving group 
than chloride for example, may exchange with the chloride thereby improving reaction rates and 
yields.72 
R OH + L O
M+L-
+ MOH
R
 
Scheme 1.3 Introduction of a polymerizable group by alkylation reaction 
 
Table 1.6 Names and structures of some common polymerizable groups used to make polymerizable 
ligands 
Name Structure Name Structure 
4-Vinylbenzyl chloride 
 
2-Chloroethyl acrylate 
 
Allylbromide  Methacryloyl chloride 
 
Acryloyl chloride 
 
2-Chloroethyl-2-methylacrylate 
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There are two main questions that ought to be considered when adopting this approach of ligand 
functionalization: 
1. Firstly, does the ligand contain a suitable nucleophilic group for attachment of the 
polymerizable group? 
2. Secondly, are there other nucleophilic centers which may also react with the 
polymerizable group? 
The first question is relatively straight forward, either the ligand has the correct nucleophilic group 
or not. If not, it could be introduced by a set of reactions, for example by hydroxylation (O-H)73 or 
amination (N-H). The second question introduces some challenges and is especially important 
considering that ligands designed for metal coordination often contain reactive hydroxyl, amine, 
thiol and carboxylic acid functionalities – alkylation of the donor atoms has obvious negative 
ramifications. Regioselective alkylation can be challenging74 and thus the typical approach for 
overcoming this issue involves the use of protecting group chemistry.  
To illustrate this concept in use, the ‘tri-functional’ molecule diethylenetriamine was monoalkylated 
with vinylbenzyl chloride with the aid of phthalic anhydride as a protecting group. The triamine 
was reacted with phthalic anhydride which protected both primary amines leaving the secondary 
amine free for reaction with vinylbenzyl chloride. This product was then deprotected using 
hydrazine to afford the vinylbenzyl functionalized ligand (scheme 1.4).75  
H
N
H2N NH2 + O
O
O
H
N
N N
O
O O
O
Cl
N
N N
O
O O
O
N
H2N NH2
H2N NH2
 
Scheme 1.4 Synthesis of polymerizable diethylenetriamine 
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As was the case for the styryl group, the allyl group has been introduced via typical nucleophilic 
substitution reactions using allyl bromide. Monosubstituted N-allylethylenediamine has been 
achieved under careful conditions, using a l arge excess of ethylenediamine to help prevent 
dialkylation (scheme 1.5).76 Similarly, an allyl ether may be formed by reaction of allylbromide 
with salicylaldehyde under basic conditions. A commonly employed reaction at this point is the 
Claisen rearrangement to form the corresponding allylphenol – 2-hydroxy-3-allylbenzaldehyde 
(scheme 1.6).77 This type of rearrangement is crucial from a coordination chemistry perspective 
since the phenol group remains available for coordination to a metal center.  
 
H2N
NH2
H2N
H
N
Br
 
Scheme 1.5 Synthesis of monosubstituted N-allylethylenediamine76 
 
OH
O
OH
O
Br
O
O
∆
K2CO3
Acetone
 
Scheme 1.6 Preparation of allyl functionalized monomer by alkylation and Claisen rearrangement77 
 
The 3-allyl substituted salcylaldehyde provides a foundation for the synthesis of numerous 
polymerizable ligands since the salicylaldehydes are widely used to prepare metal chelating salen 
ligands.77 It has however been reported that allyl monomers do not  undergo polymerization as 
readily as vinyl monomers. The reason for this is reported to be du e to the chain termination 
process known as degradative chain transfer.78 As mentioned earlier, a solvent may react with a 
growing radical rather than a monomer molecule. In scheme 1.7 for example, a growing radical 
reacts with the solvent (carbon tetrachloride) resulting in the formation of a s olvent radical (a). 
This radical may then initiate chain propagation with a n ew monomer (b). In this context the 
expression ‘termination’ is somewhat misleading, since the solvent which now contains a free 
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radical may start a new chain. If the solvent radical was inactive, for example due to resonance 
stabilization, and did not combine with a new monomer, the chain reaction would be terminated. 
This same process may occur with the allyl monomer as shown below (scheme 1.8). Here, the 
growing radical reacts with an allyl alcohol (a) which is resonance stabilized (b) and hence 
unreactive towards further propagation. The result of this would be not only termination of the 
growing chain but also termination of the chain reaction.78 
 
R CH2CH
R'
CCl4+ R CH2CHCl
R'
CHCl3+
CHCl3 + H2C CHR' Cl3C CH2CH
R'
a.
b.  
Scheme 1.7 Chain transfer in solvent radical polymerization 
 
P CH2CH
CH2
+a.
OH
H2C CH
CH2
P CH2CH2
CH2
+
OHOH
H2C CH
CH
OH
H2C CH CH OH CH
H2C CH
OHb.
 
Scheme 1.8 Degradative chain transfer in the polymerization of allyl alcohol 
 
The acryloyl and methacryloyl groups are also typically introduced by the alkylation method using 
acryloyl and methacryloyl chloride respectively.79-81 The reason for using different polymerizable 
groups are vast, but typically the choice is based on ease of functionalization and 
characterization, the solubility of the resultant material and the reactivity ratio’s if copolymerization 
is to be used. With respect to the latter point, the general rule is that like goes with like. So if using 
styrene as a co-monomer, the ligand ought to be functionalized with a styryl group and if using 
methyl methacrylate, the ligand should be functionalized with a methacryloyl group. Although this 
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is by no means a har d and fast rule, it generally ensures that the monomerized ligand is 
adequately incorporated into the resultant polymer.47 
The vinyl group cannot be directly introduced as simply as the above mentioned examples since 
vinyl chloride does not typically undergo nucleophilic substitution reactions. Thus, direct 
introduction of the vinyl group requires different synthetic methods. Coupling reactions have 
become generally popular, especially with the 2010 Nobel Prize for chemistry being awarded to 
the chemists behind these reactions. These reactions are also commonly used to introduce vinyl 
groups. Once again, protecting group chemistry should be considered since certain nucleophiles 
may hinder carbon coupling reactions by coordinating to the catalyst.82  Sellergren et al., 
discovered that directed Pd-catalyzed coupling of the vinyl group with 2-(2ˊ-hydroxy-5-
bromophenyl)imidazole was not possible due to the presence of the basic nitrogen.83 For this 
reason, benzoyl protecting groups were introduced (by a reaction with benzoyl chloride), followed 
by introduction of the vinyl group via the Stille coupling using tributyl vinyl tin and 
tetrakis(triphenylphosphine)palladium(0) (table 1.7).83 Other than the Stille reaction, vinyl groups 
may also be introduced by Suzuki,84 Grignard,80 Wittig-type,85  elimination86 or decarboxylation 
reactions.87 A few examples of these reactions have been summarized in table 1.7. 
As has already been mentioned, care should be taken when choosing to functionalize the ligand 
of choice by alkylation with a polymerizable group and protecting group chemistry is often used to 
ensure the polymerizable group is connected to the desired position of the ligand. Other than 
synthetic challenges, there are also the issues of side reactions associated with some of these 
polymerizable groups. Acrylates and acrylamides, for example, tend to undergo conjugate 
addition while the other common side reaction is premature polymerization, which may be either 
radical induced or ionic. It may thus be n ecessary to perform purification steps as well as any 
subsequent reactions under “low risk conditions” - this may include decreased temperatures and 
elimination of light. Several radical inhibitors are available and may be used as additives to 
prevent premature polymerization. Most of these inhibitors are hindered phenols or hindered 
amine light stabilizers and are typically added in 0.01-0.1% concentrations.47 
Of course once the ligands have been functionalized with a vinyl group, they may be incorporated 
into the polymer backbone by a radical polymerization procedure. A crosslinking agent is often 
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used to increase robustness and reduce solubility (an important property of heterogeneous 
catalysts) of the resultant polymer. This method, although more complicated than the Merrifield 
approach, allows for a greater degree of freedom since the amount of crosslinker and monomer 
can be altered along with many other properties of the polymer. 
 
Table 1.7 Examples of reaction used for the introduction of the vinyl group 
Reaction type Example of reaction in use 
Stille Coupling83 N
N
O
BrBz
Bz
Pd[(PPh3)4]
tributyl(vinyl)tin N
N
O
Bz
Bz  
Suzuki Coupling72 
t-Bu
OH
O
HO + OHB
OH
t-Bu
OH
O
Pd[(PPh3)4]
Na2CO3
 
Grignard80 
O HOTHF, H2O
MgBr  
Elimination86 
N N
O
N N O
Cl N N
t-BuOK
THF
LDA
 
Decarboxylation87 N
NH
OH
O
N
NH
∆
 
Wittig85 O O
O MTPP+I-
   THF
potassium 
tert-butoxide  
 
In summary, the commercial availability and simplistic functionalization of chloromethylated 
polystyrene resins makes them a c ommon choice as catalyst supports. However, the ability to 
control the size, porosity, degree of crosslinking and degree of functionalization using the 
(co)polymerization techniques offers intrinsic advantages. A scheme summarizing the different 
methods for immobilizing homogeneous catalysts is shown in scheme 1.9. In route (A) of 
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scheme 1.9, a ligand containing a polymerizable group is copolymerized with a c o-monomer 
(often a crosslinker). In route (B), a polymerizable ligand is polymerized in the absence of a co-
monomer (the ligand itself may act as a crosslinker). Finally in route (C), a ligand is reacted with a 
pre-formed polymer; both contain appropriate functionality to allow for the formation of a covalent 
bond    
 
 
Scheme 1.9 A schematic showing some of the different approaches used for obtaining ligand-
functionalized polymer-supports 
 
1.5 Aims and objectives 
The principal aim of this study (and this Part in particular) was to prepare heterogeneous 
oxovanadium(IV) oxidation catalysts. As discussed herein, the active site of the VHPO’s all 
contain vanadium bound by the imidazole group of a histidine residue. It was thus decided to 
connect imidazole and imidazoline based ligands (some of which were prepared in Part 1 of this 
thesis) to a polymer support followed by functionalization with oxovanadium(IV). Methods for the 
production of polymer supports, as well as their effectiveness as support materials will be 
investigated. The research objectives can be broken down as follows: 
1. Prepare imidazoline/imidazole functionalized Merrifield resins and the corresponding 
polymer-bound oxovanadium(IV) catalysts and assess their catalytic activity. 
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2. Prepare imidazole functionalized polymer beads by using suspension polymerization and 
assess the catalytic activity of the oxovanadium(IV) functionalized beads. 
3. Prepare imidazole-based electrospun polymer fibers and the corresponding 
oxovanadium(IV) functionalized derivatives and assess their catalytic activity. 
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Chapter 2  
Experimental materials and methods 
 
2.1  General reagents 
Vanadyl sulfate hydrate was obtained from BDH Limited (England). Standard concentrations of 
vanadium for ICP calibration were prepared from a 1002 ppm (±2 mg.L-1) stock solution 
(Teknolab, South Africa). Ultrapure TraceSelect 65% nitric acid (Sigma-Aldrich) was used when 
digesting samples for ICP. The substrates used in the oxidation reactions, styrene, ethylbenzene 
and thioanisole (Sigma-Aldrich) and oxidant 30% aqueous hydrogen peroxide (Merck) were 
stored refrigerated (4 °C). The latter was standardized every few weeks by titration with potassium 
permanganate.1 Merrifield polymer (also called chloromethylated polystyrene) crosslinked with 
divinylbenzene (5.5% crosslinked, ~5.5 mmol Cl/g resin and 16-50 mesh) was purchased from 
Aldrich Chemical Company. Phenol red, 10% tetramethylammonium hydroxide (TMAOH), 
ethyleneglycol dimethacrylate (97%, EGDMA), divinylbenzene (80% remainder ethylbenzene, 
DVB) and benzoyl peroxide (70% remainder water) were purchased from Sigma-Aldrich. 
Pd(PPh3)4 (Sigma) and r adical initiators azobisisobutyronitrile (AIBN) (Sigma) were stored in a 
refrigerator at 4 °C. Polystyrene (Mw = 192,000) and polyvinylalcohol (88% hydrolyzed, Mw = 
130,000) were purchased from Sigma-Aldrich and Me rck, respectively. All solvents and general 
chemicals including N,N-dimethylformamide, toluene, ethanol, methanol, ethyl acetate, diethyl 
ether, triethylamine (97%), N-vinylimidazole, hydroxyethylcellulose, hydrochloric acid, 
allylbromide, ethylenediamine, salicylaldehyde, methyl salicylate, sodium chloride and lithium 
chloride were purchased from commercial sources (either Sigma or Merck) and us ed without 
further purification unless otherwise stated. 
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2.2       Techniques and instrumentation 
2.2.1 General instrumentation 
The infrared spectra were recorded on either a Perkin Elmer 2000 FTIR spectrometer in the mid-
IR range (4000 – 400 cm-1) as KBr pellets or as neat compounds with a Perkin Elmer 100 ATR-IR 
(4000 – 650 cm-1). Melting points were determined using Galenkamp Melting point apparatus 
equipped with a thermometer (0 – 400 °C). 1H and 13C NMR spectra of all ligands were recorded 
on a Bruker AMX 400 NMR MHz spectrometer and reported relative to tetramethylsilane (δ 0.00). 
Electronic spectra were recorded on a Perkin Elmer Lambda 25 UV-Vis spectrophotometer using 
1 cm quartz cells. Microanalysis was carried out using a Vario Elementar Microcube ELIII. Mass 
spectra were obtained using a Thermo-Finnigan GC-MS fitted with an electron impact ionization 
mass selective detector.  
 
2.3.2 Scanning electron microscopy 
Samples were prepared for scanning electron microscopy (SEM) by coating them in gold using a 
Balzers’ Spluttering device. The samples were viewed using a TESCAN Vega TS 5136LM 
typically at 20 kV at a working distance of 20 mm. 
 
2.3.3 Atomic force microscopy 
Atomic force microscopy (AFM) imaging was performed using a C P-11 Scanning Probe 
Microscope from Veeco Instruments (Carl Zeiss, South Africa) in non-contact mode at a scan rate 
of 1 Hz using a MP11123 cantilever. The images were obtained using a spring constant range of 
20 – 80 N.m-1, and resonant frequency range of 217 – 276 Hz.  
 
2.3.4 X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy (XPS) measurements were performed with a Kratos Axis Ultra 
X-ray Photoelectron Spectrometer equipped with a monochromatic Al Kα source (1486.6 eV). The 
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base pressure of the system was below 3 x 10-7 Pa. XPS experiments were recorded with 75 W 
power source using hybrid-slot spectral acquisition mode and an angular acceptance angle of +/- 
20°. The analyzer axis made an angle of 90° with the specimen surface, with the specimen 
surface making an ang le of 45° with the X-ray angle. Charge neutraliser was used due to the 
insulating surface used to prepare the sample. The elemental analysis and metal core level were 
recorded with a step of 1 eV and pass energy of 160 eV. XPS data analysis was performed with 
Kratos version 2 program. 
 
2.3.5 Inductively coupled plasma – Optical emission spectroscopy 
The vanadium content was determined using a Thermo Electron (iCAP 6000 Series) inductively 
coupled plasma (ICP) spectrometer equipped with Optical Emission Spectroscopy (OES) 
detector. Four wavelengths were chosen for vanadium detection (290.88 nm, 292.40 nm, 309.31 
nm, 311.07 nm). These wavelengths were the most sensitive and had the minimum amount of 
interferences. Three runs were performed at each wavelength. Additional operating parameters 
have been listed in table 2.1. Calibration was performed using no less than seven standards 
typically; 0.01 ppm, 0.1 ppm, 1 ppm , 2 ppm ; 5 ppm; 10 ppm and 20 ppm. The standards were 
prepared by appropriate dilution of a 1000 ppm stock solution. All solutions were filtered through 
0.45 μM Millipore® filters to prevent nebulizer blockages. The samples to be run were digested in 
ultrapure nitric acid or a mixture of nitric acid and hydrogen peroxide. Typically, these were heated 
at 50 °C for a per iod of 5 da ys to ensure total leaching of vanadium from the sample. After 
appropriate dilutions with triple distilled, deionised Millipore water, the samples were filtered and 
the vanadium content determined. 
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Table 2.1 ICP-OES method and operating parameters 
Parameter Setting 
Plasma Ar gas flow rate 5.0 L.min-1 
Auxiliary Ar gas flow rate 1.00 L.min-1 
Nebulizer Ar gas flow rate 0.90 L.min-1 
Sampling depth 8.5 mm 
Pump rate 100 rpm 
N2 addition flow rate 0.5 L.min
-1 
Cooled spraying chamber temperature 4 °C 
Selected wavelengths 
290.88 nm 
292.40 nm 
309.31 nm 
311.07 nm 
Sample flush time 30 s 
Points per peak 3 
Time scan acquisition 50 ms/point 
RF power 1150 W 
 
 
2.3.6 Brunauer, Emmett, Teller (BET) surface area analysis 
Nitrogen adsorption/desorption isotherms were measured at 77 K using a Micromeritics ASAP 
2020 Surface Area and Porosity Analyzer. Prior to each measurement, samples were degassed 
for a minimum of one week to ensure complete removal of adsorbed impurities. Degassing was 
performed at 70 °C for the linear polymers and at 150 °C for crosslinked polymers, unless 
mentioned otherwise. Approximately 0.2 g of sample was used and an equilibration interval of 20 
seconds was allowed during the run. The surface area (BET),2 total pore volume and pore size 
distribution (BJH method)3 were calculated from these isotherms. 
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2.3.7 Gas chromatography  
Progress of the catalysed reactions was monitored using either an Agilent 7890A gas 
chromatograph (GC) or an Agilent 6890, both fitted with a flame ionization detector (FID) and a 
Zebron, ZB-5MSi, capillary column (30 m x 0.25 mm x 0.25 μm). The product identities were 
confirmed using a Thermo-Finnigan GC-MS fitted with an electron impact ionization mass 
selective detector. The GC parameters have been summarized in table 2.2. The same conditions 
were used for analysis on the GC-MS 
 
Table 2.2 GC temperature programs used identification of the oxidation products of styrene, ethylbenzene 
and thioanisole 
 Substrate 
 Styrene/Ethylbenzene Thioanisole 
Initial Temperature 70 °C 60 °C 
Hold Time 2 mins 2 mins 
Ramp 20 °C.min-1 25 °C.min-1 
 Until 270 °C Until 260 °C 
Hold Time 2 mins 2 mins 
 
 
2.3.8 Thermogravimetric analysis  
Thermogravimetric analysis (TGA) was performed using a TA Instruments SDT Q600. Typically 
the samples were heated at a rate of 10 °C.min-1 under a constant stream of nitrogen gas. The 
temperature range differed depending on the sample used. The samples were contained in 
platinum pans. The onset of decomposition or mass loss (Tonset) was determined from the normal 
TG-curve, while the maximum temperature (Tmax), was determined from the peak of differential 
TG (DTG) curve.  
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Chapter 3  
Merrifield resin-based oxovanadium(IV) catalysts for oxidation reactions 
 
3.1  Introduction 
In the early 1960’s Merrifield set out to design a solid support for peptide synthesis, an effort that 
earned him the Nobel Prize in Chemistry in 1984.1 The requirement of the polymer support was 
that it should be insoluble in all relevant solvents, and that it should contain a functional group for 
amino acid attachment. The most suitable, he f ound, was a c hloromethylated poly(styrene-co-
divinylbenzene) copolymer in the form of 200-400 mesh beads.1 This discovery, although certainly 
directed towards peptide synthesis, also led to significant advances in the field of heterogeneous 
catalysis. A typical method for producing the heterogeneous catalyst may be as follows; an 
organic molecule is covalently linked to Merrifield resin through a nucleophilic substitution reaction 
to afford the functionalized polymer. This may itself act as a catalyst (eg. chiral catalyst) or may 
act as a ligand and subsequently allow coordination with a metal. Should the latter be the case, 
the ligand functionalized polymer may be reacted with a metal salt yielding the metal containing 
heterogeneous catalyst (scheme 3.1). 
 
Cl
Ligand
Ligand Ligand
M
My+Xz-
m n
k
m n
k
m n
k  
Scheme 3.1 A Simplified reaction scheme for the immobilization of homogeneous catalysts onto Merrifield 
resin. 
 
As Sherrington realised back in 1983, the use of polymer supports in the area of heterogeneous 
catalysis was an untapped resource. Since then the field has expanded significantly.2 The 
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popularity of these polymer supports may be attributed to ease of chemical modification. Over 50 
different functional groups including, but not limited to; carboxylic acids, amines, alcohols and 
thiols (scheme 3.2),3 have been attached to these supports. 
 
Cl
OR SR NHR NRR'R''+ O O
R
P+
R
R
R
 
Scheme 3.2 Functionalization of Merrifield-type resins3 
 
Focusing only on po lymer-supported oxidation catalysts, one c an find several examples of this 
diversity being utilized. Attachment of amine related ligands to PS-Cl has been performed often in 
the presence of a base and at elevated temperatures. The electropositive carbon atom attached 
to the chlorine atom in PS-Cl is attacked by the nucleophilic amine from the ligand. Sherrington 
and co-workers have used this reaction to attach 2-(2ˊ-pyridyl)imidazole (PIM) to PS-Cl and 
subsequently reacted this with molybdenyl acetylacetonate giving the heterogenized catalyst 
which was applied in epoxidation reactions.4  Maurya and co-workers have also published over 20 
papers related to polymer-heterogenized oxidation catalysts. This group has immobilized several 
imidazole and benzimidazole ligands to chloromethylated polystyrene,5-9  some of which are 
shown in figure 3.1. The ligand-modified Merrifield resins were subsequently reacted with various 
metals including vanadium, molybdenum, tungsten, copper and nickel, and used as catalysts for 
epoxidation,10 oxidation8,9 and bromination reactions.6,11 
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Figure 3.1 Structures of some imidazole-based ligands that have been anchored to PS-Cl5-9 
 
In this chapter, the preparation of imidazole and imidazoline functionalized Merrifield resins is 
discussed. These ligand-functionalized microspherical polymer-based resins were then reacted 
with vanadyl sulfate to afford the oxovanadium(IV)-functionalized materials, which were used as 
heterogeneous catalysts. The surface chemistry was investigated using atomic force microscopy 
and scanning electron microscopy. The catalysts were further characterized by microanalysis and 
infrared spectroscopy. The catalytic potential of these complexes was demonstrated by studying 
the oxidation of methyl phenyl sulfide (thioanisole), styrene, ethylbenzene and briefly the oxidative 
halogenation of phenol red. Several factors affecting selectivity and ov erall oxidation including; 
amount of peroxide, temperature and amount of catalyst were investigated. 
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3.2 Preparative work 
3.2.1 Synthesis of the ligands 
The ligands 2-(2ˊ-hydroxyphenyl)imidazoline (piminH), 1-methylimidazole-2-carboxylic acid 
(MeIm2COOH) and imidazole-4-carboxylic acid (Im4COOH) were prepared as reported in Part 1, 
Chapter 3 of this thesis. Pertinent characterization data of these ligands can been found within 
the same section. 
3.2.2 PS-pimin 
Chloromethylated polystyrene (1.0 g, 5.5 mmol Cl) was allowed to swell in DMF (15 mL) 
overnight. To this was added piminH (0.93 g, 5.7 mmol) followed by a s olution of triethlyamine 
(1.25 g) in ethylacetate (30 mL). The reaction mixture was then heated and stirred under reflux for 
9 hours. Following this, the cream-coloured beads were allowed to cool and then filtered and 
washed with hot DMF followed by ethanol. The beads were dried in the oven overnight at 60   °C. 
Due to some degradation from mechanical stirring the beads were first passed through sieves of 
various mesh sizes such that only the largest beads remained (>15 mesh). ATR-IR (cm-1, neat): 
3407, 2927, 2162, 1648, 1594, 1447, 1294, 1231, 1104, 1014, 808, 761 cm-1. Anal. Found (%): C, 
69.80; H, 6.93; N, 5.79. 
3.2.3 PS-Im4COO 
These were prepared in a similar fashion to PS-pimin (3.2.2) except that Im4COOH (1.2 mol eq. 
wrt to Cl) The resultant white beads were filtered, washed several times with DMF and then 
methanol. The beads were dried in an oven overnight at 60 °C. IR (cm-1, KBr pellet): 3377, 3103, 
2929, 1711, 1634, 1543, 1512, 1446, 1423, 1378, 1352, 1333, 1218, 1151, 1105, 976, 817, 767 
cm-1. Anal. Found (%): C, 66.77; H, 6.88; N, 8.14.  
3.2.4 PS-MeImCOO 
These were prepared in a similar fashion to PS-pimin (3.2.2) except that Im4COOH (1.2 mol eq. 
wrt to Cl) was used. The resultant white beads were cleaned as mentioned above (3.2.3). IR (cm-
1, KBr pellet): 3426, 1711, 1604, 1574, 1512, 1465, 1427, 1334, 1262, 1160, 1019, 814 cm-1. 
Anal. Found (%): C, 56.7; H, 7.37; N, 9.48. 
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3.2.5 PS-[VO(pimin)x] 
PS-pimin (0.5 g) was allowed to swell in DMF for 2 hours. A DMF solution of vanadyl sulfate (0.6 
g, 2.75 mmol) was added to the above mixture which was stirred and heated at 90 °C for 8 hours. 
The green beads were collected by filtration and rinsed with warm DMF and methanol and then 
dried in the oven overnight at 60 °C. ATR-IR (cm-1, neat): 3393, 2924, 2162, 1677, 1594, 1447, 
1288, 1225, 1159, 1043, 978, 819 cm-1. Anal. Found (%): C, 62.12; H, 5.99; N, 4.63; S, 2.11; V, 
4.7.  
3.2.3 PS-[VO(Im4COO)x] 
These were prepared in a similar fashion as PS-[VO(pimin)x] (3.2.5) except that PS-Im4COO was 
used (0.5 g). IR (cm-1, KBr pellet): 3124, 2923, 1721, 1652, 1512, 1451, 1385, 1332, 1259, 1160, 
1114, 1039, 1020, 972, 822 cm-1 Anal. Found (%): C, 56.9; H, 5.89; N, 7.47; S, 2.62; V, 4.11. 
3.2.6 PS-[VO(MeImCOO)x] 
This polymer was prepared as for PS-[VO(pimin)x] (3.2.5) except that PS-MeIm2COO (0.5 g) was 
used. IR (cm-1, KBr pellet): 3431, 1631, 1572, 1512, 1451, 1424, 1261, 1159, 1110, 983, 806 cm-
1. Anal. Found (%): C, 49.31; H, 6.60; N, 6.99; S, 4.20; V, 4.60.  
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3.3 Catalytic activity studies 
3.3.1 Oxidation of styrene, ethylbenzene and thioanisole 
 In a t ypical catalytic oxidation experiment, 20 m L of acetonitrile was added to a 100 m L round 
bottom flask fitted with a glass condenser. The temperature of the oil bath was regulated to ±1 °C 
using an external temperature probe. The stirring rate was kept constant at 300 rpm for all 
reactions. Hereafter, styrene (1.04 g, 10 mmol), ethylbenzene (1.06 g, 10 m mol) or thioanisole 
(1.24 g, 10 mmol) was added followed by the required moles of hydrogen peroxide. Immediately 
after addition of hydrogen peroxide, the catalyst was added and this was considered the start of 
the reaction. The reaction progress was monitored using gas chromatography at specific time 
intervals.   
3.3.2 Oxidative bromination  
The oxidative bromination reactions were carried out in 25 mL of a pH 5.5 phosphate buffer (50 
mM). Phenol red (20 μM) and H2O2 (10 mM) were added to KBr (2.0 M). The reaction was 
initiated by addition of the required mass of the solid catalyst. The temperature during the reaction 
was maintained at ~20 °C and t he stirring rate was kept constant at 700 rpm. The reaction 
progress was monitored spectrophotometrically. Phenol red shows two small absorption maxima 
at 268 nm and 557 nm and a high absorption maximum at 436 nm.12 The oxidation bromination of 
phenol red can be followed by the disappearance of the peak at 436 nm and the appearance of a 
new peak at 590 nm corresponding to bromophenol blue, the tetrabrominated derivative.12 
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3.4 Results and discussion 
3.4.1 Synthesis 
The synthesis of piminH was similar to that performed by Parik13 with some slight modifications. 
These have been discussed in an earlier section (Part 1, Chapter 3). The same holds true for the 
synthesis of MeIm2COOH, while Im4COOH was purchased from Sigma-Aldrich.  
Both piminH and Im4COOH contain two nucleophilic groups both capable of taking part in 
nucleophilic substitution reactions, while MeIm2COOH contains only the free carboxylic acid. For 
piminH these are the imidazoline-NH and the phenol groups, while for Im4COOH these are the 
carboxylic acid and the imidazole-NH groups. Thus reaction of these ligands with PS-Cl can be 
expected to give two possible products – the nitrogen bound or the oxygen bound derivatives. 
This simple consideration has been largely neglected in the field of heterogeneous catalysis. For 
example, the ligand 2-(2ˊ-hydroxyphenyl)benzimidazole was reacted with PS-Cl in basic 
conditions and attachment was assumed to occur 100% via the benzimidazole-NH leaving the 
imine-nitrogen and phenol-oxygen free for coordination to the metal (in a bidentate fashion). While 
this indeed may occur, one cannot assume 100% selectivity since the pKas of the benzimidazole 
and the phenol are quite similar14 and in addition the relative order of acidity may switch 
depending on the solvent used.15 The consequence of this being that the actual coordination 
environment on the polymer is quite different to that of the neat complex.  
It has been shown for Im4COOH, that the significantly more acidic carboxylic acid group directs 
alkylation to this position rather than the NH under mildly basic conditions.16 Thus one can expect 
the resultant coordination to be m onodentate via the imidazole group (scheme 3.3). Similarly, 
alkylation of piminH provides predominantly the O-alkylated product. We demonstrated this by 
reacting piminH with benzyl chloride, affording the 2-(2ˊ-benzyloxyphenyl)-1H-imidazoline product 
which was characterized by NMR and IR. The N-H signal remained in the 1H NMR spectrum 
(figure 3.2) and t he ν(C-O-C) band at  1232 c m-1 in the infrared spectrum both confirmed O-
alkylation.  A s for 1-methylimidazole-2-carboxylic acid, the methylated amine nitrogen ensures 
alkylation via the carboxyl group. 
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Figure 3.2 1H NMR spectrum of 2-(2ˊ-benzyloxyphenyl)-1H-imidazoline (δ ppm). The N-H proton signal 
appears at 10.1 ppm 
 
The ligand bound polymers were then reacted with vanadyl sulfate, providing the heterogeneous 
oxovanadium(IV) catalysts. As a result of the above mentioned ligand attachment, the subsequent 
complex formation step may be expected to yield an oxovanadium(IV) complex with a different 
stereochemistry to that of the neat complexes; [VO(pimin)2], [VO(Im4COO)2] and 
[VO(MeIm2COO)2]. The synthesis of these polymer-anchored catalysts has been described in 
scheme 3.3. The logic behind this synthesis was that by having free imidazole/imidazoline groups 
within the cross-linked polymer a c oordination environment similar to the active site of VHPOs 
might be produced. 
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Scheme 3.3 Immobilization of oxovanadium(IV) onto imidazoline and imidazole functionalized PS-Cl. Only 
PS-[VO(Im4COO)x] has been shown as a representative example. R represents a solvent 
molecule or a nearby ligand 
 
3.4.2 Characterization 
The infrared spectrum of chloromethylated polystyrene (PS-Cl) shows a band at 670 cm-1 
corresponding to ν(C-Cl),17 and the attachment of piminH, to polystyrene was confirmed by its 
disappearance and the appearance of a new band at 1615 cm-1 corresponding to the ν(C=N). In 
the spectrum of the free ligand, a m edium and br oad band for the stretching frequency of the 
hydrogen bonded O-H appears at 2694 cm-1,18 but disappears in the spectrum of PS-pimin. This 
along with the appearance of the ν(C-O-C) at 1233 c m-1 confirms that alkylation occurs 
predominantly via the phenol group.13 Similarly, for MeIm2COOH and Im4COOH, the ν(C=O) at 
1614 cm-1 and 1655, respectively, shift to 1711 cm-1 upon attachment to PS-Cl confirming 
attachment via the carboxylic acid group to form ester linkages. 
Upon reaction of the ligand-functionalized Merrifield beads with vanadyl sulfate, PS-[VO(pimin)x] 
displayed a medium intensity band in the IR spectrum at 978 cm-1 corresponding to the ν(V=O) of 
the oxovanadium unit (figure 3.3).19  For PS-[VO(im4COO)x] and PS-[VO(MeIm2COO)x] (figure 
3.4), the ν(V=O) appeared at 972 and 983 cm-1 respectively. In all instances, broadening of the 
ν(C=N) made any meaningful conclusions regarding coordination via this group particularly 
unreliable. The position of the ν(V=O) bands in the neat complexes was different to that of the 
functionalized polymers, with the ν(V=O) for [VO(pimin)2], [VO(Im4COO)2] and [VO(MeIm2COO)2] 
appearing at 941, 981 and 972 cm-1 respectively. These divergences can be expected since, as 
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already mentioned, the polymer-anchored and neat complexes were structurally dissimilar. For  
PS-[VO(pimin)x], the bands appearing at 1225, 1159 and 1043 cm
-1 can be assigned to stretching 
vibrations of a c oordinated sulfate ion (figure 3.3), while for the imidazole-based system this 
vibration appears as a very broad band from 1236 - 1060 cm-1 (figure 3.4). This broadness was 
quite probably due to the presence of multiple overlapping bands. Thus, for all the polymer-
anchored oxovanadium(IV) catalysts, the sulfate ion appears to be coordinated, with symmetry 
lower than Td.
20 However, the exact mode of coordination, monodentate (C3v)
20 or bidentate 
(C2v)
20 remains questionable due to the complexity of the infrared spectra and presence of 
interfering vibrational bands. It is most likely, however, that the sulfate coordinates in a 
monodentate fashion as has been observed for vanadyl sulfate.21  
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Figure 3.3 Stacked IR spectra of PS-Cl, PS-pimin and PS-[VO(pimin)x] in the range 4000 – 650 cm-1 
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Figure 3.4 Stacked IR spectra of PS-Cl, PS-MeImCOO and P S-[VO(MeImCOO)x] in the range 2200 – 
650 cm-1 
  
Microanalysis results further confirmed that the polymer-bound vanadyl species was coordinated 
to sulfate, since sulfur was found in all heterogeneous catalysts. For each of the catalysts the 
sulfur/vanadium ratio was close to 1:1. The vanadium/nitrogen ratio for PS-[VO(pimin)x] was 1:5 
while for PS-[VO(Im4COO)x] and PS-[VO(MeIm2COO)x] this changed to 1:6. This corresponds to 
2.5 – 3 imidazoline/imidazole groups per vanadyl unit. It cannot be deduced, at least not without 
any great uncertainty, whether these are all bound to vanadium, or if there is a mixture of different 
species within the crosslinked polymer.  
XPS was used to investigate the surface functionality of the heterogeneous catalysts (figure 3.5). 
The V 2p3/2 binding energy appeared at 514.9 eV confirming the presence of vanadium as well as 
the +4 oxidation state of the metal (table 3.1).22 The N 1s peak from the imidazole or imidazoline 
groups appeared at 399 eV (table 3.1) and the O 1s peak corresponding to oxygen in absorbed 
water, VO (vanadyl) and SO4, appeared at 530 eV. In addition, the N 1s signal was comprised of 
two main peak due to the amine and imine nitrogen atoms (figure 3.5). The presence of sulfur as 
indicated by infrared and elemental analysis, was confirmed using XPS, with the S 2p3/2 peak 
appearing at 167 eV (table 3.1) for all catalysts.23 
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Table 3.1 Elemental binding energies of Merrifield-based catalysts as determined by XPS  
 Binding Energy (eV) 
Polymer O 1s N 1s C 1s V 2p3/2 V 2p1/2 S 2p3/2 
PS-[VO(pimin)x] 530 399 285 515 522 167 
PS-[VO(Im4COO)x] 530 399 285 515 522 167 
PS-[VO(MeIm2COO)x] 530 399 285 515 522 167 
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Figure 3.5 Wide scan XPS spectra of PS-[VO(pimin)x], PS-[VO(Im4COO)x] and PS-[VO(MeIm2COO)x]. 
Insert shows an expanded view of the high resolution N 1s signals of PS-[VO(Im4COO)x] 
 
The various functionalization steps of the Merrifield beads (PS-Cl) was also investigated by 
thermogravimetric analysis (figure 3.5). Unmodified PS-Cl decomposed in two steps, the first 
beginning at 270 °C (Tmax = 370 °C) and the second at 400 °C (Tmax = 444 °C) quite similar to that 
observed by other researchers.24 After ligand attachment, the TG curve changed significantly. An 
initial weight loss below 110 °C (Tmax = 56 °C) was observed for PS-pimin, probably due to 
absorbed water molecules. Another unique weight loss step began a t 184 °C (Tmax = 190 °C), 
quite close to the melting point of the piminH. After functionalization with oxovanadium(IV), the 
latter weight loss step disappeared and a new one appeared at 250 °C (Tmax = 300 °C) possibly 
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due to complex decomposition (figure 3.5). This confirmed coordination of the ligand to 
oxovanadium(IV) within the polymer.  
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Figure 3.5 TG and DTG curves of PS-Cl, PS-pimin and PS-[VO(pimin)x] at a heating rate of 10 °C.min-1 
under N2 
 
SEM and AFM were used to monitor the morphological changes occurring on the surface of the 
polymer beads after the various functionalization steps. For each of the different ligand systems, 
the SEM images showed the same trends. These changes are well illustrated in the 
representative example shown in figure 3.6, when Im4COOH was used as the ligand. Before 
modification the PS-Cl beads had an apparent smooth surface, whilst after reacting these with the 
ligand the surface roughness seemed to increase. After reacting these beads with vanadyl sulfate, 
the surface appeared ‘coated’ and was somewhat smoother that the ligand-functionalized beads. 
The abrasions shown on the surface of PS-[VO(Im4COO)x] beads were likely due to the agitation 
of the mechanical stirrer. The average diameter for these beads was 612 μm. 
 
Figure 3.6 SEM images of a single bead and digital (right corner of bead) images of (A) PS-Cl, (B) PS-
Im4COO and (C) PS-[VO(Im4COO)x] (average diameter Ø = 612 μm) 
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The AFM studies agreed quite well with the above mentioned trends. Shown in figure 3.7 are the 
atomic force micrographs of beads from the piminH ligand system at the various stages of 
synthesis. The unfunctionalized beads have a relatively amorphous surface. After reacting these 
with the ligand, the surface appeared significantly different. Even more significant were the 
changes that occurred after reaction with vanadyl sulfate, with small diamond-shaped structures 
appearing. The surface roughness (Ra nm) was determined from an average of five 10 x10 μm 
sections. The surface roughness for unmodified PS-Cl was 7.92 nm. For PS-pimin and PS-
[VO(pimin)x] the roughness values were 6.14 and 5.06 nm, respectively. For PS-Im4COO and PS-
[VO(Im4COO)x] they were 7.89 and 6.54 nm, respectively, and for PS-MeIm2COO and P S-
[VO(MeIm2COO)x] they were 7.56 and 6.12 nm, respectively. Once again these values 
corresponded relatively well with the trends observed visually. The slight exception may be the 
larger surface roughness of PS-Cl, which was not immediately evident from the SEM image 
(figure 3.6), but more visible at the higher resolution obtained using AFM.  
 
 
Figure 3.7 AFM images of (A) PS-Cl, (B) PS-pimin and (C) PS-[VO(pimin)x] (scale = 10x10 μm) 
 
The surface area of PS-Cl and a r epresentative catalyst, PS-[VO(pimin)x] was determined from 
nitrogen absorption/desorption isotherms (figure 3.8) using the BET method. The specific surface 
area of the PS-Cl beads was found to be 10.4 m2.g-1, while the average pore volume and size was 
0.07 cm3.g-1 and 311 Å, respectively. After functionalization of PS-Cl with piminH and 
oxovanadium(IV), the surface area dropped to 6.9 m2.g-1. The pore size remained relatively 
similar at 387 Å and the pore volume dropped slightly to 0.05 cm3.g-1. The drop in surface area 
corresponds well with the observed drop in surface roughness shown using AFM. Additional loss 
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in surface area may be attributed to filling of pores by vanadium. This was corroborated by the 
above mentioned drop in pore volume from 0.07 to 0.05 cm3.g-1. 
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Figure 3.8 Nitrogen adsorption-desorption isotherms for (A) PS-Cl and (B) PS-[VO(pimin)x] 
 
3.4.3 Catalytic activity 
The catalytic activity of the heterogeneous oxovanadium(IV) catalysts; PS-[VO(pimin)x], PS-
[VO(Im4COO)x] and P S-[VO(MeIm2COO)x], was investigated for the oxidation of thioanisole, 
styrene and ethylbenzene. The activity of these heterogeneous catalysts was compared to the 
non-geometrically equivalent homogeneous catalysts; [VO(pimin)2], [VO(Im4COO)2] and 
[VO(MeIm2COO)2]. The reaction progress was monitored using GC by comparison of retention 
times to that of the pure standards. The product identities were also confirmed using GC-MS.  
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(a) Oxidation of thioanisole 
The oxidation of sulfides has become a v aluable reaction due to the use of sulfoxides (sulfide 
oxidation products) as intermediates in the synthesis of biologically active compounds.25,26 
Additionally, oxidative desulfurization (ODS), a process used to remove sulfur from fuels, has 
recently received a renewed interest. The conventional hydrodesulfurization (HDS) process has 
been employed by refineries to remove organic sulfur from fuels for the past couple of decades 
with the lowest sulfur content achieved being around 500 ppm. Thus additional steps need to be 
developed in order to achieve the new criteria set for ultra-low sulfur fuels (<10 ppm, Euro 
standards). In this regard ODS has shown some promise.27,28 Thioanisole was chosen as the 
model sulfide to be used in this study. Although this compound does not form a large component 
of the problematic sulfide compounds in fuels, it is one of the most common reagents used to 
assess catalyst efficacy for sulfide oxidation reactions.29-32 Upon oxidation, thioanisole is 
converted primarily to methyl phenyl sulfoxide which may be further oxidised to methyl phenyl 
sulfone according to scheme 3.4.  
 
S S
O
S[O] [O]
O O
 
Scheme 3.4 Oxidation of methyl phenyl sulfide (thioanisole) gives primarily methyl phenyl sulfoxide and 
methyl phenyl sulfone ([O] represents an oxidizing agent) 
 
The temperature and am ount of catalyst were varied until optimal conditions were obtained. 
Additionally, the effect that these changes imposed on the overall conversion and product 
selectivity was monitored. According to the literature, the oxidation of sulfides invariably reaches a 
maximum conversion at a 2:1 peroxide-to-sulfide ratio6 and even less, and therefore in our study 
this ratio was kept constant. For the heterogeneous catalysts, the effect of temperature and 
catalyst amount in the range 0.0-0.035 g, on the rate of oxidation was studied as a function of 
time as shown in figure 3.9 for PS-[VO(pimin)x]. 
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Figure 3.9 The effect of catalyst amount on thioanisole oxidation. Reaction conditions: PS-[VO(pimin)x], 
thioanisole (10 mmol), H2O2 (20 mmol), acetonitrile (20 mL) and 25 °C 
 
For a f ixed amount of thioanisole (1.24 g,10 mmol) in 20 m L of acetonitrile and 30% H2O2 (20 
mmol) at room temperature, the rate of the oxidation reaction is fast for the highest catalyst 
amount of 0.035 g r eaching 98.9% conversion within 1 h.  When using 0.025 g of  catalyst a 
maximum conversion of 99.6% was obtained within 3 h a t room temperature. Using the same 
amount of catalyst and increasing the temperature from 25 °C to 60 °C (table 3.1) resulted in a 
significantly increased rate of oxidation – with near quantitative oxidation being attained in as little 
as 20 mins. When using 0.011 g a maximum of 88.8% was obtained after 4 hour reaction period. 
The overall activitiy of the imidazole-based catalysts, PS-[VO(Im4COO)x] and PS-
[VO(MeIm2COO)x], was slightly lower than the imidazoline counterpart (figure 3.10). For 
example; after 4 hour s, the maximum conversions recorded with these catalysts was 91.6 and 
96.1% respectively, compared to >99% obtained with PS-[VO(pimin)x].  
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Figure 3.10  (A) Overall oxidation of thioanisole and ( B) product selectivity for the catalysts PS-
[VO(pimin)2], PS-[VO(Im4COO)2] and PS-[VO(MeIm2COO)2] (0.025 g, ~0.2 mol% of V, wrt 
thioanisole), thioanisole (10 mmol), H2O2 (20 mmol), acetonitrile (20 mL) and 25 °C 
 
The product selectivity for all of the catalysts was relatively similar under the conditions tested. 
When using 0.025 g of any of the heterogeneous catalysts, the sulfoxide/sulfone ratio was 
maintained close to 2:1. Increasing the temperature, however, caused this ratio to change 
dramatically to 1:3 (sulfoxide/sulfone). This can be expected since under the harsher (more 
oxidizing) conditions, the sulfoxide may be converted to the sulfone via consecutive reactions as 
shown in scheme 3.4. A typical selectivity profile showing the formation of methyl phenyl 
sulfoxide and methyl phenyl sulfone, for each of the catalysts under identical conditions has been 
included in figure 3.10. Under these conditions (room temperature, 0.025 g of catalyst) the 
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sulfoxide formation increases rapidly and forms the major product along with a c omparatively 
smaller amount of the sulfone. The consecutive conversion of the sulfoxide to sulfone is best 
illustrated at higher catalyst amounts, for example in figure 3.11 which depicts a s harp initial 
increase in the formation of methyl phenyl sulfoxide, followed by a gradual decay associated with 
the steady conversion to the sulfone. Conversely, when using just 0.011 g of PS-[VO(pimin)x] at 
room temperature gave a sulfoxide/sulfone a ratio of 5:1.  
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Figure 3.11 The product selectivity over time. Reaction conditions: PS-[VO(pimin)x] (0.035 g), thioanisole 
(10 mmol), H2O2 (20 mmol), acetonitrile (20 mL) and 25 °C 
 
Based on these observations, it can be deduced that the product selectivity may be altered by 
modifying the reaction conditions. Essentially, sulfoxide selectivity may be improved by using 
milder conditions such as a lower temperature or catalyst amount. The major disadvantage of this 
would be the increased reaction times for complete conversion. On the other hand, sulfone 
selectivity can be achieved more easily by increasing the reaction time, increasing catalyst 
amount or increasing reaction temperature.  
One of the major draw cards of heterogeneous catalysts is that they can be separated and 
recycled from solution very easily. It is crucial then for the recyclability of the catalysts to be 
investigated. Both of the imidazole-based systems, PS-[VO(Im4COO)x] and PS-
[VO(MeIm2COO)x], showed excellent recyclability. As shown in figure 3.12, there was in fact a 
reduced induction period after one catalytic cycle. This was quite possibly related to the first steps 
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of the catalytic mechanism. To recap this briefly; oxovanadium(IV) is first converted to the 
dioxovanadium(V) species which is subsequently converted to the oxoperoxovanadium(V) 
species. This conversion of V4+ to V5+ can be seen very easily with the naked eye - if the beads 
were removed from solution mid-reaction they retained a yellow-orange colour, however upon 
completion of the reaction, they returned to a colour similar to that of the original beads (a grey-
blue). Closer examination of the latter using IR, revealed that the characteristic ν(V=O) was still 
present, but a s houlder to this band appeared at lower wavenumbers indicative of the 
dioxovanadium(V) species.33 Thus one can conclude that the beads likely contain a mixture of the 
oxovanadium(IV) and dioxovanadium(V) species, rather than 100% of the oxovanadium(IV) 
species as originally presumed. This explains the reduced induction period upon recycling since 
the first oxidation step is no longer required as some dioxovanadium(V) species are present on 
the beads. However, the PS-[VO(pimin)x] beads were comparably less successful in terms of 
recyclability, with an appreciable loss in activity being observed after successive cycles, probably 
due to leaching of vanadium (figure 3.12). 
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Figure 3.12 Catalyst recyclability for the oxidation of thioanisole. Reaction conditions: (A) PS-
[VO(Im4COO)x] (0.025 g), (B) PS-[VO(pimin)x], thioanisole (10 mmol), H2O2 (20 mmol), 
acetonitrile (20 mL) and 25 °C 
 
The catalytic activity of the non-geometrically equivalent homogeneous catalysts [VO(pimin)2], 
[VO(Im4COO)2] and [VO(MeIm2COO)2] as well as the common vanadyl salt, VOSO4, was also 
investigated. Specific masses of these complexes, which corresponded to approximately 0.025 g 
of the heterogeneous catalysts (0.2 mol% vanadium wrt. thioanisole), were taken to allow for 
comparison with the heterogeneous derivatives. As shown in figure 3.13, these homogeneous 
catalysts exhibit much higher activity, with >99% conversion being attained within 30 minutes. The 
vanadyl sulfate salt displayed the highest activity followed by [VO(pimin)2] and t hen 
[VO(MeIm2COO)2] and [ VO(Im4COO)2]. The activity in this case, was probably linked to the 
solubility of the complexes in acetonitrile. Vanadyl sulfate dissolved immediately and as 
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mentioned was the most active, while the imidazole based complexes dissolved quite slowly, only 
being completely dissolved after approximately 10 minutes. It is therefore quite clear that although 
some measures can be taken to increase the activity of the heterogeneous catalyst, by 
appropriate ligand design, the major improvements could be made by increasing the surface area 
of the catalyst support. A table summarizing the overall conversion, product selectivity and 
turnover frequencies (TOF) has been included (table 3.2). 
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Figure 3.13 Oxidation of thioanisole by VOSO4, [VO(pimin)2], [VO(Im4COO)2] and [ VO(MeIm2COO)2]. 
Reaction conditions: Catalyst (0.2 mol% wrt. thioanisole), thioanisole (10 mmol), H2O2 (20 
mmol), acetonitrile (20 mL) and 25 °C 
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Table 3.2 Percentage conversion, turnover frequency (TOF) and product selectivity for the oxidation of 
thioanisole 
Catalyst 
Mass 
(g) 
Temp 
(°C) 
H2O2 
(eq)† 
Conversion 
(%) 
TOFa 
(h-1) 
Sulfoxide 
(%) 
Sulfone 
(%) 
PS-[VO(pimin)x] 0.011 25 2 88.8 156 74.2 14.3 
 0.025 25 2 >99 169 66.1 33.5 
 0.025b 25 2 92.3 121 75.3 21.7 
 0.025 60 2 >99 860 24.7 74.3 
 0.035 25 2 >99 306 63.5 36.0 
PS-[VO(Im4COO)x] 0.025 25 2 91.6 88 65.8 29.9 
 0.025b 25 2 96.3 77 68.4 26.7 
 0.025 60 2 >99 485 68.2 30.5 
 0.035 25 2 99.5 57 65.5 27.8 
PS-[VO(MeIm2COO)x] 0.025 25 2 96.1 73 67.0 27.9 
 0.025b 25 2 96.6 74 61.9 33.8 
 0.025 60 2 >99 911 65.7 33.0 
 0.035 25 2 97.7 54 64.5 32.7 
†mmol relative to thioanisole a Determined as moles of substrate converted/moles of catalyst/time (h); b After one catalytic 
cycle/reaction 
 
 (b) Oxidation of styrene 
Catalytic oxidation of alkenes is an extremely important technology, frequently used for converting 
petroleum based feedstocks into useful (functional) chemicals such as alcohols, aldehydes, 
carboxylic acids and epoxides.34 The test alkene used in this study was styrene, which upon 
oxidation, may be converted to styrene oxide, which may be subsequently converted to 
phenylethane-1,2-diol, or benzaldehyde. The latter product may be f urther oxidized to benzoic 
acid as outlined in scheme 3.5.  
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Scheme 3.5 The main products of the oxidation of styrene include styrene oxide, benzaldehyde, benzoic 
acid and phenylethane-1,2-diol ([O] represents an oxidizing agent) 
 
The first parameter to be investigated was the effect of using the different catalysts as shown in 
figure 3.14. Under the conditions tested, PS-[VO(pimin)x] and PS-[VO(Im4COO)x] gave similar 
overall conversions and s electivity (see table 3.3), while the overall conversion obtained using 
PS-[VO(MeIm2COO)2] was about 20% lower. The reason for this is not completely understood, 
but may be due to the electron donating methyl substituent. On the topic of selectivity, the general 
order was; benzaldehyde > phenylethane-1,2-diol > benzoic acid > styrene oxide as illustrated in 
figure 3.15. 
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Figure 3.14 Oxidation of styrene by PS-[VO(pimin)x], PS-[VO(Im4COO)x] and PS-[VO(MeIm2COO)2]. 
Reaction conditions: Catalyst (0.025 g), styrene (10 mmol), H2O2 (20 mmol), acetonitrile (20 
mL) and 80 °C 
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Figure 3.15 Product selectivity for the oxidation of styrene by PS-[VO(pimin)x]. Reaction conditions: 
Catalyst (0.025 g), styrene (10 mmol), H2O2 (40 mmol), acetonitrile (20 mL) and 80 °C 
 
The trends observed with increasing catalyst amount were not as predictable as those observed 
for thioanisole oxidation. As shown in figure 3.16, increasing the amount of catalyst improved the 
initial rate of reaction (reduced induction period), but resulted in a drop in overall activity. When 
0.011 g, 0.025 g and 0.035 g of PS-[VO(pimin)x] were used, the overall conversions after a 6 hour 
period were 85.4, 75.1 and 69.2%, respectively. A similar trend was observed for the imidazole-
based catalysts (table 3.3). 
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Figure 3.16 The effect of catalyst amount on t he oxidation of styrene by PS-[VO(pimin)x]. Reaction 
conditions: Styrene (10 mmol), H2O2 (20 mmol), acetonitrile (20 mL) and 80 °C 
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The next parameter investigated was the effect of oxidant concentration. As shown in figure 3.17, 
increasing the amount of H2O2 improved the overall conversion by approximately 20%, with no 
marked difference on t he selectivity. The necessity for additional peroxide has been captured 
sufficiently well in figure 3.18. In this instance, the homogeneous catalyst, [VO(pimin)2] was 
initially combined with two-equivalents of peroxide. The conversion began to plateau at 56.5% 
after 1.5 hours. When additional peroxide was added however (one equivalent wrt. styrene), the 
conversion rapidly increased to 91.6% where it then stabilized. Four-equivalents of peroxide was 
sufficient to achieve >99% conversions when using the homogeneous catalyst, [VO(pimin)2]. 
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Figure 3.17 The effect of peroxide amount on the oxidation of styrene by PS-[VO(Im4COO)x]. Reaction 
conditions: Catalyst (0.025 g), styrene (10 mmol), acetonitrile (20 mL) and 80 °C 
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Figure 3.18 The effect of the amount of oxidant for the homogeneous oxidation of styrene by [VO(pimin)2]. 
Reaction conditions: Catalyst (0.2 mol%, equiv to 0.025 g of heterogeneous), styrene (10 
mmol), acetonitrile (20 mL) and 80 °C 
 
The optimal conditions for maximum styrene oxidation were obtained when using four-equivalents 
of peroxide with the reaction temperature being maintained at 80 °C. However, under these 
conditions the beads became fragile and s ubsequent deterioration made recycling experiments 
difficult. An AFM image of the surface of a PS-[VO(pimin)x] beads after such a reaction has been 
included in figure 3.19 to illustrate this point. The corresponding digital images also clearly show 
the development of surface cracks on the beads. 
 
 
Figure 3.19 An AFM image (A) and digital image (B) of the surface of a P S-[VO(pimin)x] bead after a 
catalytic reaction using styrene as the substrate, at 80 °C and with four-equivalents of H2O2, 
along with the AFM (C) and digital (D) image of the same beads before a catalytic reaction 
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Table 3.3 Percentage conversion, turnover frequency (TOF) and pr oduct selectivity (for the two major 
products) for the oxidation of styrene (Benzal = benzaldehyde, Phen-1,2-diol = phenylethane-1,2-diol) 
Catalyst 
Mass 
(g) 
Temp 
(°C) 
H2O2 
(eq)† 
Conversion 
(%) 
TOFa 
(h-1) 
Benzal 
(%) 
Phen-1,2-diol 
(%) 
PS-[VO(pimin)x] 0.011 80 2 85.4 194 50.12 16.4 
 0.025 80 2 75.1 129 49.4 17.2 
 0.035 80 2 69.2 85 47.6 16.5 
 0.025 80 4 >99 173 51.5 16.1 
 0.025 60 2 69.3 119 50.8 15.2 
PS-[VO(Im4COO)x] 0.025 80 4 >99 138 43.3 17.3 
 0.025 80 2 77.1 174 41.1 15.4 
 0.035 80 2 67.2 145 36.6 14.8 
 0.025 60 4 66.2 53 41.3 7.5 
PS-[VO(MeIm2COO)x] 0.025 80 2 57.3 119 28.6 14.7 
 0.025 60 4 49.2 62 34.0 9.3 
 0.035 80 2 60.1 129 33.0 14.1 
†mmol relative to thioanisole;  a Determined as moles of substrate converted/moles of catalyst/time (h) 
 
(c) Oxidation of ethylbenzene 
The transition metal catalyzed conversion of alkanes to oxygen-containing compounds is one of 
the most important and fundamental transformations in the chemical industry, and there is 
therefore a constant need for improving current systems.35,36 The test alkane used in this study 
was ethylbenzene which upon oxidation may be converted primarily to acetophenone, 
benzaldehyde and benzoic acid as outlined in scheme 3.6.  
 
[O] CH3
O
H
O
OH
O
+ [
O]
 
Scheme 3.6 The main products of the oxidation of ethylbenzene include acetophenone, benzldehyde and 
benzoic acid ([O] represents some oxidizing agent) 
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Compared to alkene oxidation, the oxidation of alkanes is a significantly more difficult process due 
to the absence of empty oribtals and available lone pairs coupled with the strong bonding 
between C and H.37 This resistance to oxidation was noticed by the generally low conversions 
obtained even under harsh conditions. As shown in figure 3.20, a maximum conversion of 30.3% 
was obtained for PS-[VO(pimin)x] when four-equivalents of peroxide were used and the 
temperature was maintained at 80 °C. The two main oxidation products were found to be 
acetophenone and benzaldehyde. The mechanism of formation of acetophenone proposed by 
Hoshino et al.38 involves the abstraction of an α-hydrogen from ethylbenzene to form 1-
phenylethyl radicals, followed by a reaction with oxygen to produce acetophenone while the 
formation of benzaldehyde is believed to occur via the decomposition of 1-phenylethoxyl radicals. 
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Figure 3.20 Selectivity for the oxidation of ethylbenzene using PS-[VO(pimin)x]. Reaction conditions: 
Catalyst (0.025 g), ethylbenzene (10 mmol), H2O2 (40 mmol), acetonitrile (20 mL) and 80 °C 
 
As mentioned earlier, these harsh conditions result in gradual disintegration of the catalyst beads, 
and thus milder conditions (lower temperature or peroxide amount) were adopted to limit this 
problem. Considering PS-[VO(pimin)x] first, when the temperature was kept at 80 °C and the 
peroxide was dropped from four to two-equivalents the overall conversion dropped from 30.3% to 
13.8%. As illustrated in figure 3.21, when the peroxide was kept at two-equivalents and the 
temperature reduced to 60 °C, the conversions dropped once again. For example, for PS-
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[VO(Im4COO)x], the conversion dropped from 10.6% (at 80 °C) to 8.2% (at 60 °C) even though 
the amount of catalyst was increased from 0.025 g to 0.035 g.  
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Figure 3.21 The effect of temperature and catalyst on the oxidation of ethylbenzene using PS-
[VO(MeIm2COO)x] and PS-[VO(Im4COO)x] at 60 and 80 °C. Reaction conditions: Catalyst 
(0.025 g and 0.035 g), ethylbenzene (10 mmol), H2O2 (20 mmol), acetonitrile (20 mL)  
 
It is evident that in order to obtain better conversions, the amount of peroxide needs to be 
increased, even beyond four-equivalents, whilst keeping temperatures high. However, the 
tendency of the crosslinked chloromethylated polystyrene beads to break down under these 
conditions makes them less than ideal for such applications. The summary of the results obtained 
for the oxidation of ethylbenzene is presented in table 3.4.  
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Table 3.4 Percentage conversion, turnover frequency (TOF) and pr oduct selectivity (for the two major 
products) for the oxidation of ethylbenzene (Benzal = benzaldehyde, Acetophen = acetophenone) 
Catalyst 
Mass 
(g) 
Temp 
(°C) 
H2O2 
(eq)† 
Conversion 
(%) 
TOFa 
(h-1) 
Acetophen 
(%) 
Benzal 
(%) 
PS-[VO(pimin)x] 0.025 80 4 30.3 53 15.1 4.7 
 0.025 80 2 13.8 24.1 12.6 5.0 
PS-[VO(Im4COO)x] 0.025 80 2 10.6 23 5.6 1.2 
 0.035 60 2 8.15 10 4.7 1.1 
PS-[VO(MeIm2COO)x] 0.035 60 2 6.77 10 3.9 0.6 
†mmol relative to thioanisole a Determined as moles of substrate converted/moles of catalyst/time (h) 
 
(d) Mechanism of oxidation 
As has been d iscussed previously, in the presence of hydrogen peroxide, vanadium(IV) readily 
converts to vanadium(V) along with the formation of monoperoxo and diperoxovanadium(V) 
complexes even when less than stoichiometric amounts of hydrogen peroxide are used.39 All the 
reactions in this study were carried out in the presence of at least two-equivalents of H2O2 and so 
it is likely that mainly peroxo species exist. The peroxovanadium species are more reactive than 
H2O2 and are integral in the proposed catalytic mechanism.
8,39  The first step involves the 
oxidation of vanadium(IV) followed by the formation of a peroxovanadium species which in acid 
media can form a reactive hydroxyl-peroxyvanadium(V) species, which subsequently oxidises the 
substrate. For the homogeneous catalysts we were able to confirm the first step of this process by 
spectrophotometric titrations of the complexes with H2O2 as shown in figure 3.22 for [VO(pimin)2] 
and figure 3.23 for [VO(Im4COO)2]. Before the addition of H2O2, three low-intensity peaks 
corresponding to the d-d transitions of a five-coordinate oxovanadium system were observed for 
each of the complexes.40 
The solution electronic spectrum for [VO(pimin)2] displayed three d-d transitions at 617, 542 and 
403 nm. Diluted hydrogen peroxide was added to this solution and the UV spectrum recorded 
after each successive 1-drop portions. The result, as shown in figure 3.22, was the gradual 
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disappearance of the d-d transition along with the appearance of an intense peak at around 350 
nm corresponding to the peroxo-vanadium charge transfer band (𝜋𝑉∗ → 𝑑𝜎∗).
 41,42 
For the imidazole-based systems, [VO(Im4COO)2] was used since the d-d transitions of this 
complex were distinct and easily visible, whereas the high energy d-d transition of 
[VO(MeIm2COO)2] was not easily observed. For this complex the d-d transitions appear at 742, 
541 and 314 nm. Upon addition of H2O2, these transitions disappeared and a charge transfer band 
appeared at 380 nm due to the formation of the d0 dioxovanadium(V) species (figure 3.22) which 
was not as easily observed for [VO(pimin)2]. Further addition of H2O2, produced a new band 
appearing at 325 nm which may be assigned the peroxo-vanadium charge transfer band (𝜋𝑉∗ →
𝑑𝜎∗). 41,42 
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Figure 3.22 Spectrophotometric titration of [VO(pimin)2] (1x10-4 mM, DMSO) with one-drop portions of 
H2O2 (5x10-2 mM) in water. The insert shows two of the d-d transitions which disappear upon 
addition of H2O2 
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Figure 3.23 Spectrophotometric titration of [VO(Im4COO)2] (1x10-4 mM, H2O) with one-drop portions of 
H2O2 (5x10-2 mM) in water. The insert shows two of the d-d transitions which disappear upon 
addition of H2O2 
 
(e) Oxidative bromination 
Since the design of prepared catalysts was inspired by the active site of the naturally occurring 
vanadium-dependent haloperoxidases, we thought it would be logical to check if these catalysts 
did indeed display oxidative halogenation properties. Other than the naturally occurring 
counterparts, synthetic vanadium compounds have been s hown to catalyze the oxidative 
bromination of several organic molecules including; salicylaldehyde,11 anisole,43 1,3,5-
trimethoxybenzene44 and phenol red,45 to name a few. We briefly investigated the oxybromination 
of phenol red due to the simplicity of this method. This was by no means an exhaustive study but 
served merely to investigate briefly if these catalysts would work for such reactions.  
The bromination reaction was done by monitoring the formation of tetrabrominated bromophenol 
blue spectrophotometrically at 590 nm (figure 3.24). The reaction was performed at a pH of 5.5 
since it has been shown that acidic conditions assist vanadium-catalyzed brominations.44 The 
concentrations of KBr and H2O2 were kept constant at 2.0 M and 10 mM, respectively. In the 
absence of catalyst the reaction was extremely slow (figure 3.25). However, addition of either of 
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the heterogeneous catalysts resulted in the formation of bromophenol blue, albeit rather slow 
(figure 3.25). There was only very minor differences in activity between the various 
heterogeneous catalysts, with PS-[VO(pimin)x] showing the greatest activity and PS-
[VO(Im4COO)x] the lowest (figure 3.25). The neat oxovanadium(IV) complexes [VO(Im4COO)2], 
[VO(MeIm2COO)2] and [ VO(pimin)2] showed improved activity over the heterogeneous 
counterparts (figure 3.26). In this instance [VO(pimin)2] showed the lowest activity of the lot, 
probably due to the lower water solubility of this complex. The reduced activity for the 
heterogeneous catalysts is likely to be due to the slow diffusion of reagents to the catalyst 
surface.  
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Figure 3.24 The reaction scheme for (top) and the change in the absorbance spectrum of phenol red due 
to the formation of bromophenol blue (below). Reaction conditions: PS-[VO(MeIm2COO)2] 
(0.010 g), 25 mL of pH 5.5 phosphate buffer (50 mM), H2O2 (10 mM), KBr (1 M), phenol red 
(20 μM) 
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Figure 3.25 Plot of absorbance at 590 nm corresponding to the formation of bromophenol blue vs. time for 
heterogeneous catalysts. Reaction conditions: Catalyst (0.010 g), 25 mL of pH 5.5 phosphate 
buffer (50 mM), H2O2 (10 mM), KBr (1 M), phenol red (20 μM)  
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Figure 3.26 Plot of absorbance at 590 nm corresponding to the formation of bromophenol blue vs. time for 
the homogeneous catalysts. Reaction conditions: [VO(Im4COO)2] (1.05 mg), 
[VO(MeIm2COO)2] (1.15 mg) or [VO(pimin)2] (1.33 mg) (equivalent to 0.010 g of  
corresponding heterogeneous catalyst), 25 mL of pH 5.5 phosphate buffer (50 mM), H2O2 (10 
mM), KBr (1 M), phenol red (20 μM)  
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3.5  Conclusions 
The Merrifield resin provides an excellent platform for immobilization of homogeneous 
oxovanadium catalysts. Functionalization with both the ligands and the metal was simple and the 
covalent linkage to the polymer-support ensured leaching of the metal was kept to a minimum as 
evidenced by recycling experiments. The heterogeneous catalysts successfully oxidized styrene 
nearly quantitatively; however under the conditions used for this reaction the polymer was 
susceptible to degradation. Oxidation of ethylbenzene was more challenging with a maximum of 
31% conversion being attained. As mentioned in a recent review by da Silva et al.,46 these 
catalysts provide the maximum conversion of styrene and ethylbenzene compared to others 
prepared in the same fashion. The heterogeneous catalysts proved ideal for the oxidation of 
thioanisole, which was conducted successfully under comparatively milder conditions. Rather than 
focusing on tuning the active site, more significant improvements could possibly be made by 
improving the support material. For example by increasing the mechanical strength and 
increasing the surface area. 
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Chapter 4  
Polymer-supported oxovanadium(IV) catalysts prepared by suspension 
polymerization 
 
4.1  Introduction 
Suspension polymerization has become a popular method for producing functional polymer 
microspheres. The procedure involves mixing an organic phase and an aqueous phase resulting 
in small droplets in which polymerization takes place. Generally, the organic phase contains the 
initiator, monomers and crosslinker, while the aqueous phase contains the stabilizers.1,2  
The microspherical beads prepared by this approach have been used for various applications 
including catalyst supports3 and sorbents for metal ion removal.4,5 Vinylimdazole and vinylpyridine 
are the most common functional monomers used when preparing metal coordinating polymers, 
since they both contain a lone pair of electrons on the nitrogen atom which can take part in metal 
coordination. As for the imidazole-based resins, typically N-vinylimidazole is used in preference to 
4(5)-vinylimidazole or 2-vinylimidazole, probably due to its commercial availability. However, 
despite the structural simplicity, ease of availability and strong metal binding capacity of 
imidazole, there have been no r eports involving the use of vinylimidazole based polymer 
microspheres, prepared by suspension polymerization, for oxovanadium(IV) immobilization. 
In the previous chapter (Chapter 3), we discovered that simple imidazole-containing resins 
prepared by functionalization of Merrifield beads, effectively immobilized oxovanadium(IV). Not 
only did these heterogeneous catalysts prove to be effective specifically in the oxidation of 
thioanisole, but they also showed excellent recyclability. In this chapter, we have used suspension 
polymerization to produce imidazole-containing polymer microspheres. This method allows for a 
greater degree of freedom in terms of degree of functionalization, bead diameters and degree of 
crosslinking, when compared to Merrifield modification. These imidazole-containing beads, as well 
as the oxovanadium(IV)-functionalized derivatives, were thoroughly characterized using AFM, 
SEM, BET and XPS among several other techniques. The focus of this chapter was directed 
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towards the synthetic and characterization aspects of the polymer support since this remains an 
area in which significant improvements could be made. Thus, the catalytic reactions investigated 
in this chapter were focused on the oxidation of thioanisole as this provided a good indicator of 
the catalytic activity.  
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4.2 Preparative work 
4.2.1  p(VIM-co-EGDMA) beads 
 The functional monomer N-vinylimidazole (2 g, 0.021 mol), crosslinker ethyleneglycol 
dimethacrylate (EGDMA) (7 mL, 0.035 mol) and initiator azobisisobutyonitrile (AIBN) (0.15 g, 0.9 
mmol) were stirred in an organic phase consisting of a toluene/cyclohexanol (7 mL/2 mL) mixture. 
In a separate 250 mL round bottom flask, an aqueous phase containing polyvinylalcohol (PVA) 
(0.28 g) and NaCl (0.7 g) in 80 mL of water was stirred at 300 rpm. This solution was warmed to 
60 °C to facilitate the dissolution of PVA. The organic phase was added dropwise to the aqueous 
phase under constant stirring. The temperature was increased to 70 °C and the reaction was 
allowed to proceed for 24 hours under an argon atmosphere. The mixture was left to cool to room 
temperature and the beads were collected by filtration, washed several times with hot water 
followed by hot methanol and then dried in an oven at 60 °C overnight. These beads were then 
sieved and only the larger beads were retained (<25 mesh). ATR-IR (cm-1, neat): 2946, 1721, 
1654, 1452, 1390, 1232, 1142, 750, 665. Anal. Found (%): C, 59.95; H, 7.80; N, 6.52.  
4.2.2  p(VIM-co-EGDMA)-VO beads 
A mass of 2 g of the p(VIM-co-EGDMA) beads (4.2.1) were swollen in 20 mL of DMF for 2 hours. 
To this was added excess VOSO4 (1 g, 4.6 mmol) in DMF (50 mL). The mixture was heated to 60 
°C and stirred overnight. The resultant blue-green beads were filtered and washed several times 
with DMF, water, methanol and finally diethyl ether and dried in an oven at 60 °C overnight. ATR-
IR (cm-1, neat): 2951, 1720, 1655, 1456, 1390, 1230, 1140, 960, 753, 665. Anal. Found (%): C, 
47.50; H, 6.78; N, 5.74; S, 1.98; V, 2.80. 
4.2.3 Attempted synthesis imidazole-2-carboxylic acid containing beads 
p[(N-vinylimidazole-2-aldehyde)-co-divinylbenzene]. An aqueous phase consisting of water 
(70 mL), hydroxyethylcellulose (HEC) (0.01 g) and gelatine (0.03 g) was stirred at 50 °C until the 
solids were completely dissolved. In a separate beaker, an or ganic phase consisting of N-
vinylimidazole-2-carboxaldehyde6 (4 g, 0.033 mol), 80% divinylbenzene (5 g, 0.031 mol), toluene 
(9 mL) and 75% benzoyl peroxide (0.25 g, 0.77 mmol) was stirred. The organic phase was added 
to the aqueous phase at a constant stirring rate of 350 rpm and the temperature was increased to 
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70 °C. The reaction was carried out under a constant stream of argon for a period of 20 hours and 
then allowed to cool to room temperature. The beads were collected by filtration, washed several 
times with warm water, then methanol and finally diethyl ether. The beads were dried in an oven 
(60 °C) and sieved. ATR-IR (cm-1, neat): 2929, 2172, 1692, 1605, 1452, 1275, 991, 906, 712. 
Anal. Found (%): C, 86.47; H, 7.69; N, 3.16. 
p[(N-vinylimidazole-2-carboxylic acid)-co-divinylbenzene]. A vial containing p[(N-
vinylimidazole-2-aldehyde)-co-divinylbenzene] microspheres (1.0 g) were allowed to swell in 
acetonitrile and water (10 mL/10 mL). To this was added aqueous hydrogen peroxide (5 mL, 30%) 
and this was stirred gently for one week at room temperature. The beads were filtered, washed 
several times with water, then methanol and ether and dried in vacuo. ATR-IR (cm-1, neat): 2929, 
2172, 1692, 1605, 1452, 1275, 991, 906, 712. Anal. Found (%): C, 81.37; H, 7.42; N, 2.91. 
4.2.4 Attempted synthesis 2-(2ˊ-hydroxyphenyl)imidazol(in)e containing beads 
The allyl functionalized ligands, 2-(2ˊ-hydroxyphenyl)-N-allylimidazoline7 and 2-allyl-6-(2ˊ-
hydroxyphenyl)imidazoline,8 were successfully synthesized. However, due to limited solubility in 
various organic solvents including toluene, chloroform, dichloromethane, cyclohexanol, octanol 
and ethylacetate (since these solvents are immiscible with water) suspension polymerization 
could not be c onducted. In an at tempt to improve monomer solubility the N-ethyl derivative, 2-
allyl-6-(1-ethyl-2ˊ-hydroxyphenyl)imidazoline, was prepared, but it was still not sufficiently soluble. 
We also prepared the vinyl imidazole derivative, 2-(2ˊ-hydroxy-4-vinylphenyl)imidazole but once 
again the lack of solubility made it unsuitable for suspension polymerization. The synthesis of this 
ligand will be d iscussed in a l ater chapter (Part 2, Chapter 5). Nevertheless, since the ligand-
functionalized polymers prepared in the previous chapter (Part 2, Chapter 3), were only 
monodentate with either an imidazole/imidazoline group available for coordination, we settled 
upon using N-vinylimidazole which produced a similar coordination environment.  
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4.3 Catalytic activity studies 
4.3.1 Batch oxidation of thioanisole using p(VIM-co-EGDMA)-VO beads 
In a typical reaction, 20mL of acetonitrile was added to a 100 mL round bottom flask fitted with a 
glass condenser and placed in an oil bath. The temperature of the oil bath was regulated to ±1 °C 
by using an external temperature probe. The stirring speed was kept constant at 300 rpm for all 
reactions. Thioanisole (1.24 g, 10 mmol) was added followed by the required moles of aqueous 
H2O2 and then the catalytic beads which signalled the start of the reaction.  
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4.4 Results and discussion 
4.4.1 Synthesis 
Several attempts were carried out before imidazole-containing polymer beads of the desired size 
and morphology were obtained. The use of different crosslinking agents, stabilizers, stirring rate 
and, type and ratio of porogens (or organic solvents) was investigated and found to have a 
considerable effect on the resultant bead morphology A few examples are further discussed to 
illustrate the effects of these parameters.  
Initially toluene was used as a porogen and divinylbenzene as a crosslinker since this 
combination has frequently been used to prepare styrene-co-divinylbenzene microspheres.10,11 
We also used this method to produce the p[(N-vinylimidazole-2-aldehyde)-co-divinylbenzene] 
beads (4.2.3). However, when N-vinylimidazole was used as the monomer rather than styrene (or 
N-vinylimidazole-2-aldehyde), the more hydrophilic N-vinylimidazole monomer transferred into the 
aqueous layer rather than remaining in the organic phase where polymerization occurs resulting 
in poor incorporation of the monomer in the polymer beads. This problem was also reported by 
Fontanals and co-workers,12 and overcome by increasing the reaction time and adding the 
organic phase in two portions. However, since we were not restricted to using divinylbenzene, we 
substituted this with ethylenegylcol dimethacrylate. The result of this was that the N-vinylimidazole 
was retained in the monomer phase but very large non-spherical lumps were produced (figure 
4.1). Cyclohexanol was used as a p orogen by Uğuzdoğan and co-workers, who also prepared 
vinylimidazole-co-ethyleneglycol dimethacrylate beads.13 However, when we tried using this 
porogen only a po wdery material formed (figure 4.1), probably due to the different stabilizer 
mixture used.  
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Figure 4.1 Images of two attempts at producing polyvinylimidazole-co-ethylenegylcol dimethacrylate 
beads using toluene (A) and (B) cyclohexanol as the only solvent (porogen) 
 
Since only excessively large beads formed when toluene was used and only very fine powder 
formed when using cyclohexanol, we suspected that a combination of the two would provide the 
balance and yield the desired microspherical product, which was indeed the case. An optimal ratio 
of toluene/cyclohexanol of 7:2 (v/v) was eventually settled upon as it produced the most 
monodisperse set of beads (figure 4.2). Using these conditions, the stirring speed was adjusted 
until droplets of the desired size were attained with 300 rpm proving to be optimal. The 
corresponding vanadyl-functionalized beads (figure 4.2) were prepared by reacting these 
imidazole-containing beads with vanadyl sulfate. The synthetic scheme for the preparation of both 
p(VIM-co-EGDMA) and p(VIM-co-EGDMA)-VO is shown below (scheme 4.1) 
 
 
Figure 4.2 Poly(vinylimidazole-co-ethylenegylcol dimethacrylate) before (A) and after functionalization 
with vanadium (B)  
(A) (B) 
(A) (B) 
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Scheme 4.1 Synthetic scheme for the preparation of p(VIM-co-EGDMA) microspheres. R represents a 
solvent molecule or a nearby ligand 
 
4.4.2 Attempted syntheses 
There were several attempts at making imidazole-2-carboxylic acid and 2 -(2ˊ-
hydroxyphenyl)imidazoline functionalized beads, to try and keep the ligand theme from the 
previous chapter consistent (Part 2, Chapter 3). This proved more challenging than initially 
expected. For the imidazole-2-carboxylic acid system, we firstly attempted to prepare N-
vinylimidazole-2-carboxylic acid by reacting N-vinylimidazole with BuLi followed by carbonylation 
using dry ice (CO2(s)). However the product proved difficult to extract into the organic phase and 
was thermally unstable. At this point this strategy was abandoned since normal phase suspension 
polymerization requires that the monomers are sufficiently soluble in the organic phase and not 
transfer into the aqueous phase. The next strategy involved using N-vinylimidazole-2-
carboxaldehyde since this monomer was soluble in organic solvents. We were successful in 
preparing the N-vinylimidazole-aldehyde functionalized beads by suspension polymerization using 
divinylbenzene as a crosslinker. We were hopeful that oxidation using aqueous hydrogen 
peroxide would then convert the aldehyde to a carboxylic acid group as had been done before in 
homogeneous solution (Part 1, Chapter 4). Initially the results suggested success because the 
microanalysis showed a drop in C and N percentages indicative of addition of the OH from the 
carboxylic acid and the colour of the beads became clearer (figure 4.3). However, neither the 
ν(C=O) nor any other bands in the infrared spectrum shifted at all (figure 4.4) indicating that no 
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reaction occurred at this position. Several other oxidizing agents including oxone and KMnO4 
were used to no avail. 
 
 
Figure 4.3 Images of poly[(vinylimidazole-2-carboxyaldehyde)-co-divinylbenzene] beads (A) before and 
(B) after reaction with hydrogen peroxide 
(A)
Wavenumber (cm-1)
1000150020002500300035004000
(B)
 
Figure 4.4 Infrared spectra of poly[(vinylimidazole-2-carboxyaldehyde)-co-divinylbenzene] beads (A) 
before and (B) after reaction with hydrogen peroxide. Highlighted region confirms no shift of 
the ν(C=O) 
 
Synthesis of beads containing the bidentate 2-(2ˊ-hydroxyphenyl)imidazoline ligand also proved 
unsuccessful. In this instance, the main problem was solubility of the monomerized ligands (of 
which a few variations were prepared in attempts to improve solubility). None of these dissolved 
(A) (B) 
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sufficiently in several of the organic solvents tested, showing solubility only in DMSO and DMF 
which are unfortunately miscible with water and thus unsuitable for use in suspension 
polymerization.  
The above mentioned attempts certainly illustrate one of the major problems associated with 
suspension polymerization which is monomer solubility. Unlike the Merrifield functionalization 
approach, in which almost any solvent can be used to dissolve the ligand, direct incorporation of a 
monomerized ligand by suspension polymerization commands a f ine balance of ligand 
hydrophobicity/hydrophilicity.  
  
4.4.3 Characterization 
In the infrared spectrum of the p(VIM-co-EGDMA) beads, an intense band appeared at 1721 cm-1 
corresponding to the ν(C=O) from EGDMA, while imidazolyl ring stretches were found at 1452, 
1232 and 665 cm-1.5,14,15 After reacting these beads with vanadyl sulfate a band at 960 cm-1 
appeared corresponding to the vanadyl ν(V=O) stretch (figure 4.5).16 The sulfate ion stretching 
vibrations were not obviously apparent, probably being hidden beneath the polymer bands in the 
region of 1250 – 1025 cm-1 as there was some broadening in this region.  
Wavenumber (cm-1)
65090011501400165019002150240026502900
p(VIM-co-EGDMA)
p(VIM-co-EGDMA)-VO
 
Figure 4.5 Overlaid infrared spectra of p(VIM-co-EGDMA) and p(VIM-co-EGDMA)-VO in the range 3000-
650 cm-1 
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The sulfate was however detectable by microanalysis, which indicated a sulfur content of.98% in 
the p(VIM-co-EGDMA)-VO beads. The nitrogen content, a d irect indicator of the quantity of 
imidazole incorporated, was found to be 6.52% for p(VIM-co-EGDMA) beads, which corresponds 
to an imidazole-to-EGDMA ratio of roughly 2:3. After vanadium functionalization, the nitrogen 
content dropped slightly to 5.74%, due to the incorporation of the vanadium salt. The total 
vanadium content was determined by ICP-OES after thorough leaching from the polymer using 
concentrated nitric acid. The 2.80% vanadium content determined translates to an imidazole-to-
vanadium ratio of close to 4:1 and a sulfur-to-vanadium ratio of close to 1:1. The latter 
corresponds well to the expected 1:1 ratio of the divalent vanadyl cation and divalent sulfate 
anion. As for the imidazole-to-vanadium ratio, one should be cautious of extrapolating too far and 
presuming that all of the available imidazole groups are bound to vanadium.  
Investigation of the surface chemistry of these beads was performed using XPS. In the p(VIM-co-
EGDMA) beads, the N 1s peak representative of imidazole and the O 1s peak from EGDMA 
(C=O) appeared at 399 and 530 eV (figure 4.6 and table 4.1) respectively, and within the 
reported ranges for these groups.17 These peaks were also observed for p(VIM-co-EGDMA)-VO 
along with additional peaks appearing at 515 and 522 eV corresponding to the V 2p3/2 and V 2p1/2, 
respectively (figure 4.6). The latter not only confirmed the presence of vanadium on the surface 
of the beads but also confirmed the +4 oxidation state of vanadium.17 The proximity of the V 2p 
peak to the comparatively large O 1s peak and the low intensity of the N 1s and S 2p peaks made 
quantitative surface composition analysis unreliable and so comparative total-versus-surface 
composition could not be accurately performed.  
 
Table 4.1 Elemental binding energies of p(VIM-co-EGDMA) and p(VIM-co-EGDMA)-VO as determined by 
XPS  
 Binding Energy (eV) 
Polymer O 1s N 1s C 1s V 2p3/2 V 2p1/2 S 2p3/2 
p(VIM-co-EGDMA) 530 399 285 - - - 
p(VIM-co-EGDMA)-VO 530 399 285 515 522 167 
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Figure 4.6 Wide scan XPS spectra of p(VIM-co-EGDMA) and p(VIM-co-EGDMA)-VO. The insert shows 
the expanded V 2p3/2 and V 2p1/2 signals 
 
The general thermal stability of the p(VIM-co-EGDMA) and p(VIM-co-EGDMA)-VO beads was 
determined using TG. For both polymers an early weight loss step was observed below 110 °C 
probably due to absorbed water (figure 4.7). Onset of a multistep decomposition (Tonset) process 
for p(VIM-co-EGDMA) began at 250 °C (figure 4.7), while after functionalization with 
oxovanadium(IV), a new weight loss process was observed beginning at 368 °C (Tmax = 421 °C), 
probably due to oxovanadium(IV) decomposition. 
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Figure 4.7 TG and DTG curves of p(VIM-co-EGDMA) (left) and p(VIM-co-EGDMA)-VO (right) at a heating 
rate of 10 °C.min-1 under N2 
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SEM and AFM were used to monitor the morphology of the beads. The SEM images of the p(VIM-
co-EGDMA) and p(VIM-co-EGDMA)-VO beads are shown in figure 4.8. Both sets of beads had 
rough surfaces, whilst the oxovanadium(IV) functionalized beads displayed a greater level of 
surface homogeneity. Diameter measurements were performed using the measureIT software 
from Olympus Soft Imaging Solutions. For both sets of beads, the diameters of no less than 25 
individual beads were measured. The p(VIM-co-EGDMA) beads had an average diameter of 314 
μm with a size distribution range of 251 - 372 μm. The average diameter of the vanadium-
functionalized beads was slightly larger (but within error of the non-metallated variety) at 322 μm 
with a range of 274 - 408 μm. These beads were considerably rougher and smaller than the 
Merrifield beads used in the previous chapter (Part 2, Chapter 1) which had an average diameter 
of 612 μm. 
 
Figure 4.8 SEM images of (A) p(VIM-co-EGDMA) and (B) the oxovanadium(IV) functionalized derivative 
p(VIM-co-EGDMA)-VO. The insert shows an expanded view of a single bead 
 
AFM also proved to be a useful tool for probing the surface morphology of the beads after the 
various synthetic steps. As shown in figure 4.9, the non-metallated p(VIM-co-EGDMA) beads 
have a bum py surface, which after reaction with vanadyl sulfate appears significantly more 
ordered with a ‘diamond-like’ pattern emerging. The surface roughness of the p(VIM-co-EGDMA) 
beads decreased from 41.64 nm to 21.01 nm after reacting them with vanadyl sulfate. This trend 
was similar to that observed for the Merrifield beads from Part 2, Chapter 3 and may be due to 
the formation of a vanadyl coating on the surface. The Merrifield-based beads were significantly 
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smoother than the beads prepared in this chapter (by approximately 10 fold), a property perhaps 
even more easily seen in the SEM images.  
 
Figure 4.9 Selected 2D and 3D (1x1 μm sections) of (A) p(VIM-co-EGDMA) and (B) p(VIM-co-EGDMA)-
VO  
 
The surface area of the beads was determined from nitrogen absorption/desorption isotherms 
(figure 4.10) using the BET method. The specific surface area of the p(VIM-co-EGDMA) beads 
was found to be 151 m2.g-1, while the average pore volume and size was 0.31 cm3.g-1 and 82 Å 
respectively. This surface area was slightly higher than the polyvinylimidazole-co-ethyleneglycol 
dimethacrylate beads reported by Kara et al., who reported a surface area of 59.8 m2.g-1 for their 
150-200 μM sized beads.5 The increased surface area observed in this study may be due to the 
larger amount of crosslinker used, since it has been observed that an increase in crosslinker may 
result in greater surface areas due to the formation of rigid pores.17 After reaction with vanadyl 
sulfate, the surface area dropped to 99 m 2.g-1, while the average pore volume and diameter 
remained relatively similar (0.21 cm3.g-1 and 87 Å, pore volume and pore diameter respectively). 
The drop in surface area going from p(VIM-co-EGDMA) to p(VIM-co-EGDMA)-VO may be due to 
filling of the pores by vanadium, as evidenced by the slight drop in pore volume, as well as the 
decrease in surface roughness as measured by AFM. Despite this, the surface area of these 
beads was still considerably larger than the Merrifield beads used in the previous chapter (Part 2, 
Chapter 3) which had a surface area of 10.4 m2.g-1 with 311 Å wide pores and an average pore 
volume of 0.051 cm3.g-1. This may once again be attributed to the combination of the increased 
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amount of crosslinker, roughness and the smaller size of the p(VIM-co-EGDMA) beads. It was 
hoped that the increased surface area of these beads would impact positively on the overall 
catalytic activity. 
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Figure 4.10 Nitrogen adsorption-desorption isotherms for (A) p(VIM-co-EGDMA) and (B) p(VIM-co-
EGDMA)-VO 
 
4.4.4 Catalytic activity 
The catalytic activity of the p(VIM-co-EGDMA)-VO beads was assessed using the peroxide 
facilitated oxidation of thioanisole as a test reaction. From the previous chapter (Part 2, Chapter 
3), we found this reaction to be a good indicator of catalytic activity. Furthermore, the higher 
temperatures and harsh oxidizing conditions required for effective oxidation of styrene and 
ethylbenzene was not well suited to the polymeric supports.  
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(a) Oxidation of thioanisole 
The first parameter to be optimized for the oxidation of thioanisole was the amount of catalyst 
(figure 4.11). As expected, this had a no ticeable effect on t he rate of oxidation of thioanisole.  
When using 0.1, 0.2 and 0.3 g of catalyst the TOF’s were 34.52, 35.69, 30.12 h-1 respectively. For 
this reason further studies were performed using 0.2 g of catalyst. It should be noted that when 
using the un-metallated p(VIM-co-EGDMA) beads, a conversion of less than 17% was obtained 
reinforcing the catalytic properties of the oxovanadium-containing beads. At room temperature, all 
catalyst amounts gave greater quantities of the sulfoxide than the sulfone, but as the amount of 
catalyst increased and the reaction time progressed, the ratio of sulfoxide to sulfone began to 
decrease (table 4.2). For example, when using 0.1 g of  p(VIM-co-EGDMA)-VO the ratio of 
sulfoxide-to-sulfone was 2:7 while when using 0.2 g and 0.3 g this ratio was 2:3 and 4:5, 
respectively. 
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Figure 4.11 The effect of catalyst amount on thioanisole oxidation. Reaction conditions: H2O2 (20 mmol) , 
thioanisole (10 mmol), acetonitrile (20 mL) and 25 °C 
 
As has been observed before,18 an increase in temperature resulted not only in an increased rate 
of oxidation (figure 4.12) but also a greater quantity of methyl phenyl sulfone (figure 4.13). At 50 
°C, there was a sharp increase in the formation of methyl phenyl sulfoxide, followed by a period of 
decay with an associated increase in the formation of the sulfone. For the same mass of catalyst, 
the TOF increased from 35.69 h-1 at 25 °C to 268.53 h-1 at 50 °C, while the conversions to the 
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sulfoxide were 59.6% (at 25 °C) and 31.2% (at 50 °C), and to the sulfone were 40.2% (at 25 °C)  
and 68.7% (at 50 °C). 
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Figure 4.12 The effect of temperature on thioanisole oxidation. Conditions: p(VIM-co-EGDMA)-VO (0.20 
g), H2O2 (20 mmol) , thioanisole (10 mmol), acetonitrile (20 mL)  
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Figure 4.13 The effect of temperature on product selectivity. Conditions: p(VIM-co-EGDMA)-VO (0.20 g), 
H2O2 (20 mmol) , thioanisole (10 mmol), acetonitrile (20 mL)  
 
The catalytic beads showed good recyclability, an important property of heterogeneous catalysts. 
As shown in figure 4.14 there was barely any drop in activity after subsequent catalyzed 
reactions demonstrating the excellent recyclability of these beads. In addition, there was barely 
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any significant damage to the surface of the beads after a catalytic reaction as illustrated in the 
AFM images in figure 4.15.  
Substituting methanol for acetonitrile as the solvent resulted in a s light drop in activity (figure 
4.14) which may be explained by the stabilization of the vanadium species by coordination of 
acetonitrile19 or due to the slightly higher dielectric constant of acetonitrile (37.5) compared to 
methanol (33). The reason for assessing the influence of the solvent will become more apparent 
in the next chapter (Part 2, Chapter 5). A summary of the results obtained using p(VIM-co-
EGDMA)-VO appears in table 4.2.  
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Figure 4.14 Recyclability of p(VIM-co-EGDMA)-VO beads at optimal conditions, and the effect of using 
methanol instead of acetonitrile as the solvent. Conditions: p(VIM-co-EGDMA)-VO (0.20 g), 
H2O2 (20 mmol) , thioanisole (10 mmol), acetonitrile/methanol (20 mL) and 25 °C 
 
 
Figure 4.15 AFM images of (A) p(VIM-co-EGDMA)-VO and (B) p(VIM-co-EGDMA)-VO after one catalytic 
cycle 
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Table 4.2 Percentage conversion, turnover frequency (TOF) and product selectivity for the oxidation of 
thioanisole with hydrogen peroxide (20 mmol) using p(VIM-co-EGDMA)-VO as a catalyst 
Mass  
(g) 
Temp  
(°C) 
Solvent 
 
Conversion 
(%) 
TOFa  
(h-1) 
Sulfoxide 
(%) 
Sulfone 
(%) 
0.1 25 CH3CN 75.9 34.52 59.3 16.6 
0.2 25 CH3CN 99.9 35.69 59.6 40.2 
0.2* 25 CH3CN 99.9 44.91 54.9 45 
0.2** 25 CH3CN 99.9 45.00 51.4 48.5 
0.2 50 CH3CN 99.9 268.53 31.2 68.7 
0.2 25 MeOH 96.3 21.89 72.8 23.4 
0.3 25 CH3CN 99.9 30.12 55.5 44.4 
a Determined as moles of substrate converted/moles of catalyst/time (h); * After one cycle; ** After two cycles 
 
During the catalytic reaction, the oxovanadium(IV) containing beads were oxidised to 
vanadium(V) species which was visibly noticed by a change in colour. As shown in scheme 4.2, 
the p-(VIM-co-EGDMA)-VO beads turn from a grey-blue colour to a yellow-orange colour, 
indicative of the change in oxidation state from +4 to +5 as proposed in the mechanism.  
 
 
Scheme 4.2 The proposed catalytic mechanism for the oxidation of thioanisole by vanadium including 
photographs of beads before and during a reaction 
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In the infrared spectrum (figure 4.16), the yellow-coloured beads exhibit a s trong band at 966 
cm-1 consistent with the presence of a terminally bonded V=O group, while the band appearing at 
870 cm-1 is tentatively assigned the peroxo O-O stretch, ν(O-O).20 It is therefore likely that the 
yellow-coloured beads consist predominantly of the oxoperoxovanadium(V) species as would be 
expected in conditions of excess peroxide. 
Wavenumber (cm-1)
7008009001000
(A)
(B)
 
Figure 4.16 Overlaid infrared spectra of (A) p(VIM-co-EGDMA)-VO and (B) p (VIM-co-EGDMA)-VO 
recovered mid-reaction 
 
  
203 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
4.5 Conclusions 
Polymeric microspherical beads containing the imidazole functionality were successfully prepared 
by suspension polymerization. Using this approach, we have gained access to a num ber of 
properties that cannot be modified when using the commercial Merrifield based resins. The bead 
diameter was smaller than the Merrifield resins and a larger amount of crosslinker was used 
resulting in a more resilient and robust support. Additionally, the surface area was approximately 
ten-fold greater than the Merrifield resins used in the previous chapter. The metal binding capacity 
of the imidazole in the p(VIM-co-EGDMA) beads allows this support to be applied not only to 
immobilization of oxovanadium(IV) but also many other metal based homogeneous catalysts. 
There was, however, a greater deal of complexity involved when using the suspension 
polymerization approach. Several factors including stabilizer, stirring speed and porogen used, 
affected the resultant polymer morphology. Another disadvantage is that one is limited to using 
solvents that are immiscible with water (when carrying out normal phase suspension 
polymerization). Thus, the solubility of the monomerized ligand should be c arefully considered 
and even modified since several solvents are “out-of-bounds”. Nevertheless, once a s uccessful 
synthetic protocol has been developed, suspension polymerization remains a useful approach for 
the large scale preparation of ligand-functionalized polymer microspheres.  
The heterogeneous catalysts prepared by this method proved to be effective in catalyzing the 
hydrogen peroxide facilitated oxidation of thioanisole and al so displayed excellent recyclability, 
with no drop in activity being observed after three successive catalytic reactions. The increased 
surface area and porosity of these beads over the Merrifield beads had little to no observed effect 
on catalytic activity. We therefore propose that the directly exposed surface area is a m ore 
important property than total surface area (which includes pores) for these reactions and thus 
intend to investigate the catalytic properties of ultrafine fibers. 
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4.6 References and notes 
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 (5) Kara, A.; Uzun, L.; Besirli, N.; Denizli, A. J. Hazard. Mater. 2004, 106, 93. 
(6)  In a 250 mL round bottom flask, N-vinylimidazole (15 g, 0.16 mol) was dissolved in dried 
diethyl ether (200 mL). The solution was flushed with argon to remove air and cooled to -78 
°C. Butyllithium (2.5 M, 0.17 mol) was then added slowly. After two hours of stirring, dry 
N,N-dimethylformamide (0.24 mol) was added. The reaction was allowed to proceed 
overnight after which time, water (10 mL) was added followed by 150 mL of 4N HCl. The 
aqueous layer was made basic by addition of potassium carbonate following which; the 
product was extracted into chloroform. This organic layer was concentrated and the product 
was distilled at 3.0x10-1 mbar. The clear liquid solidified and turned brown after some time. 
Yield: 72%. 1H NMR (δ, 400 MHz, DMSO-d6): 9.88 (s, 1H, CHO), 7.95 (m, 1H, vinyl-H), 
7.54 (s, 1H, Im-H), 7.34 (s, 1H, Im-H), 5.41 (m, 1H, vinyl-H), 5.12 (m, 1H, vinyl-H). Anal. 
Calcd (Found) for C6H6N2O (%): C, 59.01 (59.21); H, 4.95 (4.97); N, 29.94 (29.86). 
(7)  Methyl(3-allyl-2-hydroxy)salicylate was prepared as reported in literature.21 
Ethylenediamine (5 g, 0.041 mol) was then added to the allyl functionalized salicylate (4g, 
0.01 mol) and refluxed overnight. The reaction was allowed to cool and the product 
crystallized out and was collected by filtrated and washed with cold ethylacetate. Yield: 
52%. 1H NMR (,δ 400 MHz, DMSO-d6): 7.42 (d, 1H, Ar-H), 7.12 (d, 1H, Ar-H), 6.61 (t, 1H, 
Ar-H), 5.96 (m, 1H, allyl-H), 5.01 (m, 2H, allyl-H), 3.71 (s, 4H, Im-H), 2.51 (s, 2H, allyl-CH2). 
Anal. Calcd (Found) for C12H14N2O (%): C, 71.26 (72.21); H, 6.98 (7.12); N, 13.85 (13.54). 
(8) Allylethylenediamine was prepared as reported in literature.22 Allylethylenediamine (7.45 g, 
0.074 mol) was added to methylsalicylate (2.6 g, 0.017 mol) and refluxed overnight. The 
product was purified on a silica column using methanol/ethylacetate (4:1). After 
concentration in vacuo, a yellow solid resulted. Yield: 61%. 1H NMR (δ, 400 MHz, DMSO-
205 
 
 
 
Ryan S. Walmsley                                                                                                                   Rhodes University 
d6): 7.36 (d, 1H, Ar-H), 7.28 (t, 1H, Ar-H), 6.98 (d, 1H, Ar-H), 6.73 (t, 1H, Ar-H), 5.89 (m, 
1H, allyl-H), 5.32 (m, 2H, allyl-H), 4.01 (m, 2H, allyl-CH2), 3.94 (t, 2H, Im-H), 3.54 (t, 2H, Im-
H). Anal. Calcd (Found) for C12H14N2O (%): C, 71.26 (72.41); H, 6.98 (7.19); N, 13.85 
(13.49). 
(9)  This compound was prepared as for 2-allyl-6-(2ˊ-hydroxyphenyl)imidazoline except that N-
ethylethylenediamine and methyl(3-allyl-2-hydroxy)salicylate were used. Purification was 
achieved on a silica column using a mixture of ethylacetate and methanol (4:1). 
Concentration yielded a yellow solid. Yield: 52%. 1H NMR gave a mixture of rotamers in an 
approximately 4:5 ratio, making integration unreliable. 1H NMR (δ, 400 MHz, DMSO-d6): 
7.71 (d, 1H, Ar-H), 7.32 (d, 1H, Ar-H),  7.25 (d, 1H, Ar-H), 7.15 (d, 1H, Ar-H), 6.79 (t, 1H, 
Ar-H), 6.72 (t, 1H, Ar-H), 5.97 (m, 2H, allyl-H), 5.05 (m, 4H, allyl-H), 3.83 (t, 1.5H, Im-H), 
3.53 (t, 1.5H, Im-H), 3.38 (m, 7H), 2.71 (t, 2H), 2.58 (m, 2H), 1.19 (t, 2.35H), 1.02 (t, 3H). 
Anal. Calcd (Found) for C14H18N2O (%): C, 73.01 (73.96); H, 7.88 (7.96); N, 12.16 (12.09).  
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Chapter 5  
Electrospun fibers as support materials for oxovanadium(IV) catalysts 
 
5.1  Introduction 
The vanadium-functionalized crosslinked polymer microspheres developed in the previous 
chapters (Part 2, Chapter 3 and 4) showed excellent promise as heterogeneous catalysts. 
Theoretically, as one decreases the diameter of these materials, the surface area-to-volume ratio 
increases (provided that porosity and roughness remain constant). This may result in improved 
catalytic activity due to the greater catalytic surface area.1 Unfortunately, as one decreases the 
size of the beads, they become difficult to separate and often require a centrifugation step.2 In 
some instances this has been addressed by magnetizing the smaller beads and separating them 
by application of an external magnetic field.3  
On the other hand, small diameter fibrous materials can be prepared by alternative techniques 
such as drawing and electrospinning. The latter is an emerging and simple technique for obtaining 
very small (μm down to nm) diameter materials.4 While the diameter of each fiber can be made 
very small, the three-dimensional network structure allows these materials to be separated very 
simply from the reaction solution (figure 5.1). The fiber flexibility and porosity (inter-fiber) of the 
mat makes these materials ideal for continuous flow applications. 
While the microspherical resins are often highly porous and hence may have comparatively larger 
surface areas than the fibers, it is questionable how accessible these pores are to substrates. 
Thus, it is likely that a large degree of catalysis takes place on the surface of the beads and since 
the fiber diameters are much smaller, a greater degree of catalytic surface area is directly 
exposed to the reaction solution.  
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Figure 5.1 Characteristics of nanofibers and nanofibrous membranes 
 
Fibers produced by electrospinning have been studied for a wide variety of applications including; 
filtration, wound dressings, tissue engineering scaffolds, artificial blood vessels, photonics, 
sensorics,5 pharmacy, energy devices,6 drug delivery and solid phase extraction sorbents,7 to 
name a f ew. The most popular use of these fibers is within the biomedical realm8 with several 
reviews available on this topic,9-12 however there has been m oderate interest in using these 
materials as catalyst supports. The simplest examples of electrospun fibers acting as catalyst 
supports are the non-metallated variety. With these, an organic molecule acts as the catalyst and 
may be introduced either by copolymerization or by post-electrospinning functionalization.13-15 
More commonly, these fibers are used as supports for metal nanoparticles16-19 and to a lesser 
extent as metal oxide fibers produced by calcination.20,21 Strangely, there has been little to no 
work utilizing the ligand or coordination chemistry related approach for catalyst immobilization with 
these fibers. This may be due to the infancy of the field or due to some of the challenges 
associated with working with these non-crosslinked materials.  
In this chapter, the preparation of oxovanadium(IV)-anchored polymer fibers is described. These 
materials were thoroughly characterized using various techniques including IR spectroscopy, 
microanalysis and SEM, to name a few. The catalytic activity of these materials was investigated 
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for the hydrogen peroxide based oxidation of thioanisole under continuous flow conditions and in 
some instances, batch conditions. Preliminary studies were conducted using non-covalently linked 
catalysts which had been incorporated into polystyrene fibers by mixing. Improvements to the 
polystyrene-based system were made, firstly by covalently anchoring the catalysts and then by 
incorporating a bidentate (rather than monodentate) ligand. Further improvements were then 
made by replacing polystyrene fibers with the thermally, chemically and mechanically stable 
polybenzimidazole fibers.  
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5.2 Preparation of ligands and oxovanadium(IV) complexes 
5.2.1 2-(2ˊ-Hydroxy-5ˊ-bromophenyl)imidazole (pimBr) 
The 2-(2ˊ-hydroxyphenyl)imidazole derivatives were all prepared in a similar 
fashion to the literature procedure with minor modifications.22 5-Bromo-2-
hydroxybenzaldehyde (5 g, 0.025 mol) and glyoxal trimer dihydrate (5.2 g, 0.025 
mol) were added to glacial acetic acid (100 mL) and brought to reflux under argon until dissolved, 
then ammonium acetate (18 g, 0.025 mol) was added and reflux was continued for a further 4 hrs. 
The dark brown solution was allowed to cool and filtered through celite. The solution was made 
basic by addition of aqueous ammonia. The resultant yellow-brown precipitate was collected by 
filtration, redissolved in acetone and refluxed for an hour with activated carbon. This was filtered 
through celite and concentrated to give a cream solid. Yield: 32.5%. Mp 240-242 °C. ATR-IR (cm-
1, neat): 3370, 3230, 1588, 1551, 1492, 1488, 1391, 1287. 1H NMR (δ, 400 MHz, DMSO-d6): 8.09 
(d, 1H), 7.37 (dd, 1H), 7.28 (br-s, 2H), 6.92 (d, 1H). 13C NMR (δ, 100 MHz, DMSO-d6): 157.10, 
156.01, 131.63, 126.55, 122.30, 119.43, 115.01, 110.32. Anal. Calcd (Found) for C9H7BrN2O (%): 
C, 45.22 (45.48); H, 2.95 (2.96); N, 11.72 (11.48).  
5.2.2 N-Benzoyl-2-(2ˊ-benzoxy-5ˊ-bromophenyl)imidazole (dibenzoylpimBr).  
A mass of 0.8 g of pimBr (0.003 mol) was dissolved in THF (20 mL). To this was 
added triethylamine (0.61 g, 0.006 mol) followed by benzoyl chloride (0.84 g, 
0.006 mol). Stirring was continued overnight after which the solution was filtered 
and the filtrate concentrated to give a cream solid product. This was digested in 
warm diethyl ether and washed thoroughly with the same solvent to afford a pure 
product. Yield: 62.8%. Mp 131-133 °C. ATR-IR (cm-1, neat): 1745, 1703, 1600, 1528, 1494, 1448, 
1417, 1285. 1H NMR (δ , 400 MHz, DMSO-d6): 7.83 (m, 1H), 7.78-7.76 (m, 2H), 7.70-7.53 (m, 
5H), 7.53 (s, 1H), 7.44-7.36 (m, 4H), 7.30-7.28 (d, 1H), 7.17 (s, 1H).13C NMR (δ, 100 MHz, 
DMSO-d6): 167.54, 164.48, 148.63, 135.00, 134.93, 134.30, 133.97, 131.66, 131.24, 130.08, 
129.42, 128.80, 128.09, 125.94, 125.94, 122.87, 118.93. Anal. Calcd (Found) for C23H15BrN2O3 
(%): C, 61.76 (61.91); H, 3.38 (3.83); N, 6.26 (6.17). 
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5.2.3 N-Benzoyl-2-(2ˊ-benzoxy-5ˊ-ethenylphenyl)imidazole (dibenzoylvpim).  
The protected ligand precursor, dibenzoylpimBr (1 g, 2.24 mmol) was dissolved 
in warm toluene. To this was added tributyl(vinyl)tin (0.65 mL, 2.24 mmol) and a 
radical inhibitor 3,5-diterbutylcatechol (0.1 mol%).This mixture was heated to 
reflux under argon for 5 hours. After allowing the solution to cool, the solid was 
removed by filtration and the filtrate concentrated by rotary evaporation. The 
resultant yellow solid was digested in a mixture of diethyl ether and hexane (2:1) overnight, 
filtered and the solid washed with cold diethyl ether. Yield: 74.8%. Mp 123-125 °C. ATR-IR (cm-1, 
neat): 1736, 1707, 1598, 1504, 1448, 1288. 1H NMR (δ, 400 MHz, DMSO-d6): 7.88 (m, 2H), 7.76 
(s, 1H), 7.60-7.48 (m, 5H), 7.34-7.28 (m, 5H), 7.19 (m, 2H), 6.75 (m, 1H, vinyl-H), 5.80 (d, 1H, 
vinyl-H), 5.32 (d, 1H, vinyl-H). 13C NMR (δ, 100 MHz, DMSO-d6): 167.38, 164.64, 147.98, 145.78, 
135.80, 133.94, 130.99, 129.56, 128.78, 128.48, 122.94, 121.27, 115.27. Anal. Calcd (Found) for 
C25H18N2O3 (%): C, 76.13 (76.23); H, 4.60 (4.66); N, 7.10 (7.25). 
5.2.4 2-(2ˊ-Hydroxy-5ˊ-ethenylphenyl)imidazole (vpim)  
To a s olution of dibenzoylvpim (1 g, 2.5 mmol) in ethanol (10 mL) was added  
sodium ethoxide (prepared by addition of 100 mg of sodium to 50 mL of ethanol), 
dropwise. Once the solution became yellow, it was concentrated and dissolved 
in 0.2 M NaOH (50 mL). The pH was adjusted to 10 and the precipitate was collected by filtration 
and subjected to copious washing with ice-cold methanol followed by cold diethyl ether giving a 
pure cream solid. Yield: 54%. Mp 132-134 °C. ATR-IR (cm-1, neat): 3392, 3260, 1606, 1595, 
1530, 1504, 1388, 1279, 1259. 1H NMR (δ, 400 MHz, DMSO-d6): 8.03 (s, 1H), 7.33 (d, 1H), 6.91 
(d, 1H), 6.65 (m, 1H, vinyl-H), 5.73 (d, 1H, vinyl-H), 5.16 (d, 1H, vinyl-H). 13C NMR (δ, 100 MHz, 
DMSO-d6): 157.02, 146.57, 136.93, 129.11, 128.70, 122.89, 117.71, 114.26, 112.58, 100.37. 
Anal. Calcd (Found) for C11H10N2O (%): C, 70.95 (71.01); H, 5.41 (5.43); N, 15.04 (14.99). 
5.2.5 2-(4,5-Diphenyl-1H-imidazol-2-yl)phenol (dpimH)  
All substituted 2-(4,5-diphenyl-1H-imidazole-2-yl)phenol derivatives were 
prepared according to a literature procedure.23 Briefly, to a refluxing solution 
of benzil (2.0 g, 9.51 mmol) and ammonium acetate (14.7 g, 20 mol equiv) 
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was added salicylaldehyde (1.0 mL, 9.51 mmol) and refluxing continued for a further 3 hours. The 
mixture was allowed to cool overnight. Occasionally a portion of the product would precipitate out. 
This was collected, washed with aqueous ammonia. The remaining reaction solution was poured 
into aqueous ammonia and the resultant solid collected and combined with the other fraction. 
These combined fractions were then recrystallized from ethanol to yield a yellow solid. Yield: 70%. 
Mp 203-204 ºC. ATR-IR (cm-1, neat): 3189, 3053, 1601, 1590, 1552, 1485, 1216, 1023, 766, 691 
1H NMR (δ, 400 MHz, DMSO): 8.09 (br, d, 2H); 7.65 (m, 4H); 7.56 (m, 3H); 7.43 (m, 6H). 13C 
NMR (δ, 100 MHz, DMSO): 159.4, 145.2, 136.0, 131.9, 130.8, 128.7, 128.4, 128.1, 127.6, 126.5, 
126.4, 126.1. Anal. Calcd (Found) for C21H16N2O (%): C, 80.75 (80.17); H, 5.16 (5.22); N, 8.97 
(8.87).  
5.2.6 4-Methoxy-2-(4,5-diphenyl-1H-imidazol-2-yl)phenol (dpimMeO)  
This was prepared as for dpimH except that 5-methoxy-2-
hydroxybenzaldehyde was used instead of salicylaldehyde. Yield: 86%. 
Mp 159-160 ºC. ATR-IR (cm-1, neat): 3194m, 3048, 1605, 1586, 1499, 
1224, 1036, 764, 696. 1H NMR (δ, 400 MHz, DMSO-d6): 13.02 (s, 1H); 12.47 (s, 1H); 7.67 (s, 1H); 
7.40 (m, 10H); 6.89 (m, 2H); 3.77 (s, 3H). 13C NMR (δ, 100 MHz, DMSO-d6): 151.9, 150.8, 145.8, 
134.2, 133.6, 128.8, 127.3, 127.1, 126.7, 117.5, 116.9, 112.5, 108.8, 55.6. Anal. Calcd (Found) 
for C22H18N2O2 (%): C, 77.17 (77.10); H, 5.30 (5.38); N, 8.18 (8.09).  
5.2.7 4-Bromo-2-(4,5-diphenyl-1H-imidazol-2-yl)phenol (dpimBr)  
This was prepared as for dpimH except that 5-bromo-2-
hydroxybenzaldehyde was used instead of salicylaldehyde. Yield: 71%. Mp 
186-187 ºC. ATR-IR (cm-1, neat): 3166, 3043, 1604, 1579, 1567, 1484, 
1278, 1254, 1143, 1074, 1026, 762, 696. 1H NMR (δ, 400 MHz, DMSO-d6); 13.11 (br, s, 1H); 8.30 
(s, 1H); 7.53-7.39 (m, 11H); 6.95 (d, 1H). 13C NMR (δ, 100 MHz, DMSO-d6): 167.3, 156.7, 154.9, 
145.3, 133.2, 129.5, 128.7, 128.3, 127.9, 127.7, 119.9, 115.6. Anal. Calcd (Found) for 
C21H15BrN2O (%): C, 64.46 (64.26); H, 3.86 (3.90); N, 7.16 (7.25). 
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5.2.8 4-Nitro-2-(4,5-diphenyl-1H-imidazol-2-yl)phenol (dpimNO2)  
This was prepared as for dpimH except that 5-nitro-2-
hydroxybenzaldehyde was used instead of salicylaldehyde. Yield: 62%. 
Mp 219-220 ºC. ATR-IR (cm-1, neat): 3289, 3055, 1615, 1594, 1584, 
1471, 1336, 1129, 1074, 1024, 763, 739, 687. 1H NMR (δ, 400 MHz, DMSO-d6); 13.9 (br, s, 1H); 
9.15 (s, 1H); 8.17 (d, 1H); 7.54 (m, 4H); 7.43 (m, 4H); 7.38 (m, 2H); 7.16 (d, 1H). 13C NMR (δ, 100 
MHz, DMSO-d6): 165.5, 157.3, 154.3, 144.4, 133.2, 130.1, 128.8, 127.9, 127.6, 127.3, 126.9, 
120.3, 114.5. Anal. Calcd (Found) for C21H15N3O3 (%): C, 70.58 (70.29); H, 4.23 (4.18); N, 11.76 
(11.46). 
5.2.9 [VO(dpimH)2]  
The ligand dpimH (0.31 g, 1 mmol) was dissolved in warm methanol (10 
mL). Separately, vanadyl sulfate (0.1 g, 0.45 mmol) was dissolved in 3 
mL of a methanol/water (2:1 ratio) solution. This vanadyl solution was 
then added dropwise to the methanolic ligand solution. The mixture was 
stirred for 4 ho urs at room temperature. The resultant blue-green 
precipitate was collected by filtration and washed with water and 
methanol and then dried at 100 °C. Yield: 62%. Mp > 350 ºC. ATR-IR (cm-1, neat): 1604, 1589, 
1565, 1477, 1456, 1303, 1251, 1139, 1025, 945, 869, 750, 694. UV/Vis (DMF) λmax (ε, M
-1cm-1): 
527 (53), 632 (31), 836 (43). Anal. Calcd (Found) for C42H30N4O3V.2H2O (%): C, 69.51 (69.59); H, 
4.72 (4.71); N, 7.72 (7.64). 
5.2.10 [VO(dpimMeO)2]  
This compound was prepared as for [VO(dpimH)2] above 
except the ligand dpimMeO was used. The resultant 
compound was a yellow-green solid. Yield: 64 %. Mp > 350 
ºC. ATR-IR (cm-1, neat): 1587, 1489, 1225, 1034, 975, 764, 
692. UV/Vis (DMF) λmax (ε, M
-1cm-1): 515 (78), 625 (48), 844 
(55). Anal. Calcd (Found) for C44H34N4O5V.H2O (%): C, 68.84 
(68.71); H, 4.73 (4.81); N, 7.30 (7.26). 
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5.2.11 [VO(dpimBr)2]  
This compound was prepared as for [VO(dpimH)2] except the 
ligand dpimBr was used. The resultant compound was a blue-
green solid. Yield: 59 %. Mp > 350 ºC. ATR-IR (cm-1, neat): 1601, 
1561, 1475, 1294, 1250, 1142, 1028, 958, 696. UV/Vis (DMF) 
λmax (ε, M
-1cm-1): 522 ( 54), 639 ( 30), 823 (42). Anal. Calcd 
(Found) for C42H28Br2N4O3V.2H2O (%): C, 57.20 (57.10); H, 3.59 
(3.65); N, 6.30 (6.34).  
5.2.12 [VO(dpimNO2)2]  
This compound was prepared as for [VO(dpimH)2] except the 
ligand dpimNO2 was used. The resultant compound was an 
orange-green solid. Yield: 45 %. Mp > 350 ºC. ATR-IR (cm-1, 
neat): 1608, 1579, 1486, 1331, 1138, 1072, 964, 692. UV/Vis 
(DMF) λmax (ε, M
-1cm-1): 613 ( 49), 849 (55). Anal. Calcd 
(Found) for C42H32N6O9V.2H2O (%): C, 61.84 (62.06); H, 3.95 
(4.13); N, 10.30 (10.08). 
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5.3 Preparation of polymers and fabrication of fibers 
Electrospinning was conducted using a top-down (or vertical) approach whereby the polymer 
fibers were either collected on a stationary piece of grounded aluminium foil or using a rotating 
drum collector. The instrument setup for each of these methods is illustrated in figure 5.2.  
 
Figure 5.2 Different electrospinning configurations. Shown in (A) is the simple vertical electrospinning 
using a stationary grounded collector, while (B) shows the same setup except using a rotating 
drum collector with an oppositely charged electrode underneath to direct fiber collection 
 
5.3.1 PS-25 fibers 
A mass of 1.25 g of polystyrene (PS) was dissolved in 5 mL of a DMF:THF (4:1) solvent mixture 
to make a 2 5% (wt/v%) PS solution, which was subsequently stirred for 24 hours to ensure 
homogeneity. The solution was then transferred to a 20 mL syringe and electrospun. The voltage 
applied to the needle tip was 20 k V and the tip and collector distance was 15 cm. The internal 
diameter of the needle was 1 mm and the flow rate was 1 mL.h-1. The white fibers were collected 
by vertical electrospinning on a piece of aluminium foil that was grounded (figure 5.2a). ATR-IR 
(cm-1, neat): 1655, 1492, 1451, 749, 696. Anal. Found (%): C, 84.68; H, 8.08. 
5.3.2 PS-25-[VO(dpimMeO)2] fibers 
Same as above for PS-25 except [VO(dpimMeO)2] (0.25 g, 20 wt% relative to PS) was added to 
the mixture. The resulting fiber mat was a light green colour. ATR-IR (cm-1, neat): 1491, 1451, 
1281, 975, 811, 694. Anal. Found (%): C, 73.36; H, 7.43; N, 3.32; V, 3.00. 
 
(A) (B) 
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5.3.3  PS-15-[VO(dpimMeO)2] fibers 
Same as above for PS-25 except a mass of 1.25 g of PS was dissolved in 8.3 mL of a DMF:THF 
(4:1) solution to make a 15% PS solution. The internal needle diameter was 0.5 mm and the flow 
rate was kept constant at 0.5 mL.h-1. The resulting fiber mat was a green colour. ATR-IR (cm-1, 
neat): 1491, 1451, 1281, 975, 811, 694. Anal. Found (%): C, 85.85; H, 7.31; N, 1.28; V, 1.19. 
5.3.4  PS-25-[VO(dpimNO2)2] fibers 
Same as for PS-25 except [VO(dpimNO2)2] (0.25 g, 20 wt%) was used. The flow rate was reduced 
to 0.6 mL.h-1. The resulting fiber mat was a yellow colour. ATR-IR (cm-1, neat): 1579, 1182, 1138, 
1070, 1025, 987, 966, 891, 840. Anal. Found (%): C, 87.22; H, 7.61; N, 1.41; V, 0.86. 
5.3.5  PS-15-[VO(dpimNO2)2] fibers 
Same as for PS-25 except that [VO(dpimNO2)2] was included in the mixture. The resulting fiber 
mat was yellow in colour. ATR-IR (cm-1, neat): 1579, 1182, 1138, 1070, 1025, 987, 966, 891, 840. 
Anal. Found (%): C, 85.93; H, 7.45; N, 1.41; V, 0.84. 
5.3.6  p(St-co-VIM) copolymer 
 In a typical reaction, VIM (1.6 g, 17.0 mmol) was mixed with styrene (6.4 g, 61.4 mmol) followed 
by addition of AIBN (0.2 wt%). The vial was sealed, purged with argon and the temperature 
increased to 60 °C. The reaction was allowed to proceed at this temperature for 48 hours. The 
resultant solid polymer was subsequently dissolved in warm chloroform and pr ecipitated by 
addition of methanol. This precipitation process was repeated twice to ensure removal of 
unreacted monomers. The white polymer was dried in an oven for 48 hours at 60 °C. ATR-IR (cm-
1, neat): 3445, 3071, 3028, 2927, 1635, 1609, 1497, 1454, 1113, 1080, 1027, 910, 702. Anal. 
Found (%): C, 89.79; H, 8.41; N, 2.30.  
5.3.7  p(ST-co-VIM) fibers 
The polymer was dissolved in a DMF/THF (4:1) solvent mixture to make a 25% solution (wt/v%). 
The polymer solution was stirred for 24 hours to ensure complete dissolution and then loaded into 
a 20 m L syringe (figure 5.2a). Electrospinning was then conducted using the following 
parameters. A voltage of 21 kV was applied to the spinneret (needle tip) which had an internal 
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diameter of 1 mm, and the distance between the tip and collector was maintained at 20 cm whilst 
the flow rate was maintained at 1 mL.h-1 using a syringe pump. The resultant white fibers were 
collected on a piece of aluminium foil. ATR-IR (cm-1, neat): 3445, 3071, 3028, 2927, 1635, 1609, 
1497, 1454, 1113, 1080, 1027, 910, 702. Anal. Found (%): C, 89.78; H, 8.41; N, 2.31. 
5.3.8  p(ST-co-VIM)-VO fibers 
A strip of approximately 5 cm x 12 cm of the p(ST-co-VIM) fiber mat was cut and rinsed with water 
to make the fibers more manageable (The dry fibers were fragile and disintegrated easily when 
manipulated). These were placed into a 0.1 M VOSO4 solution (20 mL methanol/5 mL water) in a 
sealable beaker. The vessel was purged with argon and then stirred gently at 120 r pm on an  
orbital shaker for a period of 72 hrs at room temperature. The fibers were rinsed with water and 
soaked in methanol for 3 hrs and t hen filtered. This procedure was repeated until no trace of 
vanadium was detected in the washings. Finally, the fibers were filtered and dried at room 
temperature under reduced pressure for 12 hr s. ATR-IR (cm-1, neat): 3439, 3039, 2932, 1635, 
1603, 1491, 1460, 1155, 1118, 985, 760, 702. Anal. Found (%): C, 75.69; H, 7.57; N, 1.88; S, 
0.88; V, 3.50.  
5.3.9  p(ST-co-VPIM) copolymer 
Styrene (7 g, 0.067 mol) and vpim (1.4 g, 0.0076 mol) (5.2.4) were mixed together along with 
radical initiator AIBN (0.0168 g, 0.2 wt%). To this suspension was added DMF dropwise until the 
solid dissolved (approximately 2 mL DMF). Oxygen was removed by bubbling with argon following 
which the vial was sealed and transferred to an oil bath. The temperature was maintained at 60 
°C by use of a temperature regulating hotplate. After 48 hrs, the solid was dissolved in THF and 
precipitated by pouring this slowly into methanol. This was repeated twice to ensure complete 
removal of starting materials. After rinsing with methanol, the white polymer was dried in an oven 
at 60 °C overnight. ATR-IR (cm-1, neat): 3418, 3027, 2921, 1712, 1598, 1490, 1449, 1260, 1178, 
1152, 1084, 1025, 1010, 983, 966. Anal. Found (%): C, 84.84; H, 7.33; N, 2.16.  
5.3.10  p(ST-co-VPIM) fibers 
p(ST-co-VPIM) was dissolved in DMF/THF (4:1) to make various concentrations from 8 - 20% 
(wt/v%). The voltage applied to the needle tip was 15 kV while a negative voltage of -5 kV was 
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applied below the rotating drum collector (figure 5.2b). The distance between the needle and 
collector was 15 cm. The polymer solution was fed to the needle tip at a rate of 1 mL.h-1 for 8-15% 
polymer solutions and 0 .8 mL.h-1 for the 20% solution. ATR-IR (cm-1, neat): 3418, 3027, 2921, 
1712, 1598, 1490, 1449, 1260, 1178, 1152, 1084, 1025, 1010, 983, 966. Anal. Found (%): C, 
84.83; H, 7.36; N, 2.18. 
5.3.11  p(ST-co-VPIM)-VO fibers 
The p(ST-co-VPIM) fibers (0.26 g) were immersed into a methanolic VOSO4 solution (0.1 M, 20 
mL) and shaken on an orbital shaker for 72 hours. After this, unreacted vanadium was removed 
by rinsing the fibers copiously with methanol. Vanadium coordination was evidenced by a change 
in colour from cream to a deep grey-purple. Following this, the fibers were immersed in a 
pimBr/methanol solution (20 mM) for 72 hours. The fibers were washed with methanol and dried 
in vacuo. ATR-IR (cm-1, neat): 3027, 2921, 1712, 1596, 1488, 1447, 1261, 1178, 1152, 1084, 
1029, 1010, 964. Anal. Found (%): C, 82.13; H, 7.568; N, 2.21; V, 0.69.  
5.3.12  p(benzimidazole) fibers (PBIf) 
Polybenzimidazole (PBI) (2.0 g) and lithium chloride (LiCl) (0.4 g, 4 wt/v%) were refluxed in N,N-
dimethylacetamide (DMAc) (10 mL) for a per iod of 5 hour s. The solution was allowed to cool 
slightly and then centrifuged to separate undissolved polymer. The viscous polymer solution was 
then poured into a 20 mL syringe and electrospun under the following conditions. A voltage of 15 
kV was applied to the needle tip which had an internal diameter of 0.5 mm. A negative voltage of -
5 kV was applied below a rotating drum collector (figure 5.2b) and the flow rate was kept at 0.15 
mL.h-1. The distance between the needle and collector was 12 cm. The nanofiber membrane was 
peeled off the aluminium foil, sandwiched between two pieces of filter paper and immersed in 
methanol overnight to remove residual solvent and lithium chloride and finally dried in an oven at 
60 °C overnight. The fibers were a br ownish-yellow colour. ATR-IR (cm-1, neat): 3617, 3405, 
3158, 1629, 1538, 1444, 1100, 801, 692.  Anal. Found (%): C, 68.06;H, 5.11; N, 15.17.  
5.3.13  p(benzimidazole)-VO fibers (PBIf-VO) 
The PBIf fibers (0.5 g) were added to a solution containing VOSO4 (0.54 g, 2.5 mmol) in methanol 
(40 mL) and heated to reflux for 24 hours under an argon atmosphere with gentle stirring. The 
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vanadium-functionalized fibers were rinsed with hot methanol several times to ensure complete 
removal of unreacted vanadium salt. The fibers were then dried in an oven for 48 hours at 60 °C. 
ATR-IR (cm-1, neat): 3069, 1634, 1566, 1457, 1103, 1036, 978, 804. Anal. Found (%): C, 43.32; 
H, 4.91; N, 9.32; S, 7.51; V, 5.5. 
5.3.14 Attempted synthesis of p(St-co-VIMCOOH) 
Much like that discussed in the previous chapter (Part 1, Chapter 4), oxidation of the p[(styrene-
co-(vinylimidazole-2-aldehyde)]24 using hydrogen peroxide or oxone were unsuccessful and thus 
attempts at preparing this polymer were abandoned. 
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5.4 Catalytic activity studies 
5.4.1  Homogeneous batch catalysis using [VO(dpimR)2] complexes 
In a t ypical homogeneous catalytic oxidation experiment, 20 m L of acetonitrile and t he 
oxovanadium complex (0.25 mol%) were mixed in a 50 mL round bottom flask. The temperature 
of the reaction was fixed at 25(±1) °C by use of an external temperature probe. The oxidant, H2O2 
(20 mmol), was added followed by thioanisole (10 mmol) while the reaction was stirred at a 
constant rate of 300 rpm. Aliquots were withdrawn at 10 minute time intervals and analysed by 
GC.   
5.4.2 Continuous flow using PS-[VO(dpimR)2] fibers 
The catalytic activity of the polymer-incorporated oxovanadium(IV) complexes was also evaluated 
using a continuous flow approach. The fibers (0.010 g) were packed between two filter disks 
(Whatmann no. 1) in a 10 mL syringe. In a separate flask; aqueous H2O2 (1 mmol), thioanisole 
(0.5 mmol) and solvent mixture (CH3CN/H2O) were mixed for 5 minutes (figure 5.3). The addition 
of water in this instance was to prevent leaching of the catalyst (it was insoluble in water) as well 
as prevent the fibers from dissolving. This reactant solution was poured into the syringe. The 
solution was passed through the fibers at a controlled rate using a syringe pump (New Era, NE-
1000). Fractions of 1 mL were collected and analysed using GC. 
 
 
Figure 5.3 Continuous flow set-up, when using either PS-[VO(dpimR)2] or p(ST-co-VIM)-VO fibers 
 
 
222 
 
 
Part 2. Chapter 5 
5.4.3 Continuous flow using p(ST-co-VIM)-VO fibers 
This was carried out similarly to 5.4.2 above with some slight modifications. A varied mass of 
vanadyl-immobilized fibers were tightly packed in a 10 m L syringe, between two filter disks 
(Whatman No. 1) giving a catalyst bed with a diameter of approximately 11.5 mm and thickness 
ranging between 1 – 3 mm, depending on the mass of fibers used. In a separate vial, aqueous 
H2O2 (2 mmol) was added to thioanisole (0.124 g, 1 mmol) in methanol (10 mL). Methanol, rather 
than acetonitrile was used in this case since the non-crosslinked polymer fibers were partially 
soluble in acetonitrile. This solution, hereafter referred to as the reactant solution, was stirred for 5 
minutes and then transferred to a 10 mL syringe (figure 5.3) and analysis performed as 
mentioned above 5.4.2. 
5.4.4 Continuous flow using p(ST-co-VPIM)-VO fibers 
Different masses of fibers were packed into a plastic column. This was connected via 
polyethylene tubing to a syringe containing a reaction solution consisting of thioanisole (1 mmol), 
methanol (20 mL) and aqueous H2O2 (30%, 2 mol eq). The reactant solution was passed through 
the catalytic fibers at a controlled rate by use of a syringe pump (New Era-1000). The set-up has 
been described in figure 5.4. Fractions were collected in 0.5 mL portions and analyzed by GC. 
 
 
Figure 5.4 Continuous flow set-up when using p(ST-co-VPIM)-VO fibers 
 
5.4.5 Batch catalysis using PBIf-VO fibers 
This was performed similarly to 5.4.1 with some slight differences. In a typical batch reaction, 20 
mL of acetonitrile was added to a 50 mL round bottom flask. The temperature of the vessel was 
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maintained at 25 °C using a hotplate-stirrer fitted with an external temperature probe. Thioanisole 
(0.124 g, 1 mmol) was added followed immediately by PBIf-VO and 30% H2O2 (2eq). The stirring 
rate was kept constant at 100 rpm throughout the reaction. Aliquots were withdrawn at regular 
time intervals and analyzed by GC. 
5.4.6 Continuous flow using PBIf-VO fibers 
The PBIf-VO fibers were packed into a f ilter holder (Millipore Swinnex® 13) and f irmly 
compressed. In a separate vial, thioanisole (0.124 g, 1 mmol) and H2O2 (2 mmol) were mixed in 
acetonitrile for 5 minutes. This reactant solution was transferred to a 20 mL syringe and the filter 
holder containing the fibers was connected as shown in figure 5.5. The reactant solution was 
passed through the catalyst bed at  a c ontrolled rate by use of a s yringe pump (New Era NE-
1000). The product solution was collected in individual 0.5 mL fractions and each was analyzed 
by GC. The temperature of the room was maintained at 25 °C throughout the course of the 
reaction. 
 
.  
Figure 5.5 Continuous flow set-up, when using PBIf-VO fibers. The insert shows an expanded view of the 
catalyst bed 
  
224 
 
 
Part 2. Chapter 5 
5.5 Results and discussion 
5.5.1  General synthesis and characterization 
The 4-R-2-(4,5-diphenyl-1H-imidazol-2-yl)phenol (dpimR) ligands chosen in this study were based 
on the 2-(2ˊ-hydroxyphenyl)-1H-imidazoline ligand used in our previous work (Part 2, Chapter 3) 
with two major exceptions. Two extra phenyl groups were added at the 4 and 5-position of the 
imidazole ring to provide additional stability through π-π interactions with polystyrene. The 
substituent at the para-position of the phenol ring was varied to assess the effect of electron 
withdrawing/donating groups on the catalytic activity.25  
The purity of the ligands was confirmed by NMR analysis and microanalysis. The 1H NMR 
spectrum of dpimH (figure 5.6), a representative example, shows the presence of the aromatic 
signals corresponding to the benzene groups of the ligand in the region of 7.4-8.4 ppm. The 13C 
NMR (figure 5.7) spectrum further confirmed the successful synthesis with all expected carbon 
atoms being accounted for. For dpimH there were a total of twenty-one carbon atoms but in the 
13C NMR spectrum, there were a total of fifteen peaks. This can easily be explained, since nine of 
these peaks corresponded to a s ingle carbon each while the more intense remaining peaks (of 
which there were six) correspond to two-carbons each making up the total of twenty-one (figure 
5.7). 
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Figure 5.6 1H NMR spectrum of dpimH in DMSO (δ ppm). (Peaks at ~3.5 and 2.5 are due to the solvent) 
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Figure 5.7 13C NMR spectrum of dpimH in DMSO (δ ppm). The solvent peak appears upfield from the 
range shown here at ~40 ppm 
 
These ligands were reacted with VOSO4 to afford the corresponding oxovanadium(IV) complexes 
(scheme 5.1) which precipitated out of solution and were easily collected by filtration. These 
complexes will be collectively termed, [VO(dpimR)2], where R = H, Br, NO2 or MeO. The purity of 
the complexes was confirmed by microanalysis which further revealed that the complexes 
crystallized out with a minimum of one water molecule. Unfortunately, even after several attempts, 
crystals suitable for single crystal X-ray diffraction were not obtained. We speculate that the 
coordination is similar to that of the parent complex, [VO(pimin)2] (Part 1, Chapter 3), with the N 
and O-atoms sitting trans to one another as depicted in scheme 5.1, especially considering the 
steric hindrance of the benzene rings.   
N
H
N
HO
R
VOSO4.3H2O
H2O / MeOH
2
N
NH
O RN
HN
OR
V
O
R = H, Br, NO2, MeO
 
Scheme 5.1 Preparation of the bis-coordinated oxovanadium(IV) complexes with 4-R-2-(4,5-diphenyl-1H-
imidazol-2-yl)phenol ligands (R = NO2, Br, H, MeO) 
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Infrared spectroscopy of the ligands and complexes was performed and all complexes exhibited 
characteristic ν(V=O) stretches between 945 – 975 cm-1. There were also numerous coordination- 
induced shifts as illustrated in figure 5.8 for [VO(dpimBr)2]. The azomethine stretch which 
appeared at ~1600 cm-1 in the ligands, shifted to lower wavelengths in the corresponding 
oxovanadium(IV) complexes (~ 7 cm-1 shift). This, in combination with the disappearance of the 
ν(O-H) and the shift of the ν(C-O) upon coordination, confirm the bidentate N,O-coordination 
mode. 
Wavenumber (cm-1)
6508009501100125014001550170018502000
VO(dpimBr)2
dpimBr 
 
Figure 5.8 IR spectra of the ligand dpimBr and oxovanadium(IV) complex, [VO(dpimBr)2]. The ν(C=N), 
ν(C-O) and ν(V=O) have been highlighted  
 
The UV/Vis spectra of all of the complexes besides [VO(dpimNO2)2] displayed three d-d 
transitions, which can be expected for a C 4v, d
1 complex. The first transition appeared between 
515 – 527 nm (a1←b2), the second between 613 – 639 nm (b1←b2) and the third between 823 – 
849 nm (eπ←b2). The higher energy d-d transition for [VO(dpimNO2)2] was hidden beneath the 
intense charge transfer band appearing in this region (figure 5.9). The lower symmetry (C2v) of 
the prepared complexes has little or no effect on the observed spectra, since the splitting of the 
eπ* level is generally too small to be observed experimentally.
26 
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Figure 5.9 UV/Vis spectra of the [VO(dpimR)2] complexes in DMSO 
 
Synthesis of the monomerized 2-(2ˊ-hydroxyphenyl)imidazole ligand (vpim) was achieved using a 
method developed by Sellergren and co-workers.22 This elaborate synthesis adequately 
demonstrates the difficulty associated with preparing polymerizable ligands, especially 
considering the relatively large quantities of monomer that are needed. The synthetic route 
appears in scheme 5.2. Firstly, the brominated 2-(2ˊ-hydroxphenyl)imidazole (pimBr) compound 
was prepared according to the procedure developed by Rogers and Bruice.27 Following this, both 
the O-H and N-H groups from the phenol and imidazole respectively, were protected using 
benzoyl chloride since it is known that these basic groups can interfere with the Pd-catalyzed 
coupling step. After introduction of the vinyl group by this Pd-catalyzed coupling, deprotection was 
achieved using sodium ethoxide finally giving the vinylated monomer, 2-(2ˊ-hydroxy-5ˊ-
ethenylphenyl)imidazole (vpim). In retrospect, NMR spectroscopy was not the most conclusive 
means for characterizing pimBr and vpim as the signals appeared broad due to slow rotation 
around the phenylimidazole bond due to conjugation and intramolecular hydrogen bonding.27 The 
IR spectra illustrate the various changes occurring at the different synthetic steps quite well 
(figure 5.10). The N-H and O-H stretches which appear in the range 3400 – 3120 cm-1 for pimBr 
disappear after protection with the benzoyl groups. The ν(C=O) bands from the benzoyl groups in 
dibenzoylpimBr further confirm the functionalization, with two separate bands appearing at 1745 
and 1705 cm-1, corresponding to the O and N-substituted benzoyl groups. Similarly, deprotection 
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of dibenzoylvpim was evident by the disappearance of the ν(C=O) bands and appearance of the 
O-H and N-H stretches. 
H
N
N
HO
Br
N
N
O
Br
O
O
Cl
O
N
N
O
O
O
H
N
N
HO
NaOEt
Et3N
THF
[Pd(PPh3)4]
tributyl vinyl tin
toluene
 
Scheme 5.2 Synthetic route for the preparation of the polymerizable ligand, vpim 
 
dibenzoylvpim
Wavenumber (cm-1)
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Figure 5.10 IR spectra showing the changes at various stages of synthesis of vpim 
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5.5.2  Synthesis of polymers, fabrication and characterization of electrospun fibers 
(a) PS-15/25-[VO(dpimR)2] fibers 
The homogeneous [VO(dpimR)2] (R = NO2 and MeO) catalysts were incorporated into polystyrene 
by mixing them together in a solvent mixture of DMF/THF. This simple method of immobilization 
offers practical advantages in that no chemical modification of the homogeneous catalysts is 
required, however the van der Waals and π-π stacking forces are significantly weaker than 
covalent bonds28 and will undoubtedly lead to some leaching of the catalyst. This approach was 
therefore treated as more of a proof of concept to assess how polystyrene-based fibers behaved 
when used as a c atalytic membrane. Fibers of this composite material were then produced by 
using the electrospinning technique.29 The major advantage of this simple method of 
immobilization was that the structure of the catalyst may be considered almost identical to that of 
the homogeneous derivative and therefore easier to characterize. 
Inclusion of the complexes within the fibers was visually noticeable, since the colour of the fibers 
resembled that of the neat complexes (figure 5.11).  
 
Figure 5.11 SEM images and digital pictures of the electrospun fibers, from left to right; (A) PS-25, (B) PS-
15-[VO(dpimMeO)2] and (C) PS-15-[VO(dpimNO2)2] 
 
Elemental (section 5.2) analysis indicated the presence of nitrogen due to the embedded 
complexes, while infrared data (figure 5.12) further confirmed this. XPS also proved to be a highly 
useful technique, with all the expected elements (C, N, O, V) accounted for in the spectrum 
(figure 5.13). For both sets of fibers, O 1s, N 1s, C 1s and V 2p signals appeared at 
approximately 530, 399, 285 and 5 15 eV. An additional N 1s peak was observed for PS-15-
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[VO(dpimNO2)2] at 405 eV due to the nitro substituent. The position of the V 2p3/2 signal for both 
sets of fibers, further confirmed that the complexes remain in the +4 oxidation state.30 
Wavenumber (cm-1)
1000110012001300
PS-15-[VO(dpimMeO)2]
PS-25
[VO(dpimMeO)2]
 
Figure 5.12 Infrared spectra of unmodified polystyrene (PS-25) fibers, the neat complex [VO(dpimMeO)2], 
and the corresponding fibers, PS-15-[VO(dpimMeO)2]. The highlighted areas show peaks 
found in both [VO(dpimMeO)2] and PS-15-[VO(dpimMeO)2] fibers 
 
Table 5.1 Elemental binding energies of PS-15-[VO(dpimMeO)2] and PS-15-[VO(dpimNO2)2] as determined 
by XPS  
 Binding Energy (eV) 
Polymer O 1s N 1s C 1s V 2p3/2 V 2p1/2 
PS-15-[VO(dpimMeO)2] 530 399 285 514 521 
PS-15-[VO(dpimNO2)2] 530 399, 405 285 515 522 
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Figure 5.13 Wide scan XPS spectrum of PS-15-[VO(dpimMeO)2]. Insert shows an expanded view of the 
high resolution (A) V 2p signal and (B) the N 1s signals 
 
The amount of catalyst added to the polystyrene solution was kept constant at 20% (wt% wrt 
polystyrene) while the percentage of polystyrene was adjusted to tune the fiber diameters. 
Inclusion of the oxovanadium complexes in the polymer solution actually improved 
electrospinnability possibly by improving the solution conductivity. This allowed for the production 
of smooth fibers at both 25% (w/v%) and the lower 15% polystyrene concentrations (figure 5.11) 
while for the pure polystyrene, smooth fibers were only obtained at the higher 25% concentration, 
a trend commonly observed.31 Using lower than 15% concentrations gave undesirable bead-on-
string morphologies and so these two ratio’s (15% and 25%) were settled upon. The fiber 
diameters were measured from an average of 20 fibers; the 25% polystyrene-based fibers, PS-
25-[VO(dpimMeO)2] and PS-25-[VO(dpimNO2)2], had average fiber diameters of 1.37 and 1.98 
μm respectively, while for the 15% polystyrene-based fibers, PS-15-[VO(dpimMeO)2] and PS-15-
[VO(dpimNO2)2], it was 0.33 and 0.51 μm respectively.  
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Thermogravimetric analysis of PS-15-[VO(dpimNO2)2] was carried out at a he ating rate of 10 
°C.min-1 under a nitrogen atmosphere (figure 5.14). Two distinct weight loss steps were observed 
particularly in the derivative curve (DTG). The first weight loss (Tmax = 340 °C) was possibly due to 
decomposition of the oxovanadium(IV) complex while decomposition of the polymer backbone 
occurred at a higher temperature (Tmax = 414 °C). It should be noted that the glass transition 
temperature (Tg) and the melting point of polystyrene occur well below these temperatures. When 
the fibers were subjected to a melting point analysis they completely lost their original morphology 
at temperatures beyond 96 °C. 
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Figure 5.14 TG (A) and DTG (B) curve of PS-15-[VO(dpimNO2)] 
 
(b) Poly(styrene-co-vinylimidazole) fibers 
The p(ST-co-VIM) copolymers were prepared by bulk polymerization of N-vinylimidazole and 
styrene (scheme 5.3). A few different ratio’s of the styrene/N-vinylimidazole monomers were used 
for example; 3:1, 5:1 and 7:1 (ST/VIM). However, besides the imidazole content in the resultant 
copolymer there was no dramatic effect on solubility or other properties of the fibers and as such 
only one ratio was thoroughly studied (5:1) as this gave the best fibers. 
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Scheme 5.3 Synthesis of p(ST-co-VIM) copolymer 
 
Based on the elemental composition, the styrene/imidazole content for the p(ST-co-VIM) 
copolymer (ST/VIM 5:1) was approximately 10:1. This ratio provided sufficient coordinating 
functionality as well as the required solubility parameters for electrospinning. In the first attempt to 
prepare the ‘pre-electrospinning’ functionalized oxovanadium-immobilized polymer, the copolymer 
was dissolved in DMF and reacted with VOSO4. This reaction produced a green solid which was 
insoluble in several solvents and therefore could not be electrospun. It is possible that vanadium 
bound to imidazole groups from neighbouring polymer chains thereby forming crosslinks and 
rendering the polymer insoluble. Thus, a post-electrospinning functionalization method was 
adopted whereby the styrene-imidazole copolymer was first dissolved in a DMF/THF solvent 
mixture and electrospun into fibers followed by a reaction with vanadium. Another strategy that 
was considered involved preparation of the oxovanadium(IV) complexes with the polymerizable 
ligands coordinated, followed by radical polymerization. The complexes were, however, not 
sufficiently soluble and thus would have resulted in comparatively lower (compared to the ligand 
only) incorporation into the polymer. In addition, unsymmetrically coordinated complexes would 
have to be pr epared (one ligand containing a v inyl group and the other not) to eliminate the 
chance of crosslinking by the bis-coordinated complex. 
As shown in the SEM images (figure 5.15), the fibers produced were smooth and non-beaded 
with diameters ranging from 1.3-2.1 μm. Although these diameters are quite large for electrospun 
fibers, they are still a couple of orders of magnitude smaller than the Merrifield beads (~600 μm) 
(Part 2, Chapter 3) and the beads prepared by suspension polymerization (~300 μm) (Part 2, 
Chapter 4). The imidazole-containing fibers were then immersed in a methanolic vanadyl sulfate 
solution and stirred for 72 hours using an orbital shaker to produce the oxovanadium(IV)-
immobilized fibers. When this agitation method was used, the morphology of the fibers was 
unaffected as witnessed in the SEM images (figure 5.15). Conversely, agitation by stirrer bar 
broke the fibers into small pieces and as such was unsuitable. Upon functionalization with 
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vanadium, the average diameter of the fibers increased slightly (1.6-2.4 μm), possibly due to a 
thin coating of oxovanadium(IV) on the surfaces, however this cannot be concluded indisputably, 
since the diameter distribution of the fibers was quite large and thus this difference may not be 
significant.  
 
 
Figure 5.15 SEM images of p(ST-co-VIM) and p( ST-co-VIM)-VO with digital image showing colour 
changes 
 
The surface area of the p(ST-co-VIM) fibers was determined from the N2 absorption/desorption 
isotherms (figure 5.16) and found to be 53 m2.g-1, which was significantly less than the beads 
(151 m2.g-1) prepared in the previous chapter (Part 2, Chapter 4) despite the smaller diameter of 
the fibers. This was likely due to the significantly rougher surface and internal porous structure of 
the beads. The pore volume and pore size of the unfunctionalized fibers was 0.49 cm3.g-1 and 309 
Å, respectively. Functionalization of these fibers with vanadium resulted in an increase in surface 
area to 74 m2.g-1 whilst the pore volume and size were slightly higher at 0.67 cm3.g-1 and 344 Å, 
respectively. This is tentatively attributed to removal of residual electrospinning solvent after 
immersion in methanol (during the vanadium functionalization step), resulting in the formation of 
additional pores. AFM of a single fiber was attempted but proved challenging and no satisfactory 
images could be obtained. 
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Figure 5.16 Nitrogen adsorption/desorption isotherms, for (A) p(ST-co-VIM) and (B) p(ST-co-VIM)-VO 
fibers 
 
Elemental characterization data revealed an imidazole-to-vanadium ratio of close to 1:1. As 
shown in figure 5.17, the vanadium-functionalized p(ST-co-VIM)-VO fibers clearly display 
additional bands at 980 c m-1 due to the ν(V=O) and at 1154 cm-1 due to a s ulfate stretching 
vibration. As discussed previously (Part 2, Chapter 3), the broadness of this band, which is 
probably due to a s eries of overlapping bands, makes accurate assignment of the coordination 
mode of sulfate challenging. It is, however, quite likely that the sulfate coordination is 
monodentate as observed for vanadyl sulfate.  
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Figure 5.17 IR spectrum of p(ST-co-VIM) and p(ST-co-VIM)-VO 
 
XPS was used to investigate the surface functionality of the material (figure 5.18). The V 2p3/2 
binding energy appeared at 514.9 eV confirming surface functionalization as well as the +4 
oxidation state of vanadium (table 5.2).30 The N 1s peak from imidazole for both p(ST-co-VIM) 
and p(ST-co-VIM)-VO appeared at 399 eV (table 5.2). An O 1s peak observed for p(ST-co-VIM) 
may be attributed to inadequate drying of the sample before running the XPS, surface 
contaminants, or the presence of water hydrogen bonded to the imidazole residues of the 
polymer. The presence of sulfur as indicated by infrared and elemental analysis, was confirmed 
using XPS, with the S 2p3/2 peak appearing at 167 eV (table 5.2). 
 
Table 5.2 Elemental binding energies of p(ST-co-VIM) and p(ST-co-VIM)-VO as determined by XPS  
 Binding Energy (eV) 
Polymer O 1s N 1s C 1s V 2p3/2 V 2p1/2 S 2p3/2 
p(ST-co-VIM) 530 399 285 - - - 
p(ST-co-VIM)-VO 530 399 285 515 526 167 
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Figure 5.18 Wide scan XPS spectra of p(ST-co-VIM) and p(ST-co-VIM)-VO. Insert shows an expanded 
view of the V 2p signals of p(ST-co-VIM)-VO 
 
The general thermal stability of p(ST-co-VIM) and p(ST-co-VIM)-VO was investigated briefly using 
TG (figure 5.19). For p(ST-co-VIM) no significant weight loss due to water was observed below 
100 °C, however a small peak appearing at a Tmax of 119 °C in the DTG may be due to hydrogen 
bonded water, which may correspond to the O 1s signal observed in the XPS spectrum.  The TG-
curves for both p(ST-co-VIM) and p( ST-co-VIM)-VO were remarkably similar (figure 5.19) with 
Tmax values corresponding to decomposition of the polymer appearing at 401 °C and 409 °C for 
p(ST-co-VIM)-VO and p( ST-co-VIM), respectively. In this instance it is quite possible that 
decomposition of oxovanadium(IV) occurred concurrently with decomposition of the polymer and 
was thus not easily visible from the curve. The larger remaining mass at 500 °C of p(ST-co-VIM)-
VO (~21%) compared to p(ST-co-VIM) (~4.5%), may be due to residual vanadium pentoxide. 
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Figure 5.19 TG curves for (A) p(ST-co-VIM) and (C) p(ST-co-VIM)-VO and DTG curves for (B) p(ST-co-
VIM) and (D)  p(ST-co-VIM)-VO; at a heating rate of 10 °C.min-1 under N2. Insert shows an 
expanded view of the region between 30 - 200 °C 
 
(c) Poly(styrene-co-vpim) fibers 
The p(ST-co-VPIM) copolymer was prepared by polymerization of vpim and s tyrene (scheme 
5.4). Unlike the method used to prepare p(ST-co-VIM), however, a solvent (DMF) was added to 
the mixture of monomers since vpim was not sufficiently soluble in styrene alone. This also 
illustrated the advantages with this type of polymerization approach over suspension 
polymerization (Part 2, Chapter 4) which limits one to only a few solvent options (those 
immiscible with water).  
 
N
H
N
HO
+
N
HN OH
n m
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Scheme 5.4 Synthesis of p(ST-co-VPIM) copolymer 
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Microanalysis indicated a ligand-to-styrene ratio of approximately 1:10. This ratio provided a 
balance of solubility in the electrospinning solvent as well as adequate ligand incorporation. The 
polymer was once again dissolved in a m ixture of DMF/THF and e lectrospun as before. The 
relationship between polymer concentration (and hence viscosity) and fiber diameter is well 
illustrated in figure 5.20. At high concentrations, the fibers were quite large (average diameter of 
3.8 μm) but as the concentration was reduced, fibers of much lower diameter were produced (0.6 
μm using 8 wt%).  
 
 
Figure 5.20 SEM images of fibers produced by electrospinning p(ST-co-VPIM) at concentrations (wt/v%) of 
(A) 20% (Ø = 3.8 μm), (B) 15% (Ø = 2.3 μm), (C) 10% (Ø = 1.0 μm) and (D) 8% (Ø = 0.6 μm) 
at the same magnification. Ø Indicates average diameter 
 
The smaller size of the p(ST-co-VPIM) fibers electrospun from 8% solution (0.6 μm), compared to 
the larger p(ST-co-VIM) fibers (> 1.3 μm), had very little effect on t he measured BET surface 
area. In fact, the surface area of the smaller fibers was less than that of the larger p(ST-co-VIM)-
based fibers discussed earlier (b). For p(ST-co-VPIM) the surface area was 47.9 m2.g-1 while the 
pore volume and size were 0.49 cm3.g-1 and 416 Å. As was observed for the p(ST-co-VIM)-based 
fibers, functionalization of p(ST-co-VPIM) with vanadyl resulted in an increase in overall surface 
area to 60.7 m2.g-1 for p(ST-co-VPIM)-VO. The volume and size for p(ST-co-VPIM)-VO were 0.53 
cm3.g-1 and 348 Å, respectively.  
The smaller fibers (from 8% solution) were immersed in VOSO4 as previously mentioned. These 
fibers were then reacted with a solution containing pimBr to create the neutral bis-coordinated 
complex. The amount of vanadium in these p(ST-co-VPIM)-VO fibers was significantly lower at 
0.69%, as determined by ICP. This corresponded to a vanadium-to-ligand ratio of approximately 
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1:6. This coupled with the absence of sulfate (by microanalysis, XPS, and I R) suggests the 
formation of a bis-coordinated neutral complex along with some pendant ligands. Comparing the 
infrared spectra of polystyrene, vpim and t he p(ST-co-VPIM) copolymer (figure 5.21), one can 
clearly see the presence of the 2-(2ˊ-hydroxyphenyl)imidazole relevant stretches in the copolymer 
as illustrated by the highlighted regions in figure 5.21. The ν(V=O) was not easily visible and was 
probably hidden beneath a more intense band. It was, however, visually detectable that vanadium 
was bound due to the definite colour change from light brown in the p(ST-co-VPIM) fibers, to a 
blue-green in the p(ST-co-VPIM)-VO fibers (figure 5.22). The presence of vanadium was further 
confirmed by ICP and XPS. 
 
Wavenumber (cm-1)
10001200140016001800
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Figure 5.21 IR spectra of (A) vpim (B) polystyrene (C) p(ST-co-VPIM) (D) p(ST-co-VPIM)-VO. Highlighted 
regions illustrate bands common to (A), (C) and (D). 
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Figure 5.22 Digital images of p(ST-co-VPIM) (left) and p(ST-co-VPIM)-VO fibers (right) showing the 
significant colour change upon functionalization 
 
The XPS spectra (figure 5.23) once again complimented the microanalysis results, showing all 
the expected atoms. After functionalization with vanadium, the O 1s peak intensity increased 
significantly, due to the V=O as well as possibly the presence of some residual solvent. The V 2p 
peaks although low in intensity were present at 522 (V 2p1/2) and 515 eV (V 2p3/2) (table 5.3), 
confirming the +4 oxidation state of vanadium. Only qualitative characterization was possible due 
to the low intensity of the peaks. 
 
Table 5.3 Elemental binding energies of p(ST-co-VPIM) and p(ST-co-VPIM)-VO as determined by XPS  
 Binding Energy (eV) 
Polymer O 1s N 1s C 1s V 2p3/2 V 2p1/2 S 2p3/2 
p(ST-co-VPIM) 531 404 285 - - - 
p(ST-co-VPIM)-VO 531 404 285 515 522 - 
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Figure 5.23 Wide scan XPS spectra of p(ST-co-VPIM)and p(ST-co-VPIM)-VO. Insert shows an expanded 
view of the V 2p signals of p(ST-co-VPIM)-VO 
 
Thermogravimetric analysis of p(ST-co-VPIM) and p(ST-co-VPIM)-VO was performed and t he 
relevant curves can be found in figure 5.24. The Tmax for p(ST-co-VPIM) was 413 °C compared to 
pure polystyrene which had a Tmax of 401 °C. The oxovanadium(IV)-functionalized, p(ST-co-
VPIM)-VO fibers, displayed a significantly different decomposition profile (figure 5.24). Onset of 
decomposition of this polymer began lower (Tonset = 297 °C; Tmax = 343 °C) than that of the un-
metallated derivative (Tonset = 336 °C; Tmax = 413 °C). In addition, decomposition of 
oxovanadium(IV) began at  just below 400 °C . As was observed for p(ST-co-VIM)-VO (figure 
5.18) the oxovanadium-functionalized fibers, p(ST-co-VPIM)-VO had a higher remaining mass 
(~10.6%) compared to the un-metallated p(ST-co-VPIM) fibers (~6.7%) due to residual V2O5. 
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Figure 5.24 TG curves for p(ST-co-VPIM) and p(ST-co-VPIM)-VO at a heating rate of 10 °C.min-1 under N2 
 
(d) Polybenzimidazole fibers 
First manufactured by Celanese Corporation, polybenzimidazole (PBI) (figure 5.25) has been 
recognized for its exceptional thermal and chemical resistance (see table 5.4 and table 5.5).32 
This in combination with its excellent textile processing characteristics has made this polymer a 
common choice for use in fire-protective fabrics, friction products and fire-blocking substrates in 
aircraft. The advantages of using this polymer over the polystyrene-based polymers are 
immediately apparent. The concern of organic solvents dissolving the fibers can be mostly 
dismissed (chemical stability), the robustness (mechanical stability) is improved and catalysis can 
be conducted at much higher temperatures due to the thermal stability of the polymer. 
Additionally, this polymer contains the metal-coordinating benzimidazole group which has been 
exploited in the past.33,34 Thus, PBI fibers possess all the desired characteristics of a c atalytic 
support material. Until now however, only the microspherical form of polybenzimidazole has been 
used as a catalyst support material, albeit with great success.33-37 
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Figure 5.25 Chemical structure of polybenzimidazole 
 
Table 5.4 Tensile strength of PBI fibers* after immersion in inorganic acids and bases32 
Compound Concentration 
(%) 
Temperature 
(°C) 
Time 
(h) 
Tensile strength 
retained (%) 
Sulfuric acid 50 30 144 90 
Sulfuric acid 50 70 24 90 
Hydrochloric acid 35 30 144 95 
Hydrochloric acid 10 70 24 90 
Nitric acid 70 30 144 100 
Nitric acid 10 70 48 90 
Sodium hydroxide 10 30 144 95 
Sodium hydroxide 10 93 2 65 
Potassium hydroxide 10 25 24 88 
* PBI fibers from Celanese Corporation 
 
Table 5.5 Tensile strength of PBI fibers* after immersion in organic chemicals†32 
Compound Strength retention (%) 
Acetic acid 100 
Methanol 100 
Perchlorethylene 100 
Dimethylacetamide 100 
Dimethylformamide 100 
Dimethylsulfoxide 100 
Kerosene 100 
Acetone 100 
Gasoline 100 
* PBI fibers from Celanese Corporation 
† All exposures at 30 °C for 168 hours 
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To prepare the PBI fibers, a spinning solution was first prepared by refluxing PBI and LiCl in N,N-
dimethylacetamide (DMAc) for 5 hour s under argon. The LiCl has been shown to improve the 
shelf life of PBI solutions from a few days to several months and may also improve 
electrospinnability of polymers by enhancing the conductivity of the solution.38,39 After cooling to 
room temperature, the mixture was centrifuged. The spinning solution was then carefully 
decanted into a s yringe, leaving the undissolved PBI pellet behind thus making the final 
concentration slightly less than 20 wt% (wt/v%). Several electrospinning parameters were 
adjusted until a s table jet was achieved. These parameters included; applied voltage, tip-to-
collector distance, flow rate and the type of collector used. When a static metal plate collector was 
used, the fibers did not collect evenly over the surface of the plate but rather began to ‘climb’ 
towards the spinneret. This problem could not be attributed to a high flow rate since it was quite 
low (0.15 mL.h-1) and may have been due to overvoltage.40 This difficulty was circumvented when 
using a rotating drum collector which also allowed for partial alignment of the fiber rendering the 
mat much stronger in the rotation direction. At low applied voltages (<15 kV), droplets rather than 
fibers formed, likely due to insufficient charges present and hence an inability to overcome the 
surface tension of the solvent. Similarly, at high flow rates, both fibers and droplets formed. While 
other research groups have found distances of 6-7 cm to be effective for electrospinning PBI,38,40 
we found 12 cm to give the most stable jet. Given that DMAc is a high boiling point solvent (bp 
~164 °C), this extra distance may also improve solvent evaporation. Although not controlled in this 
study, the ambient humidity noticeably affected the stability of the polymer jet. The optimal 
conditions were obtained when using an applied voltage of 15 k V (and -5 kV underneath the 
rotating drum), a tip-to-collector distance of 12 cm and a flow rate of 0.15 ml.h-1.  
Following electrospinning, the sheet of fibers was peeled off the aluminium foil, sandwiched 
between two pieces of filter paper (to keep the mat flat) and s oaked in methanol overnight to 
remove residual solvent and LiCl. The texture of the polybenzimidazole nanofibers was markedly 
different from the polystyrene-based variations. The polystyrene-based fibers were fluffy, almost 
cotton-wool like, while the PBI-fibers were smooth and the sheet resembled thin paper. 
The morphology of PBI electrospun nanofibers was investigated by scanning electron microscopy 
(SEM) (figure 5.26). The average fiber diameter was found to be 262 nm  (n = 25), with a 
relatively broad range of 120 nm to 430 nm. Similar results were reported by both Weber40 and 
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Reneker.38 The specific surface area (BET) was significantly lower for the PBI fibers (7.5 and 7.7 
m2.g-1 for PBIf and PBIf-VO, respectively) than for the polystyrene-based fibers despite their 
smaller diameters. The BJH pore volume and s ize were 0.041 cm3.g-1 and 232 Å for PBIf and 
0.052 cm3.g-1 and 228 Å for PBIf-VO. As we have come to see, the porosity of these materials 
contributed significantly to the experimentally determined surface areas. Thus perhaps the most 
reasonable explanation for these reduced surface areas would be due to the presence of fewer 
pores and smoother surface compared to the polystyrene-based polymers.  
 
 
Figure 5.26 SEM images and photographs (insert) of (A) PBIf and (B) PBIf-VO fibers 
 
Infrared analysis (figure 5.27) of PBIf clearly showed the presence of the imidazole N-H stretch at 
3400 cm-1 as well as the expected benzimidazole ring stretching vibrations between 1635-1500 
cm-1.41 An O-H stretch at 3619 cm-1 was due to absorbed water owing to the hygroscopic nature 
of PBI. After reacting PBIf with vanadyl sulfate several new bands appeared including the ν(V=O) 
at 978 cm-1 along with an intense split band at 1103 and 1036 cm-1 corresponding to the ν3 sulfate 
stretching vibrations suggesting monodentate coordination of this ion.42 Microanalysis also 
confirmed the presence of sulfur in the polymer. The vanadium content, as determined by ICP-
OES, was found to be 5.5% which corresponds to a V /N ratio of 1:6 (or 1 vanadium per 3 
benzimidazole groups).  
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Figure 5.27 IR spectrum of PBIf, VOSO4 and PBIf-VO fibers 
 
Wide scan XPS spectra of PBIf and PBIf-VO shown in figure 5.28 confirm surface modification of 
the fibers. For PBIf-VO, the peaks corresponding to the S 2p, V 2p3/2 and V 2p1/2 binding energies 
appeared at 166, 515.2 and 522.6 eV, respectively (table 5.6).  
 
Table 5.6 Elemental binding energies of PBIf and PBIf-VO as determined by XPS 
 Binding Energy (eV) 
Polymer O1s N1s C1s V2p3/2 V2p1/2 S2p3/2 
PBIf 531 405, 399, 396 285 - - - 
PBIf-VO 531 399, 396 285 515 523 166 
 
The V 2p3/2 binding energy further confirmed the +4 oxidation state of vanadium (figure 5.28).
30 
There were three resolvable N 1s peaks for PBIf appearing at 405, 399 and 396 eV (figure 5.29). 
The more intense peak at 399 eV corresponds to the N-H (amine) nitrogen while the remaining 
two peaks at 396 and 405 eV correspond to the C=N (imine) nitrogen in the non-protonated and 
protonated form, respectively.43 Upon coordination, however, the peak at 405 eV disappeared 
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completely while the peak at 396 eV was significantly diminished (figure 5.29), confirming 
coordination of vanadyl via the azomethine nitrogen. The observed O 1s peak for PBIf is most 
likely due to absorbed water, the presence of which was confirmed by IR. 
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Figure 5.28 Wide scan XPS spectra of PBIf, and PBIf-VO fibers. Insert shows an expanded view of the V 
2p signals of PBIf-VO 
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Figure 5.29 High resolution XPS spectra of (A) N1s signal for PBIf; and (B) N1s signal for PBIf-VO  
 
Thermogravimetric analysis of PBIf and PBIf-VO was conducted under a nitrogen atmosphere in a 
temperature range of 30 – 800 °C (figure 5.30). For PBIf, three distinct weight losses were 
observed at below 105 °C, between 220 – 320 °C and finally between 570 – 800 °C.  The first two 
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weight loss may be due to loss of loosely bound and coordinated water molecules or solvent, 
since it is well known that PBI readily absorbs moisture even after extensive drying.44,45 As has 
been reported by others,45,46 it was only at temperatures of over 570 °C that the polymer 
backbone began to degrade demonstrating the excellent thermal stability of PBI. For PBIf-VO 
there were once again three distinct weight loss processes occurring (figure 5.30). As was the 
case for the un-metallated PBIf fibers, the first weight loss occurred below 105 °C due to loss of 
water. The weight loss occurring between 270 – 490 °C, was however unique to the 
oxovanadium(IV) functionalized PBIf-VO fibers and may be due to decomposition of the bound 
vanadium salt to V2O5.
47,48 
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Figure 5.30 TG curves for PBIf and PBIf-VO at a heating rate of 10 °C.min-1 under N2 
 
5.5.3  Catalytic activity 
(a) Catalytic activity of [VO(dpimR)2] and PS-[VO(dpimR)2] 
The activity of the homogeneous catalyst was first evaluated using a common batch reaction. The 
amount of catalyst and H2O2 was kept constant at 0.25 mol% and 2 equivalents (wrt. thioanisole) 
while the temperature was kept at 25 °C, since these conditions were found to be ef fective in 
earlier studies. It was observed that the electron withdrawing/donating substituents on the para-
position of the phenol group of the ligand had a significant impact on the overall catalytic activity 
and selectivity. The nitro substituted homogeneous catalyst showed the best activity with a > 99% 
oxidation of thioanisole, being attained after just 10 minutes at 25 °C, compared to the electron 
donating MeO substituted catalyst, which achieved the same result in 60 minutes (figure 5.31). 
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The activity of the catalysts showed the following trend as described by their turnover frequencies 
(TOF); NO2 (2400 h
-1) > Br (800 h-1) > H (600 h-1) > MeO (480 h-1). Evidently, the introduction of 
electron withdrawing groups on t he para position of the phenol group of the ligand seems to 
improve the activity perhaps by rendering the metal center electron deficient. The product 
selectivity was also dependent on the substituent groups. The milder MeO-substituted catalyst 
displayed higher selectivity towards the formation of methyl phenyl sulfoxide whereas the NO2-
substituted derivative seemed to favour the formation of the sulfone, especially as time 
progressed. This was expected since the more active NO2-substituted derivative further oxidizes 
the sulfoxide to the sulfone. A table containing product selectivity and overall conversions for the 
catalysed reactions has been included (table 5.7).  
When the solvent mixture was changed from pure CH3CN to a mixture of CH3CN/H2O the 
conversion dropped slightly, while the selectivity shifted slightly to favour the formation of sulfone 
(table 5.7). In the absence of catalyst low conversions were obtained (less than 25%). 
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Figure 5.31 Ligand substituent effects on catalytic activity. Conditions: Catalyst (0.25 mol% wrt 
thioanisole), thioanisole (10 mmol), H2O2 (20 mmol), CH3CN (20 mL), and at 25 °C 
 
The catalytic fibers, PS-15-[VO(dpimMeO)2] and PS-15-[VO(dpimNO2)2], were then subjected to a 
batch-type experiment (figure 5.32). The trend in overall conversion observed for these 
heterogeneous catalysts was quite similar to that of the homogeneous counterparts, with the nitro-
substituted analogue displaying greater activity than the methoxy-substituted analogue. 
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Figure 5.32 Oxidation of thioanisole under batch conditions using PS-15-[VO(dpimMeO)2] and P S-15-
[VO(dpimNO2)2]. Conditions: Catalyst (0.01 g), thioanisole (1 mmol), H2O2 (2 mmol), CH3CN 
(20 mL), and at 25 °C 
 
Unfortunately, the stirring process in the batch reaction caused the fibers to break, making 
separation and hence recycling difficult. This challenge was avoided when using a continuous 
flow process. This reactor set-up was more suited to the highly flexible and porous nature of the 
fiber-mats.  
Since the oxovanadium complexes were highly insoluble in water and slightly soluble in CH3CN, 
the solvent used in the subsequent catalyzed reactions was changed to a mixture of CH3CN/water 
(1:1), rather than pure CH3CN to limit leaching from the polymer. The effect of the flow rate, fiber 
diameter and catalyst type on the reaction was investigated. Only PS-15/25-[VO(dpimMeO)2] and 
PS-15/25-[VO(dpimNO2)2] were studied, since [VO(dpimMeO)2] and [VO(dpimNO2)2] were the 
least and the most active homogeneous catalysts respectively. Restricting the study to these two 
catalysts would still show if the same trend in activity would exist, without additional unnecessary 
experiments.  
The reactant solution consisting of thioanisole, H2O2 and the solvent were passed through the 
fibrous mat at a f ew different flow rates. An increase in flow rate from 0.5 mL.h-1 to 1 mL.h-1 
resulted in an improvement in overall conversions but a further increase to 1.5 mL.h-1 resulted in a 
moderate drop in conversion and so subsequent reactions were performed at 1 mL.h-1 (table 5.7). 
The different diameters of the fibers (0.33 µm and 1.37 µm for PS-15-[VO(dpimMeO)2] and PS-
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25-[VO(dpimMeO)2] respectively, and 0.51 µm and 1.98 µm for PS-15-[VO(dpimNO2)2] and PS-
25-[VO(dpimNO2)2] respectively) had no observable effect on c atalytic activity and thus 
subsequent studies were performed using the PS-15-[VO(dpimR)2] fibers. As shown in figure 
5.33, PS-15-[VO(dpimNO2)2] showed good catalytic activity, with the conversion of thioanisole 
remaining above 93% over the 10 h ( or 10 m L) period studied. As was the trend with the 
homogeneous catalysts, PS-15-[VO(dpimMeO)2] was also slightly less active than PS-15-
[VO(dpimNO2)2] with conversions dropping to 87.7 % in the 10
th fraction. The greater activity of 
the NO2-substituted catalysts similarly resulted in slightly higher formation of the sulfone 
compared to the MeO-substituted catalyst, for the same reason as discussed for the 
homogeneous catalysts. When using un-functionalized polystyrene fibers (PS-25) a m aximum 
conversion of 22.9% was obtained on the last fraction confirming that the presence of the catalyst 
is crucial for these oxidation reactions. More data regarding the effect of the above mentioned 
conditions on selectivity and overall conversion may be found in table 5.7. 
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Figure 5.33 Oxidation of thioanisole under continuous flow conditions. Conditions: thioanisole (50 mM), 
H2O2 (100 mM), PS-15-[VO(dpimNO2)2] (0.01 g) and  PS-15-[VO(dpimMeO)2] (0.01 g) of 
catalyst in 1:1 CH3CN/H2O; flow rate (1 mL.h-1) and at 25 °C 
 
For both heterogeneous catalysts, the activity drops slightly after time and f or this reason the 
leaching of vanadium from the polymer was quantified. Each of the 1 m L product fractions 
collected from the continuous flow system were evaporated to dryness. The remaining residue 
was digested in 0.5 mL of nitric acid (UltraPure, 69%) for 24 hour s and d iluted with deionised 
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water to a total volume of 15 mL. This solution was passed through a Millipore filter (0.45 μM) and 
analysed by ICP-OES. An average of 3.8(±1.4)% of vanadium was lost in each fraction, thus 
about 38% of vanadium was leached from the polymer over the 10 h period. This also probably 
means that a l arge proportion of the observed activity can be c redited to the leached, 
homogeneous catalyst. UV/Vis studies suggested that the leached species was a v anadium(V) 
species (d0) due to the disappearance of the d-d transitions expected for a s quare pyramidal 
oxovanadium(IV) species (d1). This study confirmed our initial suspicions that leaching would be a 
major problem when relying on weak forces such as π-π stacking alone. However, this provided 
us with a benchmark upon which we could subsequently improve on. Thus, all subsequent studies 
were performed using covalently-linked systems.  
 
Table 5.7 Selected overall conversion and product selectivity data for the oxidation of thioanisole using 
homogeneous oxovanadium(IV) complexes (0.25 mol% wrt thioanisole) as well as the catalytic fibers PS-15-
[VO(dpimNO2)2] and PS-15-[VO(dpimMeO)2] (0.1 g of fibers) 
Homogeneous Catalysts 
Catalyst Sulfoxide (%) Sulfone (%) Max. Conversion (%) TOF (h-1)* 
[VO(dpimH)2] 61.3 38.2 99.7 600 
[VO(dpimBr)2] 63.9 35.9 99.9 800 
[VO(dpimMeO)2] 68.2 31.5 99.8 480 
[VO(dpimNO2)2] 54.1 45.8 99.9 2400 
Heterogeneous fibers - Continuous Flow 
Catalyst ν (mL.h-1) Sulfoxide (%) Sulfone (%) Avg.Conv (%) 
PS-15-[VO(dpimNO2)2] 1.0 65.9 31.92 95.8 
PS-15-[VO(dpimMeO)2] 1.0 67.9 25.46 92.8 
PS-15-[VO(dpimNO2)2] 0.5 61.9 32.33 94.3 
PS-15-[VO(dpimMeO)2] 0.5 65.5 27.79 93.5 
PS-15-[VO(dpimNO2)2] 1.5 66.3 19.36 85.7 
PS-15-[VO(dpimMeO)2] 1.5 62.9 19.20 82.1 
* Determined as moles of substrate converted/moles of vanadium/time (h) 
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(b) Catalytic activity of p(ST-co-VIM)-VO fibers 
Based on the high leaching of the PS-[VO(dpimR)2] fibers [5.5.3 (a)] and the promising results of 
the imidazole functionalized microspheres (Part 2, Chapter 4), covalently linked imidazole 
functionalized polystyrene-co-vinylimidazole copolymers were prepared as a s tarting point for 
improvement. As mentioned earlier, for a polymer to be electrospun, it must be soluble in some 
solvent or form a melt. This consequently means that the resultant fibers will be soluble in the 
same solvents unless some sort of post-electrospinning cross-linking strategy is utilized.49,50 For 
this reason methanol was selected as the solvent to be used in the fiber-catalyzed reactions since 
methanol did not dissolve or change the fiber morphology in any way. When placed in acetonitrile 
or even in an acetonitrile/water mixture however, these p(ST-co-VIM) fibers lost structural integrity 
as shown in the SEM image (figure 5.34). As demonstrated with the microspherical beads (Part 
2, Chapter 4), methanol was not an ideal solvent for the oxidation of thioanisole, and so this 
solvent choice was governed by solubility constraints. Other solvents were considered but since 
the polymer was soluble in several organic solvents (chloroform, dichloromethane, toluene etc), 
methanol was the preferred choice of solvent for the oxidation reactions with the polystyrene 
fibers. 
 
 
Figure 5.34 SEM image of deformed electrospun polystyrene fibers after being placed in acetonitrile 
 
For reasons discussed earlier (in 5.3.1), the fibers were applied in a continuous flow type reactor 
set-up rather than a batch set-up. The effect of the amount of catalyst packed into the syringe was 
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first investigated (figure 5.35). It was only at very low catalyst amounts (0.005 g) that any drop in 
activity was observed over the period studied. This drop in activity may have been due to leaching 
of the vanadium from the fibrous support material which would have had a m ore pronounced 
effect when using lower catalyst amounts - the leaching behaviour was studied and s hall be 
discussed later. Another possibility for the drop in activity may be due to saturation of the catalytic 
sites. 
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Figure 5.35 The effect of the amount of catalyst on overall conversion. Conditions: p(ST-co-VIM)-VO, H2O2 
(2 mmol), thioanisole (1 mmol), methanol (10 mL), flow rate (1 mL.h-1) and at 25 °C 
 
Besides catalyst amount, another important parameter to be c onsidered when conducting 
continuous flow reactions is the flow rate, i.e. the speed at which the reactant solution was passed 
through the catalyst bed. This was, in our case, carefully controlled using a s yringe pump. As 
shown in figure 5.36, the flow rate was varied between 1 mL.h-1 and 6 mL.h-1. At the higher flow 
rate, less time was available for the reactant solution to interact with the catalyst bed and this 
resulted in a s ignificant drop in activity at a f low rate of 6 m L.h-1. Furthermore, the selectivity 
shifted towards the formation of the sulfoxide as the flow rate increased (table 5.8). By altering 
the catalyst amount and f low rate one can begin to shift the selectivity to either the sulfoxide 
(lower catalyst amounts or higher flow rates) or the sulfone (low flow rate, high catalyst amounts) 
depending on which product is desired. A table summarizing these results has been included 
(table 5.8). 
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Figure 5.36 The effect of flow rate on overall conversion. Conditions: 0.025 g of p(ST-co-VIM)-VO, H2O2 (2 
mmol), thioanisole (1 mmol), methanol (10 mL) and at 25 °C 
 
Since the fiber-based catalysts still showed a drop in activity as time progressed (figure 5.35), we 
found it necessary to quantify the amount of vanadium leached from the fibers so that we could 
compare this with the non-covalently linked derivatives (PS-15-[VO(dpimR)2]). Each 1 mL fraction 
of product solution that was collected was concentrated to remove any organic solvent. After 
digesting the remaining residue in nitric acid and diluting appropriately, the vanadium content was 
determined by ICP-OES. In the first fraction about 1.2 (±0.05)% of vanadium was detected. This 
decreased and then stabilized at around about 0.41 (±0.02)% (figure 5.37) making up a total 
amount of 7.18% (after combining the 10 mL fractions). Although still relatively high, this 
represents a huge improvement over the non-covalently linked counterpart. 
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Table 5.8 Summary of reaction conversions and selectivities for p(ST-co-VIM)-VO catalyzed reactions under 
continuous flow set-up 
Mass (g) ν (ml.h-1) % Sulfoxide % Sulfone Average  conversion* 
Blanka 2 5.98 4.12 10.1 
0.005 2 63.8 29.0 92.9 
0.015 2 55.6 44.1 99.7 
0.025 2 55.3 44.4 99.9 
0.035 2 42.7 57.1 99.9 
0.025 1 39.7 60.1 99.9 
0.025 2 49.0 50.8 99.9 
0.025 4 56.1 43.6 99.7 
0.025 6 55.7 18.6 74.4 
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Figure 5.37 Vanadium leaching behaviour of p(ST-co-VIM)-VO. Conditions: p(ST-co-VIM)-VO (0.025g), 
thioanisole (1 mmol), H2O2 (2 mmol), methanol (10 mL), flow rate (2 ml.h-1)  (n = 3) 
 
(c) Catalytic activity of p(ST-co-VPIM)-VO fibers 
In an attempt to further reduce leaching, we decided to use a bidentate rather than a monodentate 
ligand in the hope that the additional chelate stability would improve leaching behaviour. The 
major issue was that the low solubility of the monomerized ligand resulted in a low incorporation in 
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the copolymer and t hus low vanadium content. Initial trials using the continuous flow method 
developed for the before-mentioned systems proved unsuccessful. The larger amount of polymer 
fibers did not sit comfortably within the syringe, but swelled substantially and eventually came 
adrift. A new and improved device was designed which involved packing the fibers into a small 
column rather than placing them loosely at the end of the syringe – the device has been illustrated 
in figure 5.38. Furthermore, this device made more sense from a reproducibility and commercial 
standpoint.50 Using this method under the optimized conditions gave excellent conversion 
throughout the 10 h period studied (figure 5.39). Reducing the mass of fibers from 0.1 g to 0.06 g 
resulted in lower, albeit fairly constant, conversions (figure 5.40). The fact that at this mass (0.06 
g) there was no successive drop in overall conversion suggests that the decreased conversion 
was due to the lack of catalyst rather than catalyst leaching. Nevertheless, the leaching behaviour 
was studied and a total of 3.52% over the combined 10 h period was determined. There was, 
therefore, some improvement over the monodentate p(ST-co-VIM)-VO system in which a t otal 
leaching of 7.18% was determined. A summary of the product selectivity and overall activity of 
p(ST-co-VPIM)-VO has been included in table 5.9. 
 
 
Figure 5.38 The modified column used in the continuous flow reactions, containing the p(ST-co-VPIM)-VO 
fibers (0.1 g) 
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Figure 5.39 Continuous flow oxidation of thioanisole using p(ST-co-VPIM)-VO. Conditions: p(ST-co-VPIM)-
VO (0.1 g), thioanisole (1 mmol), H2O2 (2 mmol), methanol (10 mL), flow rate (1 ml.h-1) and at 
25 °C 
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Figure 5.40 Continuous flow oxidation of thioanisole using p(ST-co-VPIM)-VO. Conditions: p(ST-co-VPIM)-
VO (0.06 g), thioanisole (1 mmol), H2O2 (2 mmol), methanol (10 mL), flow rate (1 ml.h-1) and at 
25 °C 
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Table 5.9 Summary of reaction conversions and selectivities for p(ST-co-VPIM)-VO catalyzed reactions 
under continuous flow conditions 
Continuous Flow 
Amount (mg)  ν (ml.h-1) Sulfoxide (%) Sulfone (%) Avg.Conv (%) 
60 1 60.92 18.96 79.6 
100 1 73.41 24.91 98.3 
 
(d) Catalytic activity of PBIf-VO fibers 
The significantly improved mechanical and chemical properties of the PBIf fibers allowed us to 
carry out stirred-batch reactions without too much concern about fiber disintegration. The batch 
method was studied first to allow for quick optimization of reaction conditions.  
The mass of the catalytically active fibers was varied from 0.010 g t o 0.050 g. This equates to 
approximately 1.0 to 5.3 mol% of vanadium relative to thioanisole, respectively. At all catalyst 
masses, near quantitative conversions were obtained with TOF’s of 88.39, 36.70 and 36.71 h-1 for 
0.010 g, 0.025 g an d 0.050 g r espectively. At the higher mass (0.050 g) however, the reaction 
was nearly complete in just 30 mins compared to 1 hour at the lower masses (0.010 and 0.025 g) 
(figure 5.41). When the oxovanadium-functionalized nanofibers were substituted with the un-
functionalized PBI nanofibers (PBIf), a maximum conversion of 9.12% was observed after 90 
mins, illustrating the catalytic effect of vanadium. The recyclability of the fibers was also 
investigated as shown in figure 5.42. An initial drop in activity was observed after the first cycle 
following which the conversion remained fairly constant. The leaching data corresponds quite well 
to this trend, with an initial leaching of 7.29% vanadium after the first reaction, followed by 
leaching of between 0.52 - 0.69% in the subsequent cycles, a similar trend to that observed by 
others.52 
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Figure 5.41 Effect of catalyst amount for the batch oxidation of thioanisole using PBIf-VO. Conditions: PBIf-
VO, thioanisole (1 mmol), H2O2 (2 mmol), acetonitrile (20 mL), and at 25 °C 
 
Despite the improved mechanical stability of the PBI fibers compared to the polystyrene-based 
fibers, after a few successive runs there was some catalyst break-up. The fine paper-like texture 
of the nanofiber mat was undeniably more suited to a continuous flow system rather than being 
subjected to mechanical agitation. 
Time (mins)
0 10 20 30 40 50 60 70 80 90
%
 C
on
ve
rs
io
n
0
20
40
60
80
100 Run 1Run 2
Run 3
Run 4
 
Figure 5.42 Recyclability for the batch oxidation of thioanisole using PBIf-VO. Conditions: PBIf-VO (0.05 g), 
thioanisole (1 mmol), H2O2 (2 mmol), acetonitrile (20 mL), and at 25 °C 
 
262 
 
 
Part 2. Chapter 5 
Once again the method in which these fibers were applied was different to the other fiber-based 
catalysts. The more paper-like (rather than cottonwool-like for the polystyrene-based systems) 
texture of the PBIf-VO fiber mat forced us to modify the continuous flow device. A Millipore filter 
holder proved to be an excellent holder for these fibers, and allowed them to be tightly compacted 
which was necessary since these fibers did not swell as much as the polystyrene-based fibers.  
Since the larger mass of fibers (0.050 g) gave faster initial conversion under batch conditions 
(figure 5.41), this mass was used for the continuous flow reactions. As shown in figure 5.43, 
excellent conversion of thioanisole was obtained over the tested period. At flow rates of between 
0.5 – 2 mL.h-1, > 98% conversion was achieved. Furthermore, the product selectivity could be 
tuned by changing the flow rate. At a flow rate of 0.5 mL.h-1, for example, the ratio of 
sulfoxide/sulfone was 0.41, while at a higher flow rate of 4 mL.h-1 this shifted to 2.13, along with a 
slight drop in overall conversion (table 5.10). For comparative purposes, aliquots were withdrawn 
from the syringe before the reactant solution had passed through the catalyst bed, representing 
the un-catalyzed reaction. In the 5th,10th and 20th fraction, a conversion of 9.0%, 9.3% and 9.4% 
respectively, was observed. This clearly demonstrated the success of the catalyst.  
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Figure 5.43 Continuous flow oxidation of thioanisole using PBIf-VO. Conditions: PBIf-VO (0.05 g), 
thioanisole (50 mM), H2O2 (100 mM) in acetonitrile, flow rate (1 mL.h-1) and 25 °C 
 
Leaching under continuous flow conditions was also monitored. Here, each of the individual 
fractions was combined, concentrated and diluted appropriately. Between 0.376% - 0.808% 
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vanadium leaching (combined over 10 mL) was recorded depending on the reaction conditions. 
This was by far the lowest leaching of all the fiber-based catalysts. 
 
Table 5.10 Summary of reaction conversions and selectivities for PBIf-VO catalyzed reactions under batch 
and continuous flow conditions 
Batch Reaction 
Amount (mg) Sulfoxide (%) Sulfone (%) Max. Conversion (%) TOF (h-1)* 
50 67.23% 32.72% 99.95% 36.7 
50a 68.03% 31.44% 99.47% 18.3 
50b 70.36% 28.90% 99.27% 18.1 
50c 70.39% 28.51% 98.90% 17.7 
25  68.23% 30.95% 99.18% 36.7 
10  50.99% 47.99% 98.99% 88.4 
Continuous Flow 
Amount (mg)  ν (mL.h-1) Sulfoxide (%) Sulfone (%) Avg.Conv (%) 
50 0.5 28.88 69.79 98.68 
50 1.0 31.62 67.54 99.00 
50 2.0 40.65 58.64 99.20 
50 4.0 63.29 29.78 92.83 
aAfter one catalytic run; bAfter a second run’ cAfter a third run; * Determined as moles of substrate converted / moles of 
vanadium / time (h) 
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5.6 Conclusions 
The initial hypothesis when beginning this work was that reducing the diameter of the support 
material would result in higher surface areas and hence improved catalytic performance (i.e. when 
going from microspheres to fibers). However, the more delicate nature of the fibers (specifically 
the polystyrene-based fibers) meant that the simple batch reaction set-up that was used for the 
beads could not be applied to the fibers which disintegrated upon stirring. It was immediately 
apparent that direct comparison of the two different materials could not be performed due to the 
different reactor set-ups. The effect of fiber diameter did not seem to play a major role and thus 
was not thoroughly studied. Nevertheless, the ultrafine, flexible and porous structure of the fiber 
mats was highly suited to a c ontinuous flow set-up and under optimized conditions, excellent 
conversion of thioanisole was attained throughout the period tested. Leaching of vanadium from 
the support was reduced by covalently linking the ligand to the support rather than relying on the 
comparatively weaker vd Waals forces and pi -stacking. Further improvements to leaching were 
observed when incorporating a bidentate ligand, although the lowest leaching was observed using 
polybenzimidazole fibers as support material. These gold coloured fibers were the “gold standard” 
in terms of mechanical, chemical and thermal stability. These properties in cahoots with the metal-
coordinating nature of the benzimidazole group make this material an ideal support, not only for 
vanadium, but for a range of metals or metal nanoparticles.  
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Chapter 6  
Conclusions and future work 
 
6.1 Conclusions 
In this study, a r ange of new catalytically active VHPO-inspired oxovanadium(IV) functionalized 
materials were prepared and characterized. The Merrifield-based catalysts (Part 2, Chapter 3) 
demonstrated promising catalytic activity for the hydrogen peroxide facilitated oxidation of 
thioanisole, styrene and ethylbenzene. The harsh conditions required for achieving high 
conversions of the latter two substrates, resulted in degradation of the support material. For 
thioanisole, however, excellent conversions were obtained under milder conditions and the 
catalysts also demonstrated a high degree of recyclability.  
Suspension polymerization was then used to create a ne w metal-coordinating resin (Part 2, 
Chapter 4). These imidazole-bound, rough-surfaced microspherical beads had significantly higher 
surface areas than the Merrifield-based beads. Despite this, however, there was very little 
difference in catalytic activity between the two types of beads. Nevertheless, these beads also 
showed good catalytic activity for the oxidation of thioanisole with excellent recyclability and 
mechanical stability. 
Fibers were then fabricated by electrospinning (Part 2, Chapter 5). These fibers had small 
diameters and thus a large exposed catalytic surface area, but are comparatively long and form a 
web-like mat. This makes these materials very easy to separate from the reaction solution. The 
polystyrene-based fibers, however, proved to have limited mechanical stability under the agitation 
of a mechanical stirrer but were very successfully applied under continuous flow conditions. Near 
quantitative conversions were obtained over a r easonable time period. Leaching of vanadium 
from the support was reduced by incorporating a bidentate ligand instead of the monodentate 
imidazole ligand. The limited mechanical and chemical stability of the polystyrene-based fibers 
was then overcome by using polybenzimidazole fibers. This material proved to be ideal, not only 
was this polymer thermally, mechanically and chemically more robust, but it contained a large 
270 
 
 
Part 2. Chapter 6 
number of coordinating benzimidazole groups allowing for a high metal loading compared to the 
other copolymers. This work represents one of the first instances of using oxovanadium(IV) 
functionalized electrospun fibers as heterogeneous catalysts.  
 
Generally, the crosslinked beads displayed better mechanical robustness than the electrospun 
fibers. For this reason the fibers were less suited to the stirred-batch reactions. On the other hand, 
the flexibility and porous three dimensional mat structure of the fibers was more suited to 
continuous flow processes. The differences in surface area between the materials did not seem 
have a significant effect on overall catalytic activity. 
 
6.2 Future work 
Electrospun fibers have excellent properties for use as a catalyst support material, as they have 
extremely small diameters but are easily separable from solution. As shown in this study, these 
fibers are especially well suited for use under continuous flow conditions. However, since linear 
polymers are required to prepare the electrospinning solution, solubility and mechanical 
robustness of fibers proved to be a challenge. In the future, this could be addressed by 
electrospinning a more chemically and mechanically stable polymer (such as nylon) followed by 
grafting the necessary coordinating functionality to the fibers. In this way, high levels of 
coordinating moieties could be introduced without compromising the mechanical and chemical 
stability of the material. Another approach involves post-electrospinning crosslinking. This would 
dramatically improve the chemical stability properties of the material but could make it more 
brittle. Nevertheless, there certainly remains some room for improvement in terms of stability of 
the material. 
Based on the work in this study, it is believed that a tetradentate rather than mono or bidentate 
ligands, could improve the leaching characteristics of the metal. In addition, using a tetradentate 
ligand would result in a coordination environment more similar to the homogeneous derivative and 
allow for easier comparison between the two. 
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The imidazole-functionalized electrospun fibers prepared in this study were used to immobilize 
oxovanadium(IV), however, several other transition metals could be immobilized in the same way. 
Thus, several other metal-catalyzed reactions could be c arried out using the same materials 
prepared herein, with only slight modifications in the final synthetic step. In addition, the use of 
imidazole-containing beads for removal of heavy metals is widespread. These imidazole-
functionalized fibers, with their unique properties, could similarly be used for such applications.  
 
